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Background: Managing articular cartilage lesions is a significant clinical 
problem, due to the poor self-regenerative capacity of avascular, aneural 
cartilage.  Cartilage equivalents derived from mesenchymal stem cell (MSC) 
based approaches are found to suffer from inferior biochemical content and 
mechanical strength, when compared with native tissue properties. Since cell-cell 
and cell-extracellular matrix (ECM) interactions greatly influence the 
development and maintenance of chondrogenic phenotype, variations in 
biochemical composition of three-dimensional (3D) matrices have been 
investigated due to its economic yet efficacious role in influencing regenerative 
outcomes. Yet, there is limited understanding on how such biochemical cues 
influence cellular processes and function. Further, current tissue engineering 
approaches are limited in their ability to recapitulate the zonal cartilage 
phenotypes and variations in ECM properties of native cartilage, as such 
hierarchical heterogeneity is critical for tissue function. Thus, this study aimed at 
studying the influence of different biochemical microenvironments on MSC 
chondrogenesis, to augment current regenerative approaches. To this end, a 
chitin-alginate based 3D, fibrous hydrogel, developed using an interfacial 




Hypothesis: The main hypothesis is that modulating biochemical composition of 
3D microenvironments can lead to improvement of MSC based approaches for 
cartilage repair. 
Methods: To verify the above hypothesis, a step-wise approach was designed, as 
follows: 
 To establish chondrogenic differentiation of MSCs in vitro in IPC-based 
fibrous hydrogels. 
 To understand the influence of IPC mediated biochemical cue presentation 
on MSC chondrogenesis. 
 To study the influence of different biochemical cues in modulating zonal 
chondrogenic phenotypes. 
 To compare chondrogenic outcomes using MSC or culture-expanded 
chondrocytes with IPC-based approaches for cartilage regeneration. 
 
Results: In this study, we demonstrated that IPC-based fibrous hydrogels 
supported MSC chondrogenesis and offered a mechanically compliant 
microenvironment that sustained the proliferation of the chondro-differentiated 
MSCs. Varying biochemical compositions had distinct effects in influencing the 
phenotypic outcomes of MSC chondrogenesis. IPC-control hydrogels facilitated 
superficial zone like phenotype due to chitin-alginate backbone, with IPC-CS 
hydrogels demonstrating derivation of a middle zone cartilage phenotype through 
enhanced ECM assembly.  Significantly, the submicron alignment of collagen 
type I (Col I) in IPC hydrogels was found to facilitate superior chondrogenesis by 
xii 
 
mediating early and uniform cell-cell interactions, resulting in generation of a 
mature, mid-deep zonal neocartilage, likely through N-cadherin/β-catenin 
mediated intracellular signaling events. IPC-HA hydrogels were found to 
facilitate a hypertrophic, deep zone-like cartilage phenotype, with heightened Col 
X expression. Lastly, MSCs and culture-expanded chondrocytes were found to 
differ in their need for optimal microenvironmental niche, to result in hyaline 
cartilage phenotype. Col I induced changes in chondrocyte morphology and 
concomitant loss of rounded chondrocyte morphology impaired development of 
hyaline cartilage phenotype, whereas Col I induced dynamic changes in MSC 
morphology was found to be vital for robust chondrogenesis. 
 
Conclusion: Collectively, these results demonstrated the significant potential of 
varying biochemical cues in IPC-based hydrogels to modulate the functional 
phenotype of chondrogenic differentiation outcomes. Such knowledge would 
enable tailoring optimal matrix microenvironments for MSC based approaches in 
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Articular cartilage is an avascular, aneural musculoskeletal tissue that is essential for smooth 
articulation of diarthrodial joints.  Articular cartilage lesions due to trauma or disease represent 
a significant challenge for clinical management, owing to the poor regenerative capacity of 
avascular cartilage. The quality of cartilage repair resulting from existing surgical or clinical 
approaches remains suboptimal (Keeney et al., 2011, Aigner and Stove, 2003). Thus 
regenerative approaches for articular cartilage regeneration have been widely investigated 
(Ahmed and Hincke, 2010, Hunziker, 2009). But autologous chondrocyte based approaches are 
found to offer only symptomatic relief and result in functionally inferior fibrocartilage 
formation (Huang et al., 2010a, Huang et al., 2010b, Keeney et al., 2011). Further, concerns 
arising from chondrocyte based approaches include, donor site morbidity, variations in 
chondrogenic potential of isolated cells, and loss of phenotype during ex vivo propagation 
(Schnabel et al., 2002, von der Mark K, 1977), which have warranted the use of more 
efficacious alternates. Thus stem cell based approaches have been explored for articular 
cartilage repair to address such shortcomings (Ahmed and Hincke, 2010, Hunziker, 2009).  
Bone marrow-derived mesenchymal stem cells (BMSCs) are known to present an 
attractive cell source, due to their autologous origins, scalability, and potential for chondrogenic 
differentiation in vitro (Keeney et al., 2011, Kock et al., 2012). Yet, the biochemical and 
mechanical properties of neocartilage derived using MSCs are known to be inferior in 
comparison with both native tissue properties, and chondrocyte derived neocartilage (Erickson 
et al., 2012, Huang et al., 2010b, Keeney et al., 2011). Another noted shortcoming is the 
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inability of tissue engineering approaches to recapitulate the zonal cartilage phenotypes and 
variations in extra-cellular matrix (ECM) properties of native cartilage, as such hierarchical 
heterogeneity is critical for tissue function (Keeney et al., 2011). Thus addressing the 
suboptimal quality of engineered neocartilage using stem cell based approaches is pivotal in 
improving functional articular cartilage repair, which is the main subject matter of study in this 
thesis.  
                   Recent progress in tissue engineering paradigm has highlighted the decisive role of 
biochemical and biophysical factors, in influencing cell fate and function (Discher et al., 2009, 
Lutolf et al., 2009). Modulating biochemical composition of three-dimensional (3D) matrices 
has been ardently investigated due to its economic yet efficacious role in influencing 
regenerative outcomes (Hwang et al., 2011, Nguyen et al., 2011a, Nguyen et al., 2011b, Coates 
et al., 2012). Such approaches are especially relevant for articular cartilage tissue engineering, 
as cell-ECM interactions are vital for the development and maintenance of chondrogenic 
phenotype (DeLise et al., 2000). Recent reports involving PEG, alginate based hydrogels for 
engineering biomimetic 3D matrices by incorporating biochemical cues have demonstrated 
improvements in refining the ECM characteristics of neocartilage generated. Yet, they are 
limited in their ability to facilitate cellular migration, cell-cell, and cell-ECM interactions, and 
uniform ECM distribution that are vital for engineering functional cartilage tissue equivalent. 
Thus, exploring new strategies to fabricate functionalized 3D matrices that facilitate dynamic 
cellular, cell-ECM interactions could address such shortcomings, and broaden our     




Thus, the main aim of this thesis was to study  the effects of various biochemical cues 
on early cellular events during MSC chondrogenesis, and their functional outcomes, employing 
an improved hydrogel-based strategy for articular cartilage tissue engineering. The central 
hypothesis of this thesis was that by modulating biochemical compositions of conducive  3D 
matrices, it would aid the identification of optimal microenvironmental cues, to derive 
functionally superior and phenotypically distinct neocartilage outcomes. To this end, a chitin-
alginate based 3D, fibrous hydrogel, developed using an interfacial polyelectrolyte 
complexation  (IPC) based  approach  was employed. An IPC-based approach offered easy, yet 
efficient method for engineering microscale fibers with varying biochemical environments that 
could be assembled to form 3D hydrogels (Tai et al., 2010, Wan et al., 2004). Further, the 
cellular encapsulation in such ECM-mimicking fibers at physiological conditions, and the 
facilitation of higher cell/ECM interactions suggests significant advantages over conventional 
hydrogel systems (Leong et al., 2013, Lu et al., 2012).  A step-wise approach was adopted to 
study the influence of biochemical cues in improving MSC based chondrogenic outcomes with 
the following objectives; 
 
1.1 Objectives 
 To establish chondrogenic differentiation of MSCs in vitro in IPC-based fibrous 
hydrogels. 
 To understand the influence of IPC mediated biochemical cue presentation on MSC 
chondrogenesis. 




 To compare chondrogenic outcomes using MSC or culture-expanded chondrocytes with 
IPC-based approaches for cartilage regeneration. 
 
Thus the ultimate goal was to study various biochemical cues that would aid in tailoring 
optimal matrix properties of neocartilage generated in vitro, to augment current approaches for 
cartilage tissue engineering. Such studies could ultimately aid in refining the quality and 






2.  LITERATURE REVIEW 
2.1 Articular Cartilage 
Articular cartilage is a highly resilient, musculoskeletal connective tissue that provides a low-
friction, wear resistant, load-bearing surface for efficient joint movement. This chapter 
discusses various aspects of articular cartilage, from its developmental biology, tissue properties 
and function, followed by the need for intervention strategies and current approaches for 
cartilage repair, before concluding with current unmet needs in tissue engineering and potential 
of IPC-based approaches for articular cartilage regeneration 
 
2.1.1 Biology and development of articular cartilage 
Articular cartilage is derived from the lateral plate mesoderm through an orchestrated 
process called chondrogenesis, with overlying limb ectoderm aiding the maintenance of 
developing limb bud (DeLise et al., 2000). Chondrogenesis is initiated by stimulation of 
mesenchymal progenitors, followed by cellular condensation and differentiation to 
chondrocytes, with associated extra-cellular matrix (ECM) secretion. Proliferation signals from 
apical, ectodermal ridge, to undifferentiated mesenchymal cells in the lateral plate mesoderm, 
initiate embryonic chondrogenesis (Las Heras et al., 2012). Prior to condensation, the 
mesenchymal ECM is rich in hyaluronan, Collagen type I (Col I). Every stage of mesenchymal 
differentiation leading to chondrocytes is associated with characteristic cytokines, molecular 
and cellular events driving modifications in cell morphology, proliferation, and metabolism, 
such as synthesis of specific ECM molecules (DeLise et al., 2000, Las Heras et al., 2012, 
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Goldring et al., 2006). Sox9 is the first transcription factor to be expressed by chondroblasts, 
followed by aggrecan and Col II expression during chondrogenic condensation and 
commitment, involving N-cadherin and Neuronal cell adhesion molecule (N-CAM)-mediated 
cellular interactions. Subsequently, chondrocytes enter proliferative stage, with decreased N-
cadherin, N-CAM expression and increased cyclin D1 expression, associated with cartilage 
oligomeric matrix protein (COMP), Col IX upregulation. Transforming growth factor-beta 
(TGF-β) family of growth factors, with fibroblast growth factors (FGFs)-2,4,8,10 and bone 
morphogenetic proteins (BMPs)-2,4,7, together with wingless integrated (Wnt)/β-catenin 
pathway are implicated in the aforementioned differentiation events. Such changes are also 
paralleled by dynamic morphological changes, with an elongated, fibroblastic mesenchymal 
progenitor adopting a rounded morphology during condensation, wherein the nuclear-
cytoplasmic ratio changes in subsequent stages of chondrogenic development.  Such a complex 
and tightly orchestrated interplay of several cellular events and cytokines are illustrated in  
Fig. 1.  
Growth of articular cartilage involves appositional and interstitial mechanisms. 
Appositional mechanism involves perichondrial ECM synthesis leading to tissue thickening, 
while interstitial growth causes proliferation of chondrocytes, secreting furthermore ECM to 
form inter-territorial matrix (DeLise et al., 2000, Las Heras et al., 2012). Significant differences 
exist between pre- and post-natal articular cartilage tissue. Articular cartilage is thicker with 
vascular canals at birth and forms a majority of epiphysis, which become thinner and avascular 
with growth and development (Las Heras et al., 2012). At birth, it forms a cap over the 
epiphyseal articulating ends, but with further growth and development epiphyseal component is 




The development of articular–epiphyseal cartilage forming the stable, permanent 
articular cartilage within the synovial joints involves complex, multistep processes, which 
remain to be fully understood.  The initial step is termed joint determination, involving 
commitment of skeletogenic cells to articular fate. Articular progenitor cells originate from the 
same mass of mesenchymal cells as in growth plate cartilage, but are found at the periphery of 
the cartilage anlagen (Gadjanski et al., 2012). Such precursor cells are thought to have a distinct 
molecular expression, including the sustained expression of master-regulator of chondrogenesis, 
Sox9, along with TGF-β receptor-2 (TGFβr2), growth differentiation factor-5 (GDF5) canonical 
Wnt ligands (Wnt4, Wnt9a/14, and Wnt16) (Hartmann et al., 2001, Spagnoli et al., 2007). 
These molecules aid in the development of permanent articular chondrogenic fate (Guo et al., 
2004, Seo et al., 2009), in contrast to transient growth plate cartilage that undergo hypertrophy 
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and are eventually replaced by bone. Further, the distinct TGFβr2/Wnt/GDF5 signaling cascade 
leads to the formation of presumptive joint regions called interzones, at the future joint site 
between two cartilaginous skeletal elements (Archer et al., 2003, Khan et al., 2007). Interzone 
is comprised of elongated cells sandwiched by cartilaginous anlagen with upregulated ERG 
(Erythroblast transformation- specific related gene), CD-44, Col IIa and Col I expression 
(Iwamoto et al., 2007, Koyama et al., 2008, Pacifici et al., 2006).  Such cells are perceived to 
commit into articular chondrogenic fate, followed by joint morphogenesis (Nagy et al., 2011). 
This involves cavitation within the interzone (Archer et al., 2003, Ito and Kida, 2000), with the 
developing joint capsule connecting the cartilaginous elements (Merida-Velasco et al., 1997), 
succeeded by further development of joint structures (Khan et al., 2007). Subsequent to 
articular chondrocyte formation at the epiphyseal ends of long bone anlagen, various molecular 
signaling mechanisms, together with the local microenvironment, are known to aid in the 
longevity and phenotypic stability of articular cartilage, and prevent hypertrophy (Becerra et al., 
2010, Enomoto-Iwamoto et al., 2001, Pitsillides and Beier, 2011, Poole, 2003). They include 
higher  gene  expression  of  Proteoglycan-4 (PRG-4),  Tenascin C (TNC), Gremlin 1 
(GREM1), ERG, Abl interactor family member (ABI3BP), Thrombospondin-4 (THBS4), 
Dickkopf-1 (DKK-1), and Sine-oculis-related homeobox transcription factor (SIX1) and 
Frizzled-related protein (FRZB),  with sustained, concomitant downregulation of hypertrophic 
genes, such as  Col X, Alkaline phosphatase (ALP),  and Parathyroid hormone-like 
hormone receptor (PTH1R) (Hissnauer et al., 2010, Leijten et al., 2012). Further, the 
characteristic feature of articular cartilage is the non-penetration of vasculature, even in its 
deeper, calcified zones, while deep zones of growth plate is invaded by blood vessels and 
osteoclasts.         
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2.1.2 Structure, composition, and function of articular cartilage 
Articular cartilage is a load bearing musculoskeletal tissue, found in synovial joints, which 
enables their smooth articulation. It is also termed ―hyaline cartilage‖, owing to its white, glossy 
macroscopic appearance. Hyaline cartilage has predominantly liquid content (mainly water and 
synovial fluids) for 70-80% of its wet weight, whereas collagenous proteins, such as Col II 
account for 70-80% of its dry weight (Hayes et al., 2007). sGAGs  such as hyaluronic acid 
(HA), chondroitin-sulfate (CS), and  proteoglycans (PGs) such as aggrecan, contribute to 25% 
of its dry weight. Articular cartilage is sparsely populated by chondrocytes (<5% of dry weight), 
underscoring the vital, ECM- dependent nature of articular cartilage, for maintaining its 
physiological function. Mechanical properties of articular cartilage include, tensile strength, 
ranging from 5-25 kPa, a shear modulus of 0.1 to 4 MPa, and compressive modulus of 0.08-
2MPa, with an aggregate modulus of 800 kPa (Coates and Fisher, 2010, Hayes et al., 2007). 
The ECM properties display hierarchical, depth-dependent differences within the tissue, which 
synergistically facilitate normal tissue function (Fig. 2) (Aigner and Stove, 2003, Coates and 
Fisher, 2010, Keeney et al., 2011, Little et al., 2011). The outermost or superficial zone makes 
up 10-20% of the tissue thickness and is the most cellular zone, with closely packed, flattened 
chondrocytes that are arranged parallel to the joint surface in Col I rich matrix. It is also 
characterised by presence of zone specific components such as proteoglycan-4 (PRG-4), 
clusterin, and is the only zone to contain Col I. Superficial zone exhibits highest tensile and  
shear properties and elastic modulus, with least compressive properties, and is pivotal for 




The middle and deep zones make up the bulk of the tissue, with less cellularity and Col II, but 
higher PG and sGAG content, than the superficial zone. The middle or transitional zone makes 
up 40-50% of tissue thickness and is rich in aggrecan, HA, link-protein, and is characterised by 
randomly organised Col II fibers, with rounded cells. COMP and cartilage intermediate layer 
protein (CILP), together with Col IX represent unique components of middle zone, with 
associated increase in compressive properties and concomitant decrease in tensile and elastic 
properties.  
The deep zone which makes up 30-40% of tissue thickness, is characterised by highest 
sGAG and lowest Col II content, with columnar chondrocytes. Chondrocytes occur in a lacuna, 
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surrounded by their own pericellular matrix, which serves to cushion the cells against 
mechanical forces such as loading or compression. Col II fibers occur in a perpendicular 
fashion with deep zone-specific decorin expression and Col X expression in 
hypertrophic/calcified zone. Deep zone has the highest compressive and least tensile and elastic 
properties and it leads to the subchondral zone. Thus the cellularity and biochemical 
composition taken together with the varying mechanical characteristics serve to facilitate the 
mechanical functions of articular cartilage. 
 
2.1.3 Damage to cartilage and need for intervention 
Damage to cartilage can occur from natural ageing, trauma (acute), and disease conditions 
(chronic) such as osteoarthritis (OA). Acute, articular cartilage injuries have a predominantly 
traumatic basis, with higher incidence among young athletes and in the elderly populations. On 
the other hand, OA leads to cartilage degeneration, referring to loss of articular cartilage from 
the joint surfaces, leading to inflammation, pain, thus restricting mobility (Temenoff and Mikos, 
2000). Due to the poor self-regenerative capacity of articular cartilage, even acute cartilage 
lesions can progressively degrade causing mechanical joint instability and OA (Buckwalter and 
Mankin, 1998, Hunziker, 2002). Musculoskeletal disorders are leading cause of disability 
globally, and are a large burden to the national healthcare system. Treatment of musculoskeletal 
disorders in USA, cost $850 million dollars in 2004, comprising 7.7% of its GDP (Adam, 
2012). Since this thesis concerns with regenerative approaches for treating acute chondral 
injuries, further sections are discussed in accordance with this.  Damage to articular cartilage 
can be classified into partial or full thickness defects (Brittberg and Winalski, 2003). Partial 
thickness defects are limited to articular cartilage tissue, without the involvement of 
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subchondral bone, thus limiting supply of blood and mesenchymal progenitors to the injury site 
and limit natural healing. Full thickness defects involve both cartilage and subchondral bone 
and have a natural tendency to heal due to blood, mesenchymal stem cells, and cytokines from 
bone marrow that occupy the repair site. Yet, the quality of repair is known to fibrocartilaginous 
and does not restore hyaline tissue, impairing normal function (Hunziker, 2009, Keeney et al., 
2011, Kock et al., 2012, Kuo et al., 2006). Since articular cartilage lacks self-regenerative 
capacity, various clinical and cellular approaches have been explored which will be addressed 
in the following sections. 
 
2.2    Current clinical methods and limitations for articular cartilage repair  
This section addresses the clinical approaches for management of acute chondral defects and 
associated shortcomings. Broadly, clinical approaches for treating cartilage defects fall under 
three categories:  namely, palliative, reparative, and restorative techniques. Palliative techniques 
such as debridement, chondral shaving, and joint lavage have been reported clinically, either 
independently or in combinations (LaPorta et al., 2012). They serve to facilitate better neo-
tissue integration with host tissue, but do not restore tissue properties or function (Siparsky et 
al., 2007). They offer mere symptomatic relief and palliative benefits for older patients, such as 
pain relief and improved mobility (Hui et al., 2012). They are limited by the morbidity to 
perimeter, healthy cartilage tissues and do not account for long-term repair (Hunziker and 
Quinn, 2003). 
 Reparative, marrow stimulation techniques followed in the clinic include microfracture 
chondroplasty, abrasion arthroplasty, subchondral drilling, and spongialization. The underlying 
principle for subchondral drilling and spongialization involves the stimulation of spontaneous 
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tissue healing by stimulating bleeding (Hunziker, 2002). As its name suggests, subchondroal 
drilling refers to drilling holes into subchondral bone beneath the damaged cartilage tissue, 
which was first conceived by Pridie in 1959  (Insall 1974, Muller et al., 1990). Such 
intervention is now the treatment of choice for managing painful osteoarthritic conditions, such 
as osteochondritis dissecans. Spongialization is applied predominantly for managing localized 
patellar defects (Ficat et al., 1979), involving complete removal of subchondral plate together 
with diseased tissue, to expose the ―spongiosa‖ or cancellous bone. Its few potential benefits 
coupled with aggressive tissue morbidity make it a less attractive modality (Oberlander et al., 
1998). But microfracture has now become the method of choice, replacing the two approaches 
for managing chondral lesions.  Microfracture was first described by Steadman et al. (2002), 
involving surgical creation of multiple perforations that are 3-4mm apart in the subchondral 
bone, to populate the defect site with blood and mesenchymal stem cells from the bone marrow. 
It is commonly used for managing small chondral defects in younger patients, but is associated 
with inferior outcomes in managing large defects, as a standalone procedure with inferior 
outcomes both in athletes and elderly patients (Goyal et al., 2013b). Abrasion arthroplasty 
involves removal of dead bone to expose vasculature and facilitate blood clot formation and 
cartilage attachment (LaPorta et al., 2012). But all the above approaches result in mechanically 
inferior fibrocartilage formation with progressive deterioration in the long term. 
 Restorative techniques that have been reported in clinical management of cartilage 
defects include mosaicplasty, osteochondroal grafting and autologous chondrocyte implantation 
(ACI). Osteochondral grafting and mosaicplasty are employed for management of cartilage 
defects by transfer of hyaline-tissues, such as osteochondral auto/allo-grafts from non-weight 
bearing regions (Gomoll et al., 2010, Hui et al., 2012). The merits of such approaches include 
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pain relief, shorter rehabilitation duration and improved function in full thickness defects (1-5 
cms) in a single stage surgical procedure (Peterson et al., 2003). Limitations include donor site 
morbidity, availability and immunocompatibility of grafts and graft integration (Hui et al., 
2012, LaPorta et al., 2012). ACI was  first described by (Brittberg et al., 1994) for management 
of large chondral defects, aimed at functional, hyaline restoration of articular cartilage. It 
involves isolating healthy chondrocytes from the non-weight-bearing part of the knee via 
arthroscopy and ex vivo, culture expansion of primary chondrocytes. It uses a periosteal flap 
taken from the tibia to cover the chondral defect under which the expanded chondrocytes are 
injected. Varying success rates have been reported, but average long-term results have not been 
satisfactory (Kock et al., 2012, LaPorta et al., 2012). A Cochrane review analyzing six 
heterogenous trials involving 442 patients stated insufficient evidence for establishing the 
efficacy of ACI for treating full thickness articular cartilage defects in the knee (Vasiliadis and 
Wasiak, 2010). Limitations associated with ACI include the requirement for two-stage surgery, 
availability of healthy chondrocytes, phenotypic loss during ex vivo expansion, donor site 
morbidity, and graft complications that include hypertrophy, delamination and failure (Hui et 
al., 2012, LaPorta et al., 2012). A matrix induced ACI (MACI) has been developed to address 
limitations with ACI such as uneven chondrocyte distribution, graft complications, and donor 
site morbidity (Muller-Rath et al., 2007, Zheng et al., 2007). It involves seeding culture 
expanded autologous chondrocytes from non-weight bearing regions onto a porcine collagen 
I/III matrix, which is cultured with autologous serum for 3 days.  Subsequently, the cell-loaded 
surface is fitted into the defect, facing the subchondral bone. Comparative studies have shown 
MACI to be slightly more beneficial, albeit an expensive alternate over ACI (Behrens et al., 
2006, Goyal et al., 2013a). A common limitation with the clinical outcomes in all the 
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aforementioned procedures is the fibrocartilaginous tissue formation, instead of functional, 
hyaline tissue (Hui et al., 2012, Keeney et al., 2011, Kock et al., 2012, LaPorta et al., 2012). 
This is a significant shortcoming as fibrocartilage is associated with inferior mechanical and 
biological properties and the repair tissue degrades with physiological loading and time, 
resulting in progressive, permanent degradation of tissue structure, symptomatology and 
dysfunction (Ahmed and Hincke, 2010). These have led to the exploration of stem cell -based 
approaches for facilitating functional repair of articular cartilage tissue. 
 
2.3 Cartilage tissue engineering 
Despite advances in clinical and surgical treatment for managing cartilage defects,   the lack of 
a reliable method for consistent, superior repair of cartilage defects has resulted in a greater 
interest in tissue engineering. The tremendous growth in regenerative medicine post the ACI 
era, exploring alternative cell sources, biomaterial platform technologies, and manipulative 
strategies for altering molecular and functional outcomes, have been combined with the  
objective to develop a hyaline, functional tissue engineered cartilage equivalent. The following 
review addresses such developments in treating articular cartilage defects, including cell 
sources, biomaterial choice, growth factor-based methods for optimising functional tissue 
regeneration and current limitations that are addressed in our study. 
 
2.3.1 Requirements and characteristics of engineered tissue construct 
This section is focussed on the tissue engineering triad pertaining to articular cartilage 
regeneration, involving cells, scaffolds, and cytokines. An ideal tissue engineering strategy 
should entail a cell source that can proliferate and produce tissue-specific ECM, but necessitates 
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the use of growth factors to direct cells in the appropriate pathway of growth and 
differentiation. Engineering articular cartilage also requires a three-dimensional (3D) 
environment, as  microenvironment-driven cell-cell, and cell-ECM interactions play an 
important role in differentiation commitment, phenotypic maintenance and tissue 
morphogenesis (DeLise et al., 2000, Goldring et al., 2006). The scaffold or transient 3D support 
serves to stabilize, anchor, and orientate the cell construct. It is imperative to outline the desired 
properties and function to be emulated by the regenerated tissue to appreciate the potential of 
various approaches for cartilage tissue engineering. An ideal biomaterial-assisted strategy for 
developing a tissue engineered hyaline, -expressing articular cartilage equivalent should exhibit 
biphasic properties of native cartilage, made of approximately 80% fluid phase (80% water with 
<1% electrolytes), and 20% solid phase constituted by 10%–15% Col II and 5%–10% PGs 
(Temenoff et al., 2002, Ahmed and Hincke, 2010). Lastly, and more importantly, it should 
recapitulate the mechanical properties of native tissue, such as shear, tensile and compressive 
properties to restore normal function and facilitate good quality of life. 
 
2.3.2 Cellular approaches for cartilage tissue engineering 
Due to minimal cellularity and poor regenerative properties of articular cartilage, exogenous 
delivery of cells in biomaterial scaffolds has been widely investigated. The earliest attempts for 
cell-based regenerative therapy for cartilage defects have involved adult chondrocytes but with 




2.3.2.1 Chondrocyte based approaches 
Chondrocytes have been the first and obvious choice for attempting cell based cartilage 
regeneration. ACI can be referred to as the first cell-based therapy, while the development of 
MACI was the first approach to include biomaterials as support systems. Various sources for 
isolating chondrocytes include auricular, articular, costal and nasoseptal cartilage (Chung and 
Burdick, 2008) Auricular and nasoseptal chondrocytes have been reported to proliferate twice 
(van Osch et al., 2004), and four times as fast as articular chondrocytes, respectively, with the 
latter causing hyaline-like tissue repair in cranofical and plastic surgery (Kafienah et al., 2002). 
Even neonatal (Adkisson et al., 2010), and fetal chondrocytes have been reported 
(Mahmoudifar and Doran, 2010) to have enhanced ECM deposition, with aged (Barbero et al., 
2004) and viral transfected OA chondrocytes  (Li et al., 2004) also explored for their healing 
potential. Although such chondrocyte-based approaches delivered through intra-articular 
injection or using biomaterial strategies have been reported (Ahmed and Hincke, 2010, Kock et 
al., 2012), the underlying limitations in using chondrocyte-based approaches has not been 
overcome. Availability, scalability, phenotypic maintenance and donor site morbidity, with 
variations arising due to age, disease conditions, and low yields, mitotic ability and metabolic 
activity, have been  unsolved bottlenecks in advancing such methods (Hui et al., 2012, LaPorta 
et al., 2012).  
 
2.3.2.2 Stem cell based approaches 
The aforementioned drawbacks with chondrocyte based approaches and progressive growth of 
stem cell biology and related applications have enabled exploration of various types of stem 
cells for articular cartilage repair. A spectrum of stem cell types, ranging from adult 
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mesenchymal stem cells (MSCs), embryonic stem cells (ESCs) (Hwang et al., 2006a, Hwang et 
al., 2006b), and induced pluripotent stem cells (iPSCs) (Medvedev et al., 2010, Yamanaka, 
2009) have been reported for healing cartilage defects. A majority of efforts have involved use 
of MSCs from various sources that include bone-marrow (Chen et al., 2005, Coleman et al., 
2007, Li et al., 2005, Meinel et al., 2004, Wu et al., 2007), adipose (Diekman et al., 2009, Zuk 
et al., 2002), muscle (Adachi et al., 2002, Kuroda et al., 2006), synovium (Sakaguchi et al., 
2005, Yokoyama et al., 2005), synovial fluid (Jones et al., 2008), periosteum (Fukumoto et al., 
2003, Park et al., 2006), trabecular bone (Chen et al., 2006), placenta (Timmins et al., 2012), 
and umbilical cord (Yang et al., 2012a). Although various sources for MSC isolation have been 
identified and established, only MSCs from adipose tissue and bone marrow have been widely 
studied, with a minority reporting the use of synovial fluid derived MSCs. Although all the 
three sources facilitate use of autologous cells, and obviate surgical methods for their harvest 
synovial MSCs are known to retain fibroblastic characteristics even after differentiation (Arufe 
et al., 2010, Fan et al., 2009b), while adipose derived MSCs produce less Col II (Diekman et 
al., 2009, Mahmoudifar and Doran, 2010). Further, a comparative study of bone marrow MSC 
and adipose MSC found the former to mediate superior chondrogenic outcomes (Afizah et al., 
2007), with a clinical comparison demonstrating efficiency of bone marrow-derived MSC to be 
comparable to ACI, with better results for older patients (>45 years) (Nejadnik et al., 2010). 
 ES cell based approaches have been studied because of their theoretically infinite 
expansion and totipotent differentiation potential (Oldershaw et al., 2010). Various approaches 
for chondro-differentating ES cells has involved co-culture with mature chondrocytes (Hwang 
et al., 2008, Vats et al., 2006), embryoid body culture with exogenous 
mesodermic/chondrogenic cytokines (Toh et al., 2011, Toh et al., 2010), spontaneous (Koay et 
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al., 2007, Kopher et al., 2010), and targeted differentiation methods (Oldershaw et al., 2010). 
Although such methods have advanced the potential of ES derived cartilage repair, the ethical 
and safety concerns involving tumorigenicity have limited their clinical application. More 
recently, iPSCs cells have also been reported (Medvedev et al., 2010, Yamanaka, 2009) which 
overcomes the ethical concerns of ES cells. But the biology of reprogramming is not very well 
understood, and associated concerns over use of viral vectors, with safety concerns such as 
mutagenesis and tumorigenesis necessitate extensive preclinical studies to validate its safety 
and efficacy for such applications. Thus the mainstay of current approaches for cartilage tissue 
engineering has been bone marrow-derived MSCs, mostly due to their autologous availability, 
scalability, efficient chondrogenic differentiation potential in vitro and safety profile. Further, it 
necessitates optimal tissue engineering approaches to aid in the regeneration of stable, 
permanent articular cartilage phenotype, without progressing into hypertrophic development, 
nor leading to functionally inferior, fibrocartilage phenotype. 
 
2.3.3       Biomaterials for cartilage tissue engineering 
The enhanced understanding of articular cartilage anatomy and its structural complexity have 
been followed by significant strides made in engineering capacity and material design. Such 
progress has enabled synthesis of materials with molecular resolution across organisational 
levels, from nano- to macro- scale dimensions. Technological advancements have facilitated 
development of various strategies for creating biomaterial scaffolds with controllable 
characteristics, with precision and versatility. As clinical treatments have been unable to 
successfully address large cartilage defects, a biodegradable 3D platform for delivering cells at 
the repair site, and contain them within that physical environment represents advancement in 
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healing cartilage lesions. The biomaterial strategies for cartilage tissue engineering have 
evolved from application of inert, non-biodegradable hydrogels such as agarose, alginate and 
PEG (Buschmann et al., 1992, Elisseeff et al., 2000, Chang et al., 2001), and porous 
biodegradable polyesters (Freed et al., 1998, Freed et al., 1993), to the current attempts at 
advanced material chemistry involving both natural and synthetic platforms  (Coates and Fisher, 
2010, Hwang et al., 2011, Nguyen et al., 2011a, Bian et al., 2013). 
 
2.3.3.1  Ideal characteristics of biomaterials 
A clear understanding of the desired physical and biological properties of artificial matrices is 
essential for critical evaluation of past and current approaches, which will aid in identification 
of crucial elements that need to be refined or re-addressed. There are certain characteristics of 
an optimal biomaterial that were first laid down by (Freed et al., 1994) that include 
biocompatibility, biodegradability of scaffold matching the reciprocal rate of neotissue 
formation, its nontoxic and non-immunogenic properties with an ability to resorb after 
degradation. It should be permeable with adequate porosity to enable nutrient and cytokine 
diffusion, with high surface area for cell adhesion and attachment, and account for adequate 
space for ECM deposition. Surface properties such as hydrophilicity and charge should also be 
amenable to cell recruitment, adhesion, migration and intracellular signaling events.  It should 
serve as a mechanically stable 3D scaffold that can withstand physiological loading, without 
causing collapse of premature neotissue, owing to loading. It should fit the defects and integrate 
with host tissue at site of implantation and be versatile for treating different types of cartilage 
lesions. Lastly, the composition of an ideal cell-carrier should closely mimic the natural 
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environment of target tissue, which necessitates a cartilage specific, GAG-rich ECM to drive 
differentiation and maintenance of chondrogenic phenotype (Iwasaki et al., 2004). 
 
2.3.3.2  Synthetic, macroporous scaffolds 
Several biodegradable and resorbable polymers have been used for cartilage regeneration which 
include, poly-α-hydroxy esters such as polylactic acid (PLA) and polylactic-co-glycolic acid 
(PGA), which have been  approved by the FDA for clinical use (Yoon and Fisher, 2007). Other 
examples include another FDA- approved scaffold polycaprolactone (PCL), and other synthetic 
polymers such as polyurethanes, polyhydroxyalkanoates, and polyphosphazene (Ahmed and 
Hincke, 2010, Hui et al., 2012). The merits of such hard scaffolds is their reproducibility, 
predictable biodegradation, porosity, and stronger mechanical properties, enabling easy fit into 
defects, and facilitating load bearing (LaPorta et al., 2012). Examples of synthetic polymers 
under clinical investigations and trials include a PGA, PLA based BioSeed-C scaffolds, and 
Polylactic-co-glycolicacid (PLGA)-based TruFitbone substitute plus for the treatment of 
osteochondral defects (Ahmed and Hincke, 2010, Kock et al., 2012, LaPorta et al., 2012). Yet 
the repair mediated through such clinical approaches has not yielded satisfactory results so far 
(Dhollander et al., 2012). Since cell-cell interactions (precartilage condensation events) are vital 
for promotion and maintenance of chondrogenic phenotype, such approaches fall short in their 
ability to facilitate such cellular events and result in inferior chondrogenic outcomes and ECM 







2.3.3.3  Natural biopolymers and hydrogels 
As articular cartilage is a hydrated, load bearing, soft connective tissue, hydrogel based 
approaches are able to recapitulate the appropriate ECM properties for facilitating optimal 
cartilage repair.  Natural and synthetic polymers have been reported for both stem cell and 
chondrocyte based approaches. Natural polymers fall into further subcategories such as protein 
and carbohydrate based 3D matrices. Silk (Meinel et al., 2004, Fan et al., 2009a, Wang et al., 
2006b), fibrin (Worster et al., 2001, Gurevich et al., 2002, Nieto-Aguilar et al., 2011), and 
collagen (Hwang et al., 2011, Ng et al., 2011) based scaffolds have been reported for both 
preclinical and clinical investigations (Ahmed and Hincke, 2010, Kock et al., 2012, LaPorta et 
al., 2012). Carticel is a collagen I/III-based scaffold in use for MACI in the USA, and similar 
products under clinical investigation for MACI include Neocart, CaReS, Chondro-gide, and 
Vericart. Fibrin -based matrices include, Tissucol by Baxter, DeNovo NT and ET grafts, and 
Gelrin C. A combination of biomaterials such as collagen-GAG, to form a biphasic scaffold is 
also under clinical investigation, namely Chondromimetic. Carbohydrate- based scaffolds 
include those involving agarose, alginate, chitosan, and hyaluronan. Chitosan has been a widely 
reported scaffold for cartilage tissue engineering (Ahmed and Hincke, 2010, Kock et al., 2012, 
Di Martino et al., 2005). Combination of chitosan and β-glycerophosphate termed BST Cargel 
has been used in the clinic to disperse the uncoagulated blood following microfracture in 
cartilage lesions (LaPorta et al., 2012, Shive et al., 2006). Hyaluronan or HA- based examples 
include Hyalograft C (Marcacci et al., 2005), and HYAFF-7 and 11 (Grigolo et al., 2002, Hui et 
al., 2012) for use as matrices in the MACI procedure. Preclinical studies involving MSCs and 
chondrocytes have employed chitosan (Ahmed and Hincke, 2010, Kock et al., 2012, Di Martino 
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et al., 2005), collagen (Ng et al., 2011, Parenteau-Bareil et al., 2010), alginate (Chia et al., 
2005, Diduch et al., 2000, Homicz et al., 2003), agarose (Awad et al., 2004, Finger et al., 2007, 
Mauck et al., 2006, Charles Huang et al., 2004), hyaluronan based hydrogels (Chung et al., 
2009, Bian et al., 2013) for promoting chondrogenic phenotypes. Synthetic hydrogels include 
predominantly polyethylene-glycol (PEG) based hydrogels, since it is a FDA -approved 
biomaterial and offers ease of manipulating its physical and chemical characteristics (Hwang et 
al., 2011, Nguyen et al., 2011a, Park et al., 2006). Studies incorporating various biomolecules 
such as CS (Coates et al., 2012, Nguyen et al., 2011a, Nguyen et al., 2011b), HA (Coates et al., 
2012, Nguyen et al., 2011a, Nguyen et al., 2011b), Col I (Hwang et al., 2011), Col II (Hwang et 
al., 2011), RGD peptides (Villanueva et al., 2009), collagen mimetic peptide (CMP) (Liu et al., 
2010), and MMP-sensitive peptides (Nguyen et al., 2011a, Nguyen et al., 2011b, Park et al., 
2004) using PEG hydrogels by click chemistry, and photocrosslinking have been reported using 
MSCs and chondrocytes. Such approaches aim to incorporate native ECM properties by 
recapitulating: either the cell-ECM interactions (PEG-CS, HA, Col, RGD, CMP); or facilitate 
cell-cell interactions by promoting matrix degradation (PEG-MMP) or by providing peptide 
mimics of N-cadherin (HA-N-cad peptide hydrogel) (Bian et al., 2013); both of which are vital 
for regulating chondrogenic phenotype. 
 
 Yet, shortcomings from the above approaches involve physical attributes of biomaterials 
such as matrix compliance, referring to the ability of biomaterial to be amenable to 
differentiation induced cellular remodeling of the local microenvironment. Despite 
incorporation of the aforementioned biological factors in alginate, PEG, or HA based 
approaches resulting in minor improvements, they did not facilitate uniform cell-cell, cell-ECM 
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interactions, and adoption of optimal cell morphology during differentiation (as discussed in 
2.1.1) (Coates et al., 2012, Hwang et al., 2011, Nguyen et al., 2011a, Nguyen et al., 2011b); 
cellular migration, as cells were often found to be localised, with minimal cell-cell interactions 
(Coates et al., 2012, Hwang et al., 2011, Nguyen et al., 2011a, Nguyen et al., 2011b); which 
hampered chondrogenic differentiation of MSCs, resulting in non-uniform, neotissue 
development, with inferior properties. Thus application of improved, biofunctionalised 
strategies using compliant biomaterials are required to improve the aforementioned 
shortcomings.  
 
2.3.4  Growth factors  
As cells seeded in 3D matrices in vitro, necessitate the application of growth factors for guiding 
the fate of cells into desired differentiation pathways, various growth factors have been reported 
for mediating chondrogenic differentiation of MSCs. Growth factors that have been reported for 
MSC chondrogenesis include TGF β-1, 2, and 3, BMPs-2, 4, 6, 7, and 9, FGF-2, IGF-1and 
GDF-5 (Kock et al., 2012, Puetzer et al., 2010, Varga et al., 2012). TGF β-1, BMP-2, IGF-1 
and FGF-2 are known to enhance proliferation of differentiating MSCs (Varga et al., 2012, 
Kock et al., 2012). Further, TGF β-1, BMP-2 are known to downregulate the fibrocartilaginous 
marker Col I, while BMP-7 is known to enhance ECM maturation (Varga et al., 2012). Lastly, 
the combined effect of various growth factors have been reported, with supplementation of 
TGFβ1 to either IGF-1 or BMP-7, or their combination, having additive effects on ECM 
formation, but antagonistic effects on cell proliferation (Varga et al., 2012). An extensive 
review of over 30 studies spanning a decade of reports involving various supplements and 
growth factors was summarised by (Puetzer et al., 2010). The review concluded that a high 
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glucose DMEM media with incorporation of ascorbate,  pyruvate, premixed insulin, transferrin, 
selenium (ITS), under serum- free conditions, with supplementation of TGFβ1, was optimal for 
directing MSC based chondrogenic differentiation. Further, another report suggested replacing 
TGF-β-1 with TGF-β-3, with inclusion of proline, since an enhanced MSC pellet size, with 
much higher upregulation of sGAG, aggrecan, Col II, and Col X expressions was observed, but 
without significant differences on the upregulation of Col I expression (Barry et al., 2001, 
Mackay et al., 1998). Although some reports involved serum addition for chondrogenic media, 
limitations with such approaches are that the serum addition leads to undefined media 
composition, presence of xenogenic sources of biologics, and batch to batch variation. Since no 
significant differences in differentiation potential of MSCs under serum- free and serum- added 
chondrogenic cocktails were observed (Puetzer et al., 2010), our study chose the serum free 
approach.  Further, in vitro culture of MSCs with FGF-2 supplementation was found to increase 
the growth rate by two folds, with smaller cell size thus increasing cell yield (Solchaga et al., 
2005), but without any negative effects on their chondrogenic potential (Ito et al., 2008, 
Tsutsumi et al., 2001). With regards to an optimal in vitro predifferentiation period, a 14 day 
time period was reported to be indicative of the ability of MSCs to undergo chondrogenic 
differentiation, under the influence of aforementioned differentiation cocktail (Mueller et al., 
2010). In summary, the literature suggests optimal conditions for MSC expansion to involve 
FGF-2 supplementation, with use of serum-free, high glucose DMEM media, supplemented 
with ITS premix, ascorbate, proline, and antibiotics as necessary, for inducing chondrogenic 






2.3.5  Mechanical stimulation 
As maturation of immature cartilage tissue in vivo is associated with physiological loading, in 
vitro mechanical loading studies using MSCs have been widely investigated, to augment their 
differentiation potential. Chondrocytes in vivo experience a variety of mechanical forces such as 
shear and compressive force, hydrostatic pressure, causing deformation of cell and tissue and 
changes in fluid flow (Keeney et al., 2011, Kock et al., 2012). Such physiological loading also 
facilitates regulation of anabolic and catabolic processes for ECM and phenotypic maintenance 
of chondrocytes and is hence pivotal to be addressed. This review is limited to studies involving 
MSCs since our study used a MSC- based approach for cartilage regeneration. Various 
mechanical stimuli including static loading, unconfined or confined dynamic loading, 
hydrostatic pressure (Hu and Athanasiou, 2006, Miyanishi et al., 2006a, Miyanishi et al., 
2006b), sliding/rolling indentation loading (Schulz and Bader, 2007), tensile loading 
(Khoshgoftar et al., 2011), shear loading (Darling and Athanasiou, 2003a, Darling and 
Athanasiou, 2003b), centrifugal force (Sun et al., 2010), and gravity (Wimmer et al., 2009) 
have been explored. Static compression is known to upregulate Sox9 expression (Takahashi et 
al., 1998), whereas dynamic compression was found to increase Col II, aggrecan and ECM 
deposition (Campbell et al., 2006, Kisiday et al., 2009, Mauck et al., 2006), with hydrostatic 
pressure increasing Sox9, aggrecan, and Col II expression, PG content and properties of 
neocartilage tissue (Frank et al., 2000, Hu and Athanasiou, 2006, Miyanishi et al., 2006a, 
Miyanishi et al., 2006b). Thus dynamic compression and hydrostatic pressure have received 
much attention owing to their positive influence on both chondrocyte phenotype maintenance 
and MSC chondrogenesis. Further, combination of growth factor induced chondrogenesis under 
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mechanical stimulation involves a complex interplay of cellular and molecular events resulting 
in the development of differential ECM properties. Dynamic loading in supplementation with 
TGFβ-3 down regulates fibrocartilaginous Col I expression, increases matrix distribution, and 
improves mechanical properties of neotissue (Campbell et al., 2006, Huang et al., 2010a). 
Lastly, dynamic loading inhibits hypertrophic Col X expression (Bian et al., 2011), possibly by 
suppression of p38 mitogen activated protein kinase (p38 MAPK) pathways, mediated by 
PTHrP induced Protein kinase C (PKC) expression (Bobick and Kulyk, 2008, Stanton et al., 
2004, Zhen et al., 2001). Yet, the influence and consequent effect of such mechanical stimuli 
are largely dependent on timing, duration, loading parameters, and the material property of the 
scaffold.  Studies have found that dynamic loading after 14 days of initial pre-differentiation 
under free swelling conditions, is best suited to observe positive effects upon mechanical 
loading, under in vitro conditions (Steinmetz and Bryant, 2011). This suggested that loading at 
day 0 of stem cell-seeded biomaterials do not withstand the mechanical forces, due to lack of 
structural ECM support, reminiscent of progressive degradation observed during OA. It was 
reported that strategies to upregulate the expression of markers of matrix maturity such as 
COMP and Col IX are pivotal in aiding the development of optimal neotissue properties, for 
subsequent mechanical stimulation to augment a functional neocartilage formation 
(Amanatullah et al., 2012, Blumbach et al., 2009, Haleem-Smith et al., 2012, Opolka et al., 
2007). Thus it is essential to facilitate neocartilage generation with optimal mechanical 
properties for at least 14 days in vitro, in order to observe any beneficial effects of mechanical 






2.3.6 Shortcomings of current approaches and need for engineering zonal phenotypes 
 
When considering a MSC based hydrogel-assisted strategy with TGFβ-3 supplementation, 
certain shortcomings have been reported in recent studies. One of the hallmarks of MSC based 
approaches in generating neocartilage equivalents under the influence of TGFβ-3, is the 
reported lower expression of Col II (Mauck and Burdick, 2011), to almost half the native tissue 
expression levels, accompanied by the expression of fibrocartilaginous Col I, and hypertrophic 
Col X expression (Mahmoudifar and Doran, 2012). Not only is the type of collagenous 
secretion suboptimal, but the structural arrangement of the deposited Col II and Col I do not 
follow the depth-dependent, zonal arrangement in native tissue, but result in a homogenous, 
random distribution that severely impaired its mechanical properties and tissue function 
(Ahmed and Hincke, 2010). Further, the higher Col I content (relative to Col II) accounts for 
more tensile than compressive properties, thus deviating from the compression dominant 
function of hyaline cartilage. Also, deposition of ECM components such as Col II and sGAG 
was also suboptimal, with non-uniform distribution in the current hydrogel based strategies 
(Kock et al., 2012).  Such shortcomings also stem from the non-compliant nature of widely 
used PEG, alginate, and HA hydrogels, which also fail in promoting critical cell-cell 
condensation events and cell-ECM interactions in promoting optimal hyaline cartilage 
regeneration (as discussed in 2.3.3.3). In all, the hierarchical zonal variations in ECM properties 
of native cartilage tissue have not been recapitulated through such approaches. Thus recent 
studies have attempted to overcome such shortcomings through various strategies which are 




2.4  Engineering zonal cartilage phenotypes 
In order to improve the efficiency of tissue engineering approaches for articular cartilage 
regeneration, there are increasing efforts to develop functionalized scaffolds that mimic aspects 
of the stem cell microenvironment. Recent insights from regenerative medicine paradigm 
implicate the provision of appropriate biochemical and physical microenvironments for refining 
the fate and function of repair tissue (Discher et al., 2009, Lutolf et al., 2009). This part of the 
review discusses such strategies aimed at facilitating a refined neocartilage tissue with optimal 
ECM characteristics and tissue function.  
 
2.4.1 Stratified hydrogels constructs using zonal chondrocytes 
Since cartilage exhibits variations in mechanical properties, cellular organisation and ECM 
composition, efforts have been made to recapitulate such variations by varying the cellularity 
(Kim et al., 2003, Klein et al., 2003, Sharma et al., 2007), substrate stiffness (Ng et al., 2009, 
Ng et al., 2005), creating pore size gradients in 3D matrices (Woodfield et al., 2005).  Attempts 
using zonal chondrocyte populations embedded in bi-layered hydrogel systems, representing a 
co-culture setup have been reported, to facilitate development of depth-dependent cellular, and 
ECM properties of articular cartilage. Such studies were reported by Kim et al (2003) using 
alginate hydrogels, while Kim et al (2003), and Sharma et al (2007) employed 
photopolymerising PEG-diacrylate (PEG-DA) hydrogels for encapsulating bovine zonal 
chondrocytes, such as superficial and deep zone chondrocytes. Ng et al (2009) reported 
encapsulation of superficial and deep zone chondrocytes in agarose gels of varying mechanical 




stratification observed in native cartilage, by layering superficial zone chondrocytes followed 
by deep zone chondrocytes. Ng et al (2005) reported chondrocytes in 3% agarose hydrogel has 
similar sGAG but lesser Col II content, relative to 2% gels, with improvement in mechanical 
properties of 2% hydrogels over time, suggesting the initial stiffer microenvironment (3%) did 
not aid chondrogenic maintenance. Further, studies by Kim et al  (2003), Sharma et al  (2007), 
and Ng et al  (2009), suggested paracrine signaling betweenthe two zonal populations had a role 
in recapitulating the superficial and deep zone collagenous, GAG, and mechanical properties. 
Deep zone chondrocytes were found to synthesise higher collagen, GAG content with higher 
compressive and shear properties (Kim et al., 2003, Klein et al., 2007, Sharma et al., 2007). 
Such layered constructs were found to have superior ECM properties than non-layered zonal 
populations cultured separately. Efforts to emulate the anisotropic cellularity and ECM 
properties also included engineering anisotropic pore size gradients to result in heterogenous 
ECM distribution (Woodfield et al., 2005). Immature, bovine chondrocyte were seeded in a 3D 
copolymer polyethylene glycol terephthalate/polybutylene terephthalate (PEGT/PBT) scaffold 
that was created by fiber deposition technique. Although pore size gradients of 200-1650 
micron (diameter) were created which resulted in anisotropic sGAG and Col II accumulation, 
no differences were seen in the GAG:DNA content, and the overall expression levels of 
aforementioned ECM components were found to be half of that in native cartilage. Layering 
zonal cell populations might have an innate potential to reacquire anistropic zonal ECM 
properties, but they are limited in their clinical use since availability of healthy chondrocytes 




2.4.2 Mechanical stimuli  
A few studies have addressed the influence of mechanical properties in developing zonal 
properties, since physiological loading is an important regulator for matrix maturity of articular 
cartilage in vivo. Kock et al  (2010)  reported a sliding indentation protocol with the hypothesis 
that depth-dependent exposure to mechanical cues shapes depth-dependent matrix content and 
properties. The study reported creation of much higher sGAG content in the top half of the 
scaffold construct. Mechanical loading in immature, musculoskeletal animal tissues is known to 
cause topographical heterogeneity in joint surfaces and influences development of collagen 
orientation (Brama et al., 2009), when the force is parallel to the joint surface. Forces acting in 
vertical fashion, such as compressional loading, are known to influence the distribution of ECM 
components in human tissues (Weeren et al., 2008).  Kock et al  (2010) demonstrated that such 
reports were indeed valid, as the direction of force was found to induce collagen alignment. 
Khoshgoftar et al  (2011) used a numerical model to predict that physiological collagen 
structure could be facilitated by application of compressive and shear forces in combinations. 
Also, mechanical loading studies on bovine chondrocytes in 2% and 3% agarose hydrogels was 
reported (Ng et al., 2006). It was found that 2% agarose hydrogels facilitated higher elastic 
modulus with better matrix formation, whereas 3% hydrogels did not facilitate such increases in 
mechanical properties and were limited in their ECM formation. A more recent study (Thorpe 
et al., 2013) was the first to  report  MSCs  and the  application of mechanical stimuli on 
engineering ECM anisotropy in neocartilage tissue  (Thorpe et al., 2013). Porcine MSCs in 
agarose hydrogels were subjected to dynamic compression while their lower half was radially 
confined. This was found to result in hypoxic environment in the confined half of the hydrogel, 
with consequent increases in sGAG and reduction of Col II accumulation. The unconfined half 
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was found to have higher Col II and decreased sGAG, possibly arising from increased strain on 
the upper half of hydrogel. Noteworthy was the suppression of hypertrophy throughout the 
hydrogel, with upregulation of PRG-4 in the upper half, thus aiding development of depth 
dependent ECM properties. Although mechanical stimulation might have the potential to aid 
development of optimal matrix properties and ECM distribution, such approaches necessitate a 
conducive biomaterial strategy, firstly, to enable robust chondrogenesis and ECM deposition, 
which can then be refined to acquire depth-dependent properties post mechanical loading. 
 
2.4.3 Modulating biochemical composition 
One of the more widely reported approaches involving MSC based approaches for engineering 
hyaline cartilage with depth-dependent ECM properties has been the modulation of biochemical 
composition of hydrogels with adhesive cues, as cell-ECM interactions are vital during in vivo 
development of cartilage tissue and for maintenance of chondrogenic phenotype (DeLise et al., 
2000). Hwang et al (2011) reported the incorporation of Col I, Col II and HA in PEG hydrogels 
and found Col I and Col II favoured  MSC chondrogenesis, whereas HA was found to 
upregulate hypertrophic development. Coates et al  (2012) reported a comparative study 
involving zonal chondrocytes and MSCs in alginate hydrogels with CS and HA incorporation, 
which reported differences in cell behaviour and phenotypic outcomes. While CS and HA 
decreased PRG-4 and Col I expression, with upregulated Col II expression in MSC populations, 
alginate matrices were found to favour maintenance of superficial zone phenotypes in 
chondrocyte population, with increased PRG-4 and COL I expression. More recently, layered 
PEG hydrogels with varying biochemical compositions have been reported to result in zonal 
phenotypic outcomes involving MSCs from immortalised mouse cell lines (Nguyen et al., 
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2011a,b). Lower CS incorporation (9%) with MMP incorporation was found to favour a 
superficial zone phenotype, with higher CS concentrations (10%) leading to middle zone 
phenotypes, and HA incorporation resulting in deep zone phenotypes. Thus, these reports 
establish the potential of biochemical cues in facilitating the refinement of phenotypic outcomes 
in MSC chondrogenesis.  
 
 
2.5 IPC-based approaches to modulate biochemical composition of hydrogels for zonal 
cartilage tissue engineering 
Hydrogels provide suitable 3D niches for cartilage regeneration due to similarities in their 
material properties, such as offering softer, hydrated matrices.  Although recent studies (Hwang 
et al., 2011, Nguyen et al., 2011a, b)  have reported the generation of varying neocartilage 
phenotypes by modulating ECM composition of PEG hydrogels, certain critical shortcomings  
remain to be addressed. Such hydrogels maintain localized encapsulated cells in singularity 
with spherical morphology, inherently limiting direct cell–cell interactions, (even at seeding 
density of 20 million cells per ml) that are essential for early mesenchymal condensation 
process; a necessary requisite for initiating MSC chondrogenesis (DeLise et al., 2000, Tacchetti 
et al.,1992). Although enhanced chondrogenic differentiation was facilitated with the provision 
of biochemical cues, the ECM deposition by PEG-encapsulated cells was found restricted to 
pericellular regions, despite prolonged in vitro culture (Bahney et al., 2011, Hwang et al., 2011, 
Nguyen et al., 2011a, Nguyen et al., 2011b, Sharma et al., 2007).  The resultant ECM 
deposition through such approaches did not recapitulate the ECM integration and distribution 
observed in native cartilage. Further an understanding of how such biochemical environments 
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influence cellular processes and function, such as commitment and subsequent differentiation 
events, is presently lacking. Importantly, phenotypic characterization of neocartilage generated 
in taking the aforementioned approaches, through a systematic analysis of zone specific marker 
expression was neither studied, nor demonstrated. Thus the imperative need for understanding 
the role of microenvironmental cues on chondrogenic differentiation of MSC is pivotal, before 
optimal strategies for engineering 3D niches with varying ECM compositions can be developed.  
To facilitate such an understanding, use of an aqueous-solvent based, room temperature 
process termed interfacial polyelectrolyte complexation (IPC) was envisaged (Wan et al., 2004, 
Yim et al., 2006).  Recent studies have established that IPC-based fibrous hydrogels constitute a 
favourable 3D niche for supporting stem cell proliferation and differentiation (Lu et al., 2012, 
Tai et al., 2010, Wan et al., 2004, Yim et al., 2006). Stem cell fate could also be engineered 
using IPC-based hydrogels by incorporating individual components of the ECM, which were 
reported to influence differentiation of human MSCs and the function of differentiated primary 
rat hepatocytes (Tai et al., 2010, Wan et al., 2012, Leong et al., 2013). In addition to offering a 
physiological, hydrated microenvironment (Wan et al., 2004, Yim et al.,2006), the prime 
advantage in employing an IPC-based fibrous hydrogel approach was the prospect of cellular 
encapsulation, within the 3D fibers presenting the biochemical cues, which take place at a 
physiological pH and temperature.  Such cell-laden fibers containing the biochemical cue could 
be assembled to constitute a 3D hydrogel (Tai et al., 2010, Wan et al., 2012). This was 
considered a significant improvement, since cellular infiltration and remodeling of the ECM 
mimicking fibrous 3D matrices, have not been previously reported  (Coburn et al., 2011). 
Further, the porous architecture (65-85%) allowed for efficient nutrient/waste exchange and 
accessibility to soluble growth factors (Lu et al., 2012, Tai et al., 2010). It was shown that the 
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incorporated biochemical cue in IPC-based fibrous hydrogels was uniformly distributed 
throughout the surface and the interior of the fiber (Tai et al., 2010, Wan et al., 2012). This 
resulted in a high degree of spatial resolution of the biochemical cue incorporated within the 
drawn fiber. Further, the close proximity of IPC-mediated cue presentation with encapsulated 
cells enabled uniform cellular interactions, and cell-ECM interactions (Leong et al., 2013), a 
criteria  lacking in existing hydrogel approaches. Such a fiber assembled hydrogel system could 
also facilitate systematic studies both at the cellular and functional levels, to understand the 
effects of microenvironmetal cues on chondrogenic differentiation of mesenchymal stem cells 
(MSCs). It would aid the identification of optimal microenvironmental cues, and possible 
mechanisms in deriving functionally superior and phenotypically distinct neocartilage 
outcomes, such as that akin to the superficial, middle and deep zones of articular cartilage. Thus 
this study explored the application of IPC-based fibrous hydrogel for MSC based articular 
cartilage tissue engineering. 
Since an IPC-based approach necessitates use of oppositely charged materials, 
positively charged chitin, which is derived from crab shells (Kim et al., 2008) was employed as 
polycation. Alginate, a negatively charged biomaterial derived from brown algae ( Li and 
Zhang, 2005) was used as the polyanion. Chitin and alginate based biomaterial approaches have 
been successfully employed in a plethora of tissue engineering approaches (Kim et al., 2008, 
Kuo et al., 2006, Li and Zhang, 2005). Specifically, chitin-alginate based 3D IPC-hydrogels are 
known to support the proliferative and differentiation potential of encapsulated MSCs, and 
augment cartilage tissue engineering approaches (Kim et al., 2008, Kuo et al., 2006, Li and 
Zhang, 2005, Yim et al., 2006). Further,  chitin-alginate derived 3D matrices offer a GAG 
containing ECM, mimicking GAG rich native tissue microenvironments, and could better 
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facilitate cellular and ECM mediated events (Iwasaki et al., 2004). This study employed Col I, 
CS, and HA incorporated IPC hydrogels in an attempt to improve the tissue properties and 
zonal phenotypic outcomes of MSC derived neocartilage tissue, since mesenchymal progenitors 
in vivo exist in Col I and HA rich environment (DeLise et al., 2000, Sandell 1994), and CS is 
known to positively influence chondrogenic differentiation (Coates et al., 2012, Hwang et al., 
2011, Nguyen 2011a, b). Thus IPC-based approaches were employed to understand the effects 
of varying biochemical compositions on MSC chondrogenesis on both early, cellular and 







3. MATERIALS AND METHODS 
3.1 Cell culture and chondrogenic differentiation  
3.1.1 MSC isolation and culture 
MSCs were generated from bone marrow aspirates of consented human donors, after obtaining 
approval from Institutional Review Board (IRB). The bone marrow aspirate was washed three 
times with HBSS (Invitrogen). MSCs were isolated from the bone marrow aspirates using the 
RosetteSep
TM
 (STEMCELL Technologies, Singapore) kit. Isolated MSCs ware resuspended in 
an expansion media prepared using low glucose DMEM (Invitrogen) media supplemented with 
10% FBS (Invitrogen) and cultured in CELLSTAR
TM
 T175 flasks (Greiner Bio-One, North 
America), with 20ml of the expansion media at 37°C in 5% CO2 atmosphere. After 72 h, non-
adherent cells were removed. When adherent cells reached 70–80% confluency, they were 
trypsinised wherein the media in culture flask was removed, followed by incubation of cells at 
37°C in 5% CO2 atmosphere with 5ml of using TrypLE
TM
 (LifeTechnologies, Singapore) for 5 
mins. An equal volume of expansion media was added and the cell number in the resultant 
solution was calculated using Neubauer improved haemocytometer. The cell suspension was 
then centrifuged at 200g for 5 mins in Hybrid Refrigerated Centrifuge 6200 (Kubota 
Corporation, Japan). The resulting pellet was resuspended in a known volume of expansion 
media and further expanded in T175 flasks as mentioned above. A homogenous MSC 
population was obtained after 1–2 weeks of culture and MSCs at passage 3 were used for all 




3.1.2 Primary chondrocyte isolation and culture 
Chondrocytes were isolated from pig articular cartilage. Briefly, cartilage slices collected from 
femoral condyle were digested first with 0.25% TrypLE (LifeTechnologies, Singapore) for 30 
min, then with 0.25% (w/v) type-II collagenase solution (LifeTechnologies, Singapore) in 
DMEM for 12–16 h at 37◦C. Isolated chondrocytes were expanded in low glucose 
DMEM (Invitrogen) with 10% FBS in the presence of 1ng/ml TGFβ-1 (R&D Systems, 
Minneapolis, MN), 2ng/ml PDGF (R&D Systems, Minneapolis, MN) and 2 ng/ml of bFGF-1 
(R&D Systems, Minneapolis, MN). Expanded chondrocytes were use at passage 1 for all 
further experiments. 
 
3.1.3 Chondrogenic differentiation of MSCs and chondrocytes 
 Chondrogenic differentiation media containing high glucose DMEM (Invitrogen) 
supplemented with 10
-7
 M dexamethasone (Sigma-Aldrich), 1% ITS+ premix (BD Bioscience 
Inc.), 50 mg/ml ascorbic acid, 1 mM sodium pyruvate (Sigma-Aldrich) and 4 mM proline 
(Sigma-Aldrich). Chondogenic differentiation was induced by adding 5 ng/ml of TGF-β3 (R&D 
Systems, Minneapolis, MN) to the chondrogenic medium. The cell laden constructs were 
cultured overnight at 37°C in 5% CO2 in expansion media, before switching to chondrogenic 
medium for rest of 2-3 week culture period, with a medium change every 3 days. MSC pellets 
consisting of 2.5 x10
5
 cells each were subjected to chondrogenesis for 2-3 weeks, as controls to 






3.2 Material synthesis for IPC hydrogels  
 
3.2.1 Chitin & Alginate 
Chitin from crab shells was purchased from Sigma Aldrich (Singapore). Water soluble chitin 
(WSC) prepared via a modified protocol as in Sannan et al (1976), was obtained through a 
collaborative effort with Dr. Andrew Wan, at the Institute of Bioengineering and 
Nanotechnology (IBN), A*STAR, Singapore. Chitin was deacetylated (65%) with sodium 
hydroxide (Sigma Aldrich) to make it soluble in water. Sodium alginate (medium viscosity, 
A2033) was purchased from Sigma Aldrich (Singapore). The alginate was dissolved in 
autoclaved de-ionized water to make a 2%wt. solution. The resulting solution was sterile 
filtered and subsequently diluted for the desired concentrations.  
 
3.2.2 Collagen type I (Col I)  
Collagen type I (Col I) was methylated to enable its incorporation using polyelectrolyte 
chemistry. Methylated Col I (MC) was prepared by methylation of type I rat tail collagen (BD 
Biosciences) as described previously (Chia et al., 2000). Collagen was first isolated by acetone 
(Fluka) precipitation and dried in a vaccum oven at room temperature for 1 hour. The isolated 
collagen was methylated in acidified methanol (90% acidified with 10% IM HCl) (Fluka) for 24 
h and subsequently dialyzed using a cellulose membrane (3500MWCO) (ThermoScientific) for 
24 h. The resulting solution was freeze-dried (FreeZone 2.5L, Labconco) for 48 h to obtain 





3.2.3 Chondroitin sulfate (CS) and Hyaluronic acid (HA) 
Chondroitin-6-sulfate (CS) from shark cartilage (9007-28-7) and hyaluronic acid (HA) from 
human umbilical cord (31799-91-4) were purchased from Sigma (Singapore). CS and HA was 
dissolved in autoclaved deionized water to make 1% solutions. Requisite volumes of 1% 
solutions of CS and HA were mixed with 1% sodium alginate solution, to result in a final 
concentration of 0.25% CS, and 0.25% HA in the resulting IPC fiber.     
 
3.3 Fabrication of cell encapsulated hydrogels 
3.3.1 Encapsulation of MSCs in IPC hydrogel  
The general method for fabrication of IPC hydrogel by the assembly of interfacial 
polyelectrolyte complexation (IPC) fibers was adapted from a previous report (Leong et al., 
2013) (Fig. 3).  IPC hydrogel synthesis and fabrication was done in collaboration with Dr. 
Andrew Wan, at the Institute of Bioengineering and Nanotechnology (IBN), A*STAR, 
Singapore. The first step involved pipetting 5µl droplets of polyelectrolyte solutions, namely, 
0.5% (w/v) water soluble chitin (WSC) (Aldrich, 800-2000cP,1% in 1% acetic acid, Brookfield) 
solution in 2% acetic acid, and 1% (w/v) of sodium alginate (low molecular weight) (Sigma), 
on a parafilm coated (hydrophobic) surface, to prevent spreading of the pipetted 
polyelectrolytes. MSC or chondrocytes were suspended in the WSC solution at a density of 1  
10
4
 cells/μl, to achieve a final density of 10x106 cells per ml.    
For assembly of multiple cell-laden fibers to fabricate a fiber assembled hydrogel, nine 
droplets of each polyelectrolyte solution were dispensed in a circular fashion, with a droplet 
pair in the centre of the parafilm covered, Styrofoam surface (Fig. 3). A configuration of nine 
pipette tips (Rainin, 10µL, low retention tips), with another tip in the centre was mounted on a 
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Styrofoam surface (with their tips facing away), to mirror the droplet configuration. The surface 
with mounted tips was lowered to bring the two droplets of each droplet pair into contact to 
create an interface. The resulting nascent fiber was drawn upwards at a speed of 0.3 mm/s by 





   
  







Once the drawn fibers reached 5cm in length, the surface with tips was rotated gently to 
result in the fusion of all fibers drawn. The fused fiber was continuously drawn upwards, with 
deposition of single droplet of the 0.25% sodium solution (shown as yellow droplet in Fig. 3), 
to maintain fiber fusion.  The fused fiber thus obtained was assembled by spooling on a two-
pronged device, and fused further to form a hydrogel, by dipping sequentially in 0.5% WSC 
solution, phosphate buffered saline (PBS), 0.5% alginate solution and PBS, twice. Such 
Fig. 3 Schematic of the process flow for fabrication of fiber assembled interfacial polyelectrolyte complexation 
(IPC) hydrogel. Polyionic solutions containing biologics are first localized on a template. Multiple IPC fibres are 
drawn in parallel and fused at a single point by rotating the template. The fused fiber is continuously drawn 
upwards, with deposition of single droplet of the 0.25% sodium solution (shown as yellow droplet). The fused 
fibers are assembled by spooling and collected on a 2-pronged device to form fiber assembled IPC hydrogels. 
Adapted from Leong MF et al, 2013. 
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immersion of spooled fiber bundles in polyelectrolyte solution was performed to enhance its 
adhesivity and integrity, through secondary complexation (Wan et al., 2006). Fiber assembled 
constructs thus obtained were termed as ―IPC hydrogels‖. All the aforementioned procedures 
were performed with sterile equipment, in a sterile environment. 
To ensure consistency of cell encapsulation in appropriate densities, between samples 
and across experiments, cell populations in appropriate concentration/solution were split in 
accordance with total number of hydrogels to be fabricated. A cell count was performed prior to 
fiber drawing, which was compared with similar analysis of left-over solutions post fiber 
drawing, to ensure consistent cell seeding. Such analysis was performed alongside cell viability 
analysis, using LIVE/DEAD
®
 staining kit (as described in section 3.10.), post hydrogel 
assembly. Cell-laden hydrogels with consistent cell seeding densities, demonstrating high cell 
viability, as seen from test samples in each run, were used for all the experiments reported in 
this study. 
 
3.3.2 Fabrication of biochemical cue incorporated IPC hydrogels and MSC encapsulation 
Col I was incorporated into the IPC hydrogel as methylated Col I (MC) in the polycation 
solution to make 1% WSC, 0.25% MC solution.  Droplets (5µl) of such MC/WSC solution 
were interfacially drawn against 5 µL of 1% (w/v) of sodium alginate solution, as mentioned 
above and hydrogel thus obtained was termed ―IPC-Col I‖ hydrogel. Similarly, biochemical 
cues, CS and HA were incorporated into the IPC fiber by mixing them with the polyanion 
solution to make either 1% alginate, 0.25% CS or 1% alginate, 0.25% HA solutions. 5µl 
droplets of such CS/alginate, or HA/alginate solution was interfacially drawn against 5 µL of 
1% WSC solution to form CS, HA incorporated IPC-CS, IPC-HA fibers, which were used in 
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the aforementioned procedures (3.3.1) to form IPC hydrogels . Hydrogel thus obtained were 
termed ―IPC-CS‖, ―IPC-HA‖ hydrogels, respectively. MSCs were encapsulated at a density of 1 
 104 cells/μl, to achieve a final density of 10x106 cells per ml, as in 3.3.1. Such cell-laden IPC 
hydrogels with varying ECM compositions were cultured overnight at 37°C in 5% CO2 in 
expansion media, before switching to chondrogenic medium for rest of 2-3 week culture period. 
 
3.3.3  Cell encapsulation in Collagen type I hydrogel 
A stock solution of 11.46 mg/mL of collagen Type I from rat tail (Sigma) in 0.15 M of acetic 
acid was used to form 3D Col I hydrogels at a final concentration of 2.5mg/mL in 24 well 
Transwell
®
 inserts. A collagen mixture was prepared on ice containing (per mL) 218 µL of Col 
I stock  solution, 577 µL of DMEM solution , 100µL of 10X PBS and 100µL of cell suspension 
(final concentration of 10x10
6
 cells per ml), which was neutralised with 5 µL of ice-cold 1N 
NaOH solution. The resulting mixture was in a humidified incubator at 37°C in 5% CO2 
atmosphere for 60 mins for gelation to occur, following which 350 µL of in DMEM 
(Invitrogen) supplemented with 10% FBS (Invitrogen) was added to the insert. After overnight 
expansion, chondrogenic medium was added for rest of 2-3 week culture period, with a medium 
change every 3 days. 
 
3.4. Characterization of IPC hydrogels 
3.4.1 Field emission scanning electron microscopy (FE-SEM) 
SEM was used to observe the morphology of the IPC-control and various cue incorporated IPC 
fibers. Cell-free IPC hydrogels (control, Col I, HA and CS) were fixed in 2% glutaraldehyde 
(Sigma Aldrich) and subsequently dehydrated through graded ethanol solutions (50%, 70%, 
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95% and 100% ethanol, thrice in each solution). The IPC hydrogel was dried using critical point 
dryer (Tousimis, USA). Dried samples were sputter-coated with platinum (Auto Fine Coaters, 
JEOL, Japan) and viewed under SEM (JEOL, Japan) using 10kV loading current.   
 
3.4.2 Fourier Transform Infrared Spectroscopy (FTIR)  
FTIR was used to determine the incorporation of biochemical cues in the IPC hydrogels. Cell-
free IPC hydrogels (control, Col I, HA and CS) were air-dried to form a film. The resulting 
films were placed in FTIR pans and their corresponding spectrums were obtained with a FTIR 
spectrometer (ThermoScientific, USA). Spectrums for cue incorporated samples were compared 
against spectrums of control samples without cues. Distinct peaks were identified using a 
library containing characteristics peaks and corresponding functional groups.  
 
3.4.3 Swelling ratio and water content of IPC hydrogels 
Freshly formed IPC hydrogels (control, Col I, HA and CS) were placed in autoclaved deionized 
water for 2 h. A preliminary experiment was conducted to determine that there was no further 
increase in the hydrated weight of the hydrogels after 2 h. Hence, the hydrogels were weighed 
to determine the hydrated weight (Wthyd) at the second hour. The hydrogels were subsequently 
freeze- dried and the dry weight was determined (Wtdry). The swelling ratio was determined by 
dividing the hydrated weight (Wthyd) with the dry weight (Wtdry). Water content of IPC 






3.4.4 FITC conjugation of biochemical cues 
An optimal concentration of 0.25% was determined for the incorporation of the different 
biochemical cues (Col I, CS and HA). Optimization was carried out based on the highest 
possible cue concentration that allows formation of IPC fiber. The incorporation of Col I, HA 
and CS in IPC fibers was studied by conjugating them with FITC. FITC (ThermoScientific) was 
conjugated to methylated Col I (MC) by mixing 0.2 mg FITC per mg of MC, at a pH of 9.5 and 
was incubated overnight at 4
o
C (3). The product was dialyzed using a cellulose membrane 
(3500MWCO) (ThermoScientific) overnight, to remove unreacted FITC and subsequently 
freeze-dried to obtain soluble FITC conjugated Col I (FITC-Col I). FITC was conjugated to CS 
and HA by mixing FITC (dissolved in DMSO) with CS or HA dissolved in deionized water 
(0.2mg FITC/mg of CS or HA). The solutions were mixed for 1 h and incubated overnight at 
4
o
C. The resulting solutions were dialyzed overnight using a cellulose membrane 
(3500MWCO) (ThermoScientific), to remove unreacted FITC, and subsequently freeze-dried to 
obtain soluble FITC conjugated CS (FITC-CS), and HA (FITC-HA). 
 
3.4.5 Release profile of biochemical cues in IPC hydrogels 
IPC hydrogels with FITC conjugated biochemical cues (FITC-Col I, FITC-HA, FITC-CS) were 
placed in 1ml of 1X PBS in a 24-well culture plate (Greiner Bio-One, North America) in a 
humidified incubator at 37°C in 5% CO2, to simulate culture conditions. The spent PBS was 
collected and replaced with fresh 1X PBS daily. At each time point, the hydrogels (n=5) were 
air-dried to form a film. The fluorescence intensities of both the spent PBS and dried film were 
determined using a multi-well plate reader (M200 Pro, Tecan, USA). The intensities of the 
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spent PBS and dried film were plotted against time to study the release kinetics of the 
biochemical cues in the IPC hydrogels. 
 
3.4.6 Determination of hydrogel contraction 
Phase-contrast images of both IPC-control, IPC-Col I hydrogels and Col I hydrogels were 
acquired during in vitro culture at days 1, 4, 7, 14, with an Olympus IX71 upright microscope. 
The area measurement of the hydrogels was obtained from their respective phase contrast 
images by manually defining the contour of the hydrogels using ImageJ software (NIH, USA).  
The percentage (%) loss in area of hydrogels was calculated using the formula, 
                         
                              % loss in area = [1- (a(t) – a(o) )]  100, 
 
where a(t) refers to area of hydrogel at time point under study and a(o) refers to area 
measurement at day 1 of the same hydrogels. Quadruplicates of each hydrogel group were 
analysed from three independent experiments. 
 
3.5. Histological and immunohistochemical evaluation 
The samples were harvested at day 21, washed with PBS, and fixed by adding 4% 
paraformaldehyde (Sigma-Aldrich) and were left overnight at 4°C.  After removing the 
paraformaldehyde, the samples were dehydrated in ethanol and embedded in paraffin for 
histological and immunological staining. For Alcian blue staining, the sections were incubated 
with 0.5% Alcian blue (A3157, Sigma-Aldrich) in 0.1M HCl (320331, Sigma-Aldrich) for 30 
min and counterstained with nuclear fast red (60700,Sigma-Aldrich).  For Safranin-O staining, 
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the sections were incubated in hematoxylin (HHS32,Sigma-Aldrich) for 5 min, followed by a 
dip in accumulate differentiating solution for 5 sec, washed in tap water and stained with fast 
green(F7258,Sigma-Aldrich) for 5 min. This was followed by washing in 1% acetic acid 
solution (9508-03, JT Baker) for 10 sec, and staining with Safranin-O (146640250, 
AcrosOrganics) for 5 min.  
For immunohistochemistry, ultra vision detection kit (TP-015-AF, Thermoscientific) 
was used.  Endogenous peroxidase in the sections was first blocked with hydrogen peroxide 
before pepsin treatment for 20 min. Monoclonal antibodies used included mouse anti-collagen 
type II (1:500; Clone 6B3; Chemicon Inc.), mouse anti-collagen type I (1:500; Sigma C2456), 
mouse anti-collagen X (1:25; Quartett 2031501018), rabbit anti-lubricin (1:200; ab 94933), 
rabbit anti- collagen IX (1:10; ab 75807), and rat anti-cartilage oligomeric matrix protein 
(COMP) (1:15; ab 11056). A mouse, rabbit or rat IgG isotype (Zymed Laboratories Inc.) was 
used as control, according to the host used for raising the primary antibodies. The primary and 
control antibodies were incubated overnight, before incubation with biotinylated goat anti-
mouse, or anti-rabbit, or anti-rat (Lab Vision Corporation) for 30 min. Streptavidin peroxidase 
was added for 45 min and 3,3'-Diaminobenzidine was used as a chromogenic agent and 
counterstaining was done with Gill’s Hematoxylin. The slides were dehydrated before 
mounting. 
 
3.6. Immunofluorescence staining and analysis 
3.6.1 Immunofluorescence staining 
Samples were fixed in 4% paraformaldehyde for 15 min and permeabilized with 0.2% Triton X-
100 in PBS for 10 min. After blocking with 5% BSA/PBS, they were incubated with primary 
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antibody of interest, overnight at 4°C. Later they were washed with 0.05% Tween20 in PBS and 
incubated with appropriate secondary antibodies for 1 h in dark. After washing with PBS, 
samples were counterstained with DAPI (Millipore) before mounting using Fluoromount 
(F4680, Sigma-Aldrich). The primary antibodies used in this study included, mouse anti-
collagen type II (1:200; Clone6B3; ChemiconInc., Temecuela, CA), rabbit anti-sox9 (1:200; sc-
20095; SantaCruz),   mouse anti-N-cadherin (1:200;CloneGC-4, #C3865; Sigma), rabbit anti-β-
catenin (1:1000; #9562;Cell signalling Tech). The secondary antibodies used were AlexaFluor 
594 goat anti-mouse IgG (1:200), and AlexaFluor 488 goat anti-rabbit IgG (1:200). For F-actin 
staining, after samples were fixed and permeabilized, rhodamine phalloidin (1:500; 90228; 
Millipore)) was added for 15 min, washed with PBS before counterstaining with DAPI 
(Millipore), and were mounted using Fluoromount (F4680, Sigma-Aldrich). For confocal 
imaging of Col I hydrogels, samples were cryosectioned and fixed with ice-cold acetone (VWR 
International) at 4°C, before staining with appropriate fluorophores, as described above. Images 
were captured using a Zeiss LSM 510 Meta confocal and Nikon AIRsi, and analysed using 
LSM image browser, Nikon elements and ImageJ. (NIH, USA) 
3.6.2 Quantification of immunofluorescence signals 
Quantification of fluorescence signals from confocal microscopy generated images were 
performed using ImageJ (NIH, USA). Different regions of the hydrogels were imaged, with n≥5 
image fields per sample, per region. An average of immunofluorescence signals from triplicate 
hydrogel samples was calculated. 
3.7. Quantification of ECM  and DNA content 
The IPC scaffolds, Col I hydrogel and MSC pellets were digested with 10 mg/mL of Pepsin 
(Sigma-Aldrich) in 0.05 M acetic acid at 4°C for 5-7 days, followed by overnight enzymatic 
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digestion with  Elastase (1 mg/ml, Sigma-Aldrich) at pH 8.0. The digests were centrifuged at 
10,000rpm for 5 min at 4°C and stored at -20°C until further used for ECM quantification 
studies.  Quadruplicates of each scaffold group were analysed from three independent 
experiments. The amount of sulfated glycosaminoglycan (s-GAG)  deposited in the various 
study groups was quantified using Blyscan sulfated glycosaminoglycan assay kit (Biocolor Ltd, 
Newtownabbey, Ireland), as per the manufacturer’s recommendations.  Briefly, the digests from 
various study groups were mixed with 250 µL Blyscan dye and placed on a mechanical shaker 
for 30 min at room temperature. Following high speed centrifugation (>10,000xg) for 10 min 
250 µL of dissociation reagent was added to the resulting precipitate and vortexed for 10 min to 
release the bound dye. Quantification of sGAG was done by measuring the absorbance of re-
dissolved dye at 656 nm using Flurostar Optima plate reader, using a standard curve generated 
from a known standard sGAG solution supplied by manufacture.  Values for sGAG content thus 
obtained were normalized to the total DNA content of respective samples, measured using 
Picogreen dsDNA assay (Molecular Probes, OR, USA). Collagen Type II content was measured 
using a captured enzyme-linked immunosorbent assay (ELISA, Chondrex, Redmond, WA), as 
per the manufacturer’s recommendations. Absorbance measurements at 490 nm were taken 
using a TECAN Infinite M200 and the concentration of Col II was extrapolated from a standard 
curve generated using a type II collagen standard supplied with the kit. Similar to sGAG, Col II 
content was also normalized to the DNA content of respective samples.  
3.8.  Real time PCR analysis 
After 2-3 weeks under chondrogenic induction medium, samples were digested in 0.25% 
collagenase solution at 37°C for 1-2 h. Cells were collected by centrifugation and total RNA 
was extracted using the RNeasy Mini Kit (Qiagen, Valencia, CA) following the manufacturer’s 
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recommendations. RNA concentration was determined using the NanoDrop (NanoDrop 
Technologies, Wilmington, DE) and reverse transcription reactions were performed with 100 ng 
total RNA using iScript
TM
 cDNA synthesis kit (Biorad Laboratories, Hercules, CA).  Real-time 
PCR reactions were conducted using the SYBR green system.  Primer set sequences used in this 
study are listed in (Table 1).  
 




Expression of PRG-4 and CILP was analyzed with the customized Taqman probe-based 
gene expression system (Applied Biosystems). Real Time RCR reactions using the ABI 7500 
Real Time PCR System (Applied Biosystems) were performed at 95
o
C for 10 min, followed by 
40 cycles of amplifications, consisted of denaturation step at 95
o
C for 15 s, and extension step 
at 60
o
C for 1 min.  The level of expression of the target gene, normalized to GAPDH, was then 
calculated using the 2
-ΔΔCt
 formula with reference to the undifferentiated MSC. 
 
3.9. Integrin inhibition studies 
β-1 integrin blocking studies were carried out where MSCs were first preincubated with 
5µg/mL of anti- β-1 integrin antibody (BD 552828) in serum-free DMEM media, following 
which double the volume of media was added and centrifuged. The resulting cell pellets were 
resuspended in appropriate seeding densities in growth media supplemented with 2.5 µg/mL of 
anti- β-1 integrin antibody (BD 552828) prior to seeding in IPC Col I scaffolds. Scaffolds with 
such cells were expanded overnight in expansion media before changing to the chondrogenic 
induction medium for the remainder of 2-week culture period, where both these media were 
supplemented with anti-β-1 integrin antibody at a final concentration of 2.5µg/mL. An IgG2aκ 





 staining and MTS assay 
Cell viability was assessed by LIVE/DEAD
®
 staining kit (Invitrogen, USA). IPC-hydrogels in 
culture media were supplemented with 2µM calcein AM (green) and 4µM ethidium 
homodimer-1 (red) solution (final concentrations, as per the manufacturer’s recommendations) 
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and incubated for 15-20 mins 37°C in 5% CO2, prior to imaging. Cells staining green were 
considered as viable cells while those in red were dead cells. MTS assay for measuring cell 
proliferation was performed using CellTiter 96® AQueous One Solution Cell Proliferation 
Assay (Promega, USA). MSCs were seeded at density of 10,000 cells per well in 96-well plates 
with 100µl medium, in quadruplicates for each time point, under expansion and chondrogenic 
differentiation conditions. At days, 1, 4, 7 and 14, 20µl of CellTiter 96® AQueous One Solution 
was added to each well and incubated for 1hr at 37°C in 5% CO2. Absorbance intensities were 
measured using a multi-well plate reader (M200 Pro, Tecan, USA) to determine proliferation. 
 
3.11. F-actin disruption by Cytochalasin D 
A 2mM stock solution of Cytochalasin D (CytD) (Sigma Aldrich #C8273) dissolved in 
dimethylsulfoxide (DMSO) was used for actin disruption experiments. Different concentrations 
of CytD were tested initially that included 1µM, 0.5µM, 0.25µM, and 0.1µM. Different 
dilutions of 2mM stock solution were made (1mM, 0.5mM, 0.25mM, 0.1mM) using DMSO 
(100%, Sigma Aldrich) for all the final concentrations tested, to keep the amount of DMSO 
added to the media as a constant throughout all experiments. This was to ensure that 
concentration of DMSO never exceeded the manufacturer’s recommended concentration of 
0.1%, to limit any adverse effects on the cells. Thus final concentrations of CytD solutions, 
1µM, 0.5µM, 0.25µM, 0.1µM, were prepared by aliquoting 1: 1000 dilution of CytD stock 
solutions, 1mM, 0.5mM, 0.25mM, and 0.1mM, respectively, in the appropriate culture media. A 
1:1000 dilution of DMSO made with culture media served as controls. Cell-laden IPC-Col I 
hydrogels, with either MSCs or chondrocytes, were exposed to the above mentioned CytD 
concentrations, throughout the period of the experiment, starting with overnight expansion in 
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the expansion media, followed by chondrogenic differentiation for 1-2 weeks. Cell-laden IPC-
Col I hydrogels, with either MSCs or chondrocytes, exposed to 1:1000 dilution of DMSO 
throughout their culture period, served as controls. Cell viability in both the CytD and control 
groups was assessed by LIVE/DEAD
®
 staining kit (Invitrogen, USA), at 24 h post treatment 
and at the end of one week of chondrogenic differentiation, for both MSC and chondrocyte 
laden IPC-Col I hydrogels.  
3.12. Statistical analysis 
Statistical analysis (GraphPad Instat3) was done using Student’s t-test for comparison of two 
groups. Analysis of variance (ANOVA) with Tukey’s HSD (honest significant difference) post 
hoc analysis for comparison of multiple groups was performed, after testing the data for 
normality. Tukey’s post hoc analysis was employed to reduce type I errors, since all possible 
pairwise comparisons between study groups were considered for statistical analysis. Data were 
presented as mean ± SD, with the level of significance set at P < 0.05. All quantitative data 
reported here were averaged from replicates of three independent experiments, with accurate 
sample size (replicates) for experimental methods provided in appropriate chapters that follow. 
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CHAPTER 4  
 




This chapter details studies that were performed to fulfill the first aim of this thesis, which is to 
establish chondrogenic differentiation of MSCs  in vitro, employing  IPC-based fibrous 
hydrogels. Initial studies involved the fabrication of cell-laden IPC hydrogels, and hydrogel 
matrices with varying ECM compositions, such as CS, Col-I, and HA, followed by their material 
characterization. Subsequent studies in this chapter involved comparing cell viability, 
proliferation and chondrogenic differentiation in unmodified, IPC-control hydrogels with IPC-
Col I hydrogels, and optimizing cell seeding densities for MSC chondrogenesis.   
Approaches for material characterization of IPC hydrogels involved FTIR-analysis 
(Methods: 3.4.2) for qualitative characterization of cue incorporation, wherein detection of 
specific functional groups corresponding to incorporated biochemical cues could be evaluated. 
SEM analysis (Methods: 3.4.1) was employed to understand native IPC fiber morphology and 
any differences post cue incorporation. Hydrogel characteristics of IPC-based fibers were 
evaluated by water content, and swelling ratio analyses (Methods: 3.4.3), which reflected the 
ability of IPC-based 3D matrices to mimic native, hydrated environment of articular cartilage. 
All the above studies were performed immediately after IPC fiber synthesis. Quantification and 
release kinetics of incorporated biochemical cues was carried out by employing fluorophore 
(FITC) conjugated cues (Methods: 3.4.4), which were assayed at different time points (days 1, 2, 
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3, 5 and 7) under cell expansion culture conditions (Methods: 3.4.5). While fluorescence 
conjugation offered ease of quantitative analysis by measuring fluorescence intensities in IPC 
fibers and media supernatant at different time points, the analysis was performed over seven days 
since any ECM-driven cellular event could be initiated significantly within such timelines. 
Cytocompatibility of IPC-based hydrogels was analysed by LIVE/DEAD staining (Methods: 
3.10) fourty-eight hours post cellular encapsulation, to appreciate the maintenance of viable cells 
in such 3D matrices. A MTS assay was performed (Methods: 3.10) at different time points over 
two weeks (days 1, 4, 7, and 14) to analyse sustained proliferative ability of encapsulated MSC, 
under expansion and chondrogenic differentiation conditions, in vitro. Lastly, since induction of 
chondrogenic differentiation necessitates a critical cell-density threshold, three different cell 
densities for encapsulation were tested in IPC-control and IPC-Col I hydrogels: (i) low - 1x10
5
 
cells per fiber; (ii) medium - 2.5x10
5
 cells per fiber; and (iii) high - 5x10
5
 cells per fiber. They 
were derived around the conventional cell-density threshold of a scaffold-free cell pellet, namely 
2.5x10
5 
cells, widely used to analyse the chondrogenic differentiation potential of MSCs. The 
extent of chondrogenic differentiation in such hydrogels was studied by histological analysis of 
secreted ECM components, employing Safranin-O and Collagen type II immunohistochemical 
staining (Methods: 3.5). 
 
4.2 Results 
4.2.1 IPC hydrogel assembly and biochemical cue presentation 
Fabrication of IPC-based fibers and its assembly into 3D hydrogels involved creating interfaces 
between the two polyelectrolyte solutions, chitin and alginate, which was drawn upwards to 
form a nascent hydrogel fiber (Fig. 4A). MSC or chondrocytes were suspended in chitin 
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solution at a density of 1  104 cells/μl. For hydrogel construct assembly, multiple cell-laden 
fibers were drawn simultaneously (Fig. 4D) and fused by immersing in 0.25% sodium alginate 
solution. The hydrogel thus obtained (Fig. 4E) was termed as ―IPC-control‖ hydrogel. Col I was 
incorporated into the IPC hydrogel as methylated Col I, mixed with the polycationic solution, 
chitin, at final concentration of 0.25% (w/v).  The other biochemical cues, namely, CS and HA, 
were incorporated into the IPC fiber by mixing them in solution with the polyanion, sodium 
alginate, at a final concentration of 0.25% (w/v). Hydrogel thus obtained were termed with 
reference to the biochemical cue that was incorporated, such as, ―IPC-Col I‖, ―IPC-CS‖, or 






Fig. 4 Fabrication of interfacial polyelectrolyte complexation (IPC) fiber and fiber assembled hydrogels, with 
cell and biochemical cue encapsulation. (A) Schematic illustration of drawing a hydrogel fiber from the interface 
of the 1% water soluble chitin (WSC) and 1% sodium alginate droplets. (B) Polyelectrolyte  complexation and 
nucleation of IPC fibers as indicated by arrows. (C) Confocal image of FITC-conjugated type I collagen (Col I) 
incorporated IPC fibers showing Col I distribution. (D) Assembly of multiple fibers by fusion and collection on a 
spooling device. (E) Fiber assembled hydrogel with illustration of Col I alignment on nuclear fibers and cell 
distribution in the IPC fibers. (F) Confocal image of FITC-Col I incorporated IPC fibers, with F-actin staining 





A distinguishing feature of IPC-based fiber assembly was the formation of submicron 
size, nuclear fibers (Fig. 4B) within each 3D IPC fiber. Such submicron fibers were known to 
form as the polyelectrolytes neutralized and coalesced during fiber drawing (Wan  et al., 2004). 
Further, incorporated biochemical cues were found to align along such submicron fibers, 
offering regular and oriented form of cue presentation to the encapsulated cells (Fig. 4E). This 
was demonstrated by the incorporation of FITC-conjugated Col I cue, wherein it was distributed 
uniformly throughout the fiber length (Fig. 4C), and was presented as parallel, submicron 
fibers, facilitating proximal interactions with encapsulated MSCs (Fig. 4F). 
 
4.2.2 Material characterization of IPC fibers with different cues 
A FTIR analysis was carried out to validate the incorporation of different biochemical cues, 
wherein they were premixed with either of the polyelectrolyte solutions, prior to fiber drawing. 
The FTIR spectrum indicated differences in absorbance spectrum between IPC-control fibers, 




 were observed 
following CS, and Col I incorporation, respectively, which were absent in spectral profile of 
IPC-control fibers, thus validating their incorporation (Fig. 5A). However, such distinct peaks 
were not observed in the FTIR profile for HA incorporated fibers, relative to IPC-control, 
suggesting the need for further validation by analysis of other physical properties. SEM analysis 
of fibers with different cues also showed differences in IPC-Col I, IPC-HA hydrogels, relative to 
IPC-control hydrogels (Fig. 5B). Surface morphology of IPC-Col I fibers was found to be 
rougher, whereas IPC-HA fibers were found to be smoother, in comparison to IPC-control fibers. 







To validate that IPC fiber assembled hydrogels indeed constituted a hydrogel 
environment, swelling ratio and water content analyses were performed (Fig. 6). While it was 
found that the different IPC hydrogels studied (with or without biochemical cues) had a very 
high water content of above 95% (Fig. 6C), their swelling ratios were found to differ. IPC-CS 
hydrogels exhibited the least swelling (<30%), with IPC-Col I and IPC-HA hydrogels swelling 
the most (>70%), relative to IPC-control hydrogels, which swell upto 40% (Fig 6B). 
Fig. 5 FTIR and SEM analysis of IPC fibers with different cues. FTIR analysis (A) for validating 
biochemical cue incorporation and SEM analysis (B) of IPC fiber morphology after biochemical cue 








Further studies involved studying the cue incorporation efficiency and their release 
profile from IPC hydrogels. FITC-conjugated Col I, CS and HA were incorporated into IPC 
hydrogels, which enabled fluorescence quantification to analyse their incorporation and release 
over time. IPC-control hydrogels (without any cues) served as controls to eliminate any false 
positives from autofluorescence of the biomaterials. 
 
Fig. 6 Swelling ratio and water content analysis of IPC hydrogel with different cues. Macroscopic images of 
hydrated IPC hydrogels with different cues (A) and their swelling ratio (B) and water content analysis (C). 








 All the study groups of IPC hydrogels were kept in PBS, immediately after 
encapsulation, and fluorescence intensity measurements were taken at days 1, 2, 3, 5, and 7, of 
all the hydrogels and the PBS solutions housing them. Phase contrast and fluorescence images 
taken during the study enabled visualization of uniform cue incorporation throughout the 
Fig. 7 Quantification of biochemical cue incorporation and its release profile in IPC hydrogels. (A) Phase 
contrast and fluorescent images of IPC hydrogels with FITC-conjugated CS and HA taken at days 1, 4, and 7. 
(Scale bar: 200µm). Analysis of incorporation efficiency (B) and release profile (C) of FITC conjugated Col I, 
CS and HA performed at days 1, 2, 3, 5, and 7, post IPC hydrogel fabrication.  
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hydrogels, and alignment of incorporate cues within IPC hydrogels (Fig. 7A). Fluorescence 
analysis, after normalizing with background readings from IPC-control hydrogels, indicated that 
80% of incorporated Col I and CS were retained at all the time points studied (Fig. 7B, 7C). On 
the other hand, 82% of incorporated HA was retained post-encapsulation at day 1, with release 
of additional 10% HA in the subsequent time points, resulting in about 72% retention by day 7. 
Thus it was established that about 70% of incorporated HA and 80% of incorporated Col I and 
CS were retained in IPC-hydrogels in the first 7 days, suggesting that IPC hydrogels offered a 
good 3D platform to study the influence of biochemical cues on cellular processes. 
 
4.2.3 Studying cell viability and proliferation in IPC hydrogels 
A live-dead staining analysis was performed after 48 h of culture in expansion conditions, to 
understand the cytocompatibility of IPC hydrogels. Significant amount of encapsulated cells 
were found to be viable in both the hydrogels with very less cytotoxicity in general (Fig. 8A). 
The cells were distributed evenly in the IPC hydrogel fibers and exhibited differences in cell 
morphology. The cells in IPC-Col I hydrogels aligned with a fibroblastic morphology while 
those on IPC-control hydrogels were found to form local aggregates. An MTS assay was 
performed to examine differences in MSC proliferation (as a function of their metabolic 
activity) in the two hydrogel systems, under expansion (Fig. 8B), and chondrogenic culture 
conditions (Fig. 8C). No significant differences were observed between the two hydrogels in 
both culture conditions at day 1. At day 4, IPC-Col I hydrogels in expansion media facilitated 
significantly higher cell proliferation, relative to that observed in IPC-control hydrogels under 








No significant differences were observed in IPC-control hydrogels at day 4 between the 
two culture conditions. At day 7, IPC-control and IPC-Col I hydrogels showed significantly 
higher cell proliferation under chondrogenic conditions, relative to the respective hydrogels in 
the expansion media. Also, IPC-Col I hydrogel had significantly higher cell proliferation than 
IPC-control hydrogels at day 7 under chondrogenic conditions. But, MSC proliferation fell in 
both hydrogel groups under expansion conditions at day 7, relative to that observed at day 4 
under similar conditions. Cell proliferation increased significantly under expansion conditions 
Fig. 8 Cell viability and proliferation studies on IPC-control and IPC-Col I hydrogels. (A) Cell viability and 
distribution by phase contrast and LIVE/DEAD staining at day 3. (Scale bar: 100µm). Cell proliferation 
studies by MTS assay on IPC-control and IPC-Col I hydrogelsunder expansion (B) and chondrogenic 
differentiation (C), at days 1, 4,7 and 14.* denotes p<0.05 between IPC-control and IPC-Col I hydrogels 
under similar culture conditions, at same time points.# denotes p<0.05 between same hydrogel systems under 
different culture conditions, at same time points. 
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by day 14 in IPC-Col I hydrogels, with no significant increase in IPC-control hydrogels, relative 
to day 7 under similar culture conditions. Under chondrogenic conditions, cell proliferation fell 
in both the hydrogel groups at day 14, relative to that observed at day 7 under similar culture 
conditions. Yet, significant differences were observed between IPC-control and IPC-Col I 
hydrogels under chondrogenic conditions at day 14. 
 
4.2.4 Optimising cell seeding densities for MSC chondrogenesis in IPC hydrogels 
Primary MSCs isolated from human bone marrow samples of consented donors were 
encapsulated in water soluble chitin and alginate based 3D IPC fibers, which were assembled to 
form a 3D hydrogel. To investigate the ability of the IPC hydrogels to support differentiation of 
MSCs, the cell-laden 3D constructs were cultured under in vitro chondrogenic conditions for 2-
3 weeks. Preliminary studies involved testing different cell seeding densities for MSC 
chondrogenesis in IPC hydrogels. Three different densities for cell encapsulation were studied, 
which included: (i) low - 1x10
5
 cells per fiber; (ii) medium – 2.5x105 cells per fiber; and (iii) 
high - 5x10
5
 cells per fiber. IPC-control and IPC-Col I hydrogels with encapsulated MSCs at 
different cell seeding densities was cultured under chondrogenic conditions for 2-3 weeks. IPC-
Col I hydrogels facilitated uniform cell spreading and chondrogenesis throughout the construct 
(Fig. 9B), as opposed to formation of local cell clusters in IPC-control hydrogels (Fig. 9A). An 
interesting phenomenon was the observed contraction of the IPC-hydrogels with the 
progression of chondrogenic differentiation. Varying trends of hydrogel contraction were 
observed among the different cell densities. IPC-Col I hydrogels (Fig. 9B) contracted more than 






             
 
 
Fig. 9 Macroscopic analysis of IPC-control and IPC-Col I hydrogels under chondrogenic differentiation 
conditions. (A) Phase contrast images acquired during chondrogenic differentiation of MSCs encapsulated at 
different seeding densities in IPC-control (A) and IPC-Col I hydrogels (B) at days, 3, 4, 7 and 14. (Scale bar: 
500µm). Graph showing differences in contraction of IPC-control (C) and IPC-Col I (D) hydrogels at 
different seeding densities studied. 
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IPC-control hydrogels followed a cell density dependent increase in hydrogel contraction, with 
10%, 20%, and 30% contraction of their initial size, at low, medium and high cell seeding 
densities, respectively (Fig. 9C). IPC-Col I hydrogels followed a different trend and varied in a 
cell number independent fashion (Fig. 9D). The medium cell seeding density caused the highest 
contraction here, up to 50% by day 3, followed by 35% and 30% in the high and low seeding 
densities respectively.  Scaffolds with a high seeding density contracted maximally up to 45% 
by day 7 whereas contraction of scaffolds with medium seeding density progressed till day 14, 
to reach a maximum of 62% contraction, by day 14.  The scaffolds with low seeding density 
also contracted progressively till day 14, but in a gradual, constant fashion reaching 58% 
contraction 
 
Histological evaluation of chondrogenic outcomes in the two hydrogels at different cell 
seeding densities was performed at day 21. In general, the extent of chondrogenic 
differentiation was in agreement with increasing cell seeding densities and hydrogel 
contraction, as evidenced by intense Saf-O and Col II staining (Fig. 10). IPC-Col I hydrogels 
facilitated superior chondrogenesis in comparison with IPC-control hydrogels, at all the seeding 
densities studied. For subsequent exploration of the cellular and molecular events brought about 
by the Col I incorporation (or by other biochemical cues, CS and HA) during early 
chondrogenesis, a medium cell seeding density was chosen. The medium cell seeding density 
was also reflective of the cell density used in MSC pellet controls, in which 2.5x10
5 
cells per 







Fig. 10  Histological analysis of chondrogenic differentiation with different cell seeding densities in IPC 
hydrogels. Histological analysis of chondrogenic outcomes at day 21 in IPC-control (A) and IPC-Col I 
hydrogels (B) by safranin-O and Col II immunohistological staining. (Scale bar: 200µm). 
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4.3 Discussion  
Among the regenerative approaches for articular cartilage regeneration that have been 
investigated (Ahmed and Hincke, 2010, Hunziker, 2009), bone marrow derived mesenchymal 
stem cells (BMSCs) offer an attractive strategy, due to their autologous origins, scalability, and 
potential for chondrogenic differentiation in vitro  (Keeney et al., 2011, Kock et al., 2012). Yet 
the quality of regenerated neocartilage tissue derived from such approaches remain suboptimal, 
with inferior composition and distribution of ECM components, relative to native tissue. To 
improve the quality and function articular cartilage repair, various biochemical and biophysical 
factors influencing cell fate and function have been studied (Discher et al., 2009, Lutolf et al., 
2009). Chief among such approaches is the modulation of biochemical composition of 3D 
matrices, owing to their efficacious role in influencing regenerative outcomes (Hwang et al., 
2011, Nguyen et al., 2011a, Nguyen et al., 2011b, Coates et al., 2012), which are especially 
relevant for articular cartilage tissue engineering, as cell-ECM interactions are vital for the 
development and maintenance of chondrogenic phenotype (DeLise et al., 2000). Although 
PEG, alginate based hydrogel strategies for engineering biomimetic 3D matrices by 
incorporating adhesive cues have demonstrated some improvements (Hwang et al., 2011, 
Nguyen et al., 2011a, Nguyen et al., 2011), they are limited in their ability to facilitate cellular 
migration, cell-cell, and cell-ECM interactions, and uniform ECM distribution that are vital for 
engineering functional cartilage tissue equivalent. This necessitates establishing a conducive 3D 
matrix for facilitating dynamic cellular, cell-ECM interactions, to improve chondrogenic 
outcomes in taking a MSC based approach. To this end, this study explored the application of 
IPC-based fibrous hydrogel for MSC based articular cartilage tissue engineering. An IPC-based 
approach offered easy, yet efficient strategy for engineering microscale fibers with varying 
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biochemical environments, that could be assembled to form 3D hydrogels (Tai et al., 2010, 
Wan et al., 2004). Thus IPC-based hydrogels were fabricated with varying biochemical 
compositions and their material characteristics, cytocompatibility were analysed. Further, MSC 
chondrogenesis was studied in unmodified, IPC-control, and Col I incorporated IPC-Col I 
hydrogels, to establish its efficacy as a conducive 3D matrix to support MSC chondrogenesis, 
and which can offer engineered 3D matrices to augment chondrogenic outcomes. 
 
4.3.1 Physical properties and biochemical cue incorporation of IPC hydrogels  
IPC hydrogels in general were found to facilitate efficient incorporation of the biochemical cues 
tested, namely, Col I, CS, and HA. FTIR analysis of IPC-based fibers validated efficient 
biochemical cue incorporation of CS, Col I, whereas HA incorporation could not be clearly 
demonstrated (Fig. 5). SEM analysis indicated characteristic parallel ridges (Tai et al., 2010) in 
all fibers, with surface roughness observed in IPC-Col I fibers, and a smoothened surface 
morphology of IPC-HA fibers, relative to IPC-control and IPC-CS hydrogel fibers (Fig. 5B). 
Further studies characterized the physical properties of cue incorporated IPC hydrogels. Water 
content analysis validated the hydrogel-like property of the IPC-based constructs, wherein all 
the hydrogels studied had more than 95% water content (Fig. 6C). Swelling ratio analysis 
revealed that IPC-Col I and IPC-HA hydrogels have a  very high potential for hydration (Fig. 
6B). These results were in-line with earlier studies, since collagen hydrogels are known to swell 
greatly in solution (Li et al., 2012), and HA incorporation was reported to result in even higher 
matrix hydration (Hwang et al., 2011, Nguyen et al., 2011a, Nguyen et al., 2011b, Responte et 
al., 2012). The relatively lower swelling levels of IPC-CS hydrogels might have arisen from the 
polyelectrolyte neutralisation chemistry, as ionic crosslinking of chitin and CS scaffolds is 
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known to result in lower swelling ratios (Peng et al., 2006). Studies assessing the biochemical 
cue incorporation efficiency (Fig. 7B) and its release profiles (Fig 7C) found more than 80% 
efficiency of CS and HA incorporation, and 70% for HA incorporation at all the time points 
studied.  HA demonstrated a 20% burst release at day 1, but was subsequently found to be 
released only by another 10% cumulatively by day 7 (Fig. 7C). Together with less than 5% 
burst release observed for Col I and CS at day 1, the results indicated good incorporation and 
retention efficiency of such biochemical cues in IPC hydrogels. Hence the potential of IPC 
hydrogels to present different matrix microenvironments for analysing chondrogenic 
differentiation was validated.  
 
4.3.2 Cytocompatibility of IPC hydrogels 
Studies addressing cytocompatibility of IPC hydrogels were carried out with IPC-control and 
IPC-Col I hydrogels, to represent basal and cue-incorporated IPC hydrogel systems. Both IPC-
hydrogels were found to support high cell viability, as evidenced by live/ dead staining of 
MSCs encapsulated in the hydrogel systems (Fig. 8A). MSCs in IPC-control and IPC-Col I 
hydrogels adopted distinctly different cell morphologies, validating successful cue 
incorporation in the IPC-Col I hydrogels and their ability to efficiently present the matrix cue 
microenvironments to the encapsulated cells. The cells in IPC-Col I hydrogels aligned with a 
fibroblastic morphology while those on IPC-control hydrogels were found to form local 
aggregates. Cell proliferation was also supported in both the hydrogels, under both expansion 
and differentiation conditions studied. Expansion conditions facilitated a general increase in 
both hydrogels until day 7, but was followed by a decrease of cell proliferation in both the IPC-
control and IPC-Col I hydrogels (Fig. 8B). Cell proliferation in IPC-Col I was found to increase 
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at day 14 to levels similar to that at day 7, but such increase was not observed in IPC-control 
hydrogels. Adoption of round cell morphology and cell aggregation might have resulted in 
contact inhibition of the encapsulated MSCs. In chondrogenic medium, IPC-Col I hydrogels 
facilitated a gradual increase in cell proliferation, which peaked at day 7 (Fig. 8C).  IPC-control 
hydrogels demonstrated highest proliferation at day 1, with no significant differences until day 
14, whereupon  it was found to decrease. Thus Col I incorporation- induced fibroblastic cellular 
morphology might have supported better cell proliferation in general. The increase in 
chondroprogenitor cell number under chondrogenic condition was noteworthy, as generating 
higher cell number of chondrogenically committed cells in vitro has been amongst the 
challenges facing regenerative approaches for articular cartilage repair.  
 
4.3.3 Establishing optimal cell density for MSC chondrogenesis in IPC hydrogel 
Since establishing a critical cell packing density to initiate cell-cell interactions is known to be 
essential for initiating MSC chondrogenesis (DeLise et al., 2000, Tacchetti et al., 1992), 
different cell seeding densities were studied to optimise initial cell numbers. Although both 
IPC-control and IPC-Col I hydrogels facilitated uniform cell distribution at day 1 (Fig. 9A, 9B), 
only the latter was found to maintain such uniform distribution throughout the culture period of 
chondrogenic differentiation.   
Significant construct contraction was observed in IPC-Col I hydrogels (Fig. 9B), where 
they pulled the fibers inwards, along the direction of contraction, presumably due to strong cell-
Col I interactions. MSCs in the IPC-control construct remained as isolated cell clusters with a 
random distribution (Fig. 9A), with less construct contraction (Fig. 9C).  The above 
observations were shared across the different cell seeding densities, with increasing cell 
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densities causing higher contraction, with the exception of high seeding density in IPC-Col I 
hydrogels (Fig. 9D). This might have occurred since the higher cell number and resultant 
packing density hampered hydrogel contraction, beyond a threshold volume that was needed to 
house them. Further, significant contraction of IPC-Col I hydrogels was neither observed in 
unseeded constructs, nor in cell-laden constructs under proliferative (non-differentiation) 
conditions. This was consistent with studies implicating the degree of construct contraction to 
be both indicative, and in direct correlation with chondrogenic differentiation (Ng et al., 2011), 
as IPC-Col I constructs did bring about superior chondrogenic outcomes in this study. 
Histological evaluation of chondrogenic outcomes in IPC hydrogels with different cell seeding 
densities revealed that the extent of chondrogenic differentiation was in agreement with 
increasing cell numbers, where a high cell density per fiber exhibited most significant 
chondrogenesis. IPC-Col I hydrogels were found to facilitate superior chondrogenesis in 
comparison with the IPC-control hydrogels, at all different seeding densities studied (Fig. 10B). 
A striking difference between the two systems was that the scaffolds with Col-I facilitated 
uniform cell spreading and chondrogenesis throughout the construct, as opposed to formation of 
local cell clusters in the uncoated scaffolds (Fig. 10A, 10B), which was in-line with phase 
contrast observations (Fig. 9A, 9B).  Although scaffolds containing Col I for MSC 
chondrogenesis have been reported previously, either as a hydrogel (Ng et al., 2011) or by 
chemical conjugation in synthetic hydrogels such as PEG (Hwang et al., 2011), the uniformity 
and robustness of chondrogenesis facilitated by IPC-Col I hydrogels, only after 3 weeks of 
differentiation was considered to be very significant. Further, the differences in cell morphology 
between IPC-control and IPC-Col I hydrogels were maintained, irrespective of the cell seeding 
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densities studied. Thus the ensuing studies explored the underlying causes for such cell 
behaviour and their influence in mediating chondrogenic outcomes.  
In summary, the above studies demonstrated the efficacy of IPC-based approaches for 
MSC encapsulation in 3D fibers to form fiber assembled hydrogels. IPC hydrogels were found 
to offer cytocompatible 3D environments and supported cellular processes such as proliferation, 
and chondrogenic differentiation of MSCs. Col I incorporation in IPC hydrogels was found to 
result in an elongated cell morphology, better proliferation and chondrogenic differentiation, 
relative to IPC-control. Thus, the potential of IPC hydrogels to present functionalised matrix 
microenvironments for studying chondrogenic differentiation was validated by Col I 
incorporation. The enhanced proliferation of chondrogenically committed cells in IPC-Col I 
hydrogels suggest a significant improvement over reported approaches, as generating sufficient 
chondroprogenitor populations in vitro represents a significant challenge for regenerative 
approaches aimed at cartilage repair. The efficacy of IPC-based hydrogels in mediating MSC 
chondrogenesis is underscored by the use of a lowered TGFβ-3 concentration (5ng/ml) in this 
study, against the 10ng/ml concentration that is usually employed in such experiments. The 
findings of this study employing reduced growth factors concentrations accentuate the potential 










The objective of this chapter was to evaluate the effects of IPC mediated biochemical cue 
presentation on MSC chondrogenesis and consequent phenotypic outcomes. Col I was 
employed for studies discussed in this chapter since Col I hydrogels, which could be formed 
with ease and efficiency under similar in vitro conditions, constituted good control groups for 
investigating the influence of IPC mediated cue presentation on MSC chondrogenesis. Further, 
mesenchymal progenitors developing into cartilaginous tissues in vivo, are known to exist in 
Col I rich microenvironments (DeLise et al., 2000, Sandell, 1994), providing a developmental 
context to study the influence of Col I. IPC mediated biochemical cue presentation on MSC 
chondrogenesis was studied by employing  IPC-control and IPC-Col I hydrogels, with the 
control group constituted by a conventional Col I hydrogel. Initial cell seeding density, final 
collagen concentration, and other conditions were kept the same between IPC-Col I and Col I 
hydrogels to facilitate a valid comparison. Also, to validate the efficacy of 3D hydrogels in 
facilitating robust MSC chondrogenesis, a scaffold-free, cell pellet control was included, as 
such high density micromass cultures are a well-accepted  in vitro model for MSC 
chondrogenesis. 
Analyses of the studies were done at two levels, namely early cellular and molecular 
events, and consequent functional phenotypic outcomes. Analysis of chondrogenic outcomes 
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was carried out by studying chondrogenic gene expression using RT-PCR analysis (Methods: 
3.8), quantification of chondroprogenitor population by picogreen assay, and ECM deposition 
by Blyscan assay for sGAG, and ELISA for Col II protein expression (Methods: 3.7), with 
sample size of n=6. Day 14, and day 21 time points were chosen for analysis for 
aforementioned studies to enable observation of changes in progenitor population and lineage 
commitment between the different study groups, over the course of chondrogenic 
differentiation. Histological analysis for studying ECM organisation and distribution of secreted 
ECM components, by Safranin-O staining and Col II immunohistochemistry (Methods: 3.5), 
was carried out only at day 21. A day 21 timepoint was chosen since IPC hydrogels 
encapsulating chondrogenically primed MSC would be implanted in orthotopic defect sites in 
animal model studies, after three weeks of in vitro culture. Although this thesis did not contain 
any in vivo animal model study, such analysis was done at day 21, to aid and keep with future 
animal studies.  
Analyses of early cellular events in 3D hydrogels (n=4) included studying cell 
morphology by F-actin staining at days 1, 4, and 7 (Methods: 3.6.1), and expression of markers 
for chondrogenic condensation, N-cadherin and β-catenin, and chondrogenic differentiation, 
Sox9 and Col II by immunofluorescence staining (Methods: 3.6.1), at days 4 and 7, since such 
markers would not be expressed by undifferentiated MSCs at day 1. An immunofluorescence 
analysis was chosen for studying early events, since cell morphology and molecular expression 
and their cellular localization could be efficiently delineated through high resolution, confocal 
microscopy. It could also offer additional information on cell number and their distribution, and 
differentiation induced cellular remodeling of local environment, if any. Lastly, the significance 
of early cellular and cell-ECM interactions on the derivation of functional, chondrogenic 
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phenotypes was studied by blocking cell-collagen interactions in IPC-Col I hydrogels, through 
functional inhibition of β1 integrin (n=5, Methods: 3.9). Such studies were also analysed for 
early cellular and molecular events, such as cell morphology (F-actin staining at days 1, 4, and 
7) and expression of markers for chondrogenic condensation (N-cadherin and β-catenin) at days 
4, and 7, by immunofluorescence staining (n=4, Methods: 3.6.1). RT-PCR analysis of 
chondrogenic gene expression (n=5, Methods: 3.8) was performed at day 14, after integrin 
inhibition, to evaluate the role of cell-ECM interactions in modulating chondrogenic outcomes. 
 
5.2 Results 
5.2.1 MSC chondrogenesis in hydrogel constructs  
Striking differences in MSC behaviour were observed within the first 24 h of 
encapsulation in IPC-control, and IPC-Col I hydrogels.  MSCs in IPC-Col I hydrogel aligned 
uniformly along the IPC fibers with an elongated, fibroblastic morphology, whereas they 
formed small clusters within the IPC-control fibers (Fig. 11A). Macroscopic analysis showed 
differences in hydrogel contraction for the three groups of hydrogel (Fig. 11A). MSCs-laden 
IPC-Col I hydrogel exhibited significant contraction, up to 60% of its original area, within the 
first 7 days of chondrogenic induction (Fig. 11B). In contrast, MSCs-laden IPC-control and Col 
I hydrogel exhibited significantly less amount of contraction (<20% and 40% respectively) 







Analysis of mRNA expression of chondrogenic markers, Col II, Aggrecan and Sox9 at 
days 14 and 21 by RT-PCR revealed that IPC hydrogels facilitated significant upregulation of 
these markers in comparison with IPC-control hydrogel, Col I hydrogel and the control pellet 
Fig. 11 Scaffold contraction in different hydrogels with encapsulated MSCs during chondrogenesis. (A) Phase 
contrast images of different hydrogels during the course of chondrogenesis. (Scale bar: 1 mm). (B) Analysis of 
MSCs mediated hydrogel contraction during chondrogenesis in the different groups. n≥4 per group, mean ±SD. 
# denotes p<0.05 between IPC-Col I and IPC–control or Col I hydrogel at same time point. 
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culture (Fig. 12A). Analysis of zonal cartilage marker expression demonstrated that IPC-control 
and IPC-Col I hydrogels were influencing phenotypic fate of the differentiated cells. Expression 
of superficial zone markers, Col I and Proteoglycan-4 (PRG-4), and middle zone marker, 
cartilage intermediate layer protein (CILP), were found to be upregulated in IPC-control 
hydrogel (Fig. 12A). On the other hand, markers for matrix maturity, cartilage oligomeric 
matrix protein (COMP) and collagen type IX (Col IX) were found to be significantly 
upregulated in IPC-Col I hydrogel, over that of IPC-control and Col I hydrogels. When 
expression levels of the aforementioned markers were normalized to their respective degree of 
differentiation, as indicated by Col II mRNA expression level, the phenotypic differences were 
maintained and more pronounced between IPC-Col I hydrogel to that of IPC-control and Col I 
hydrogel (Fig. 12B).  In comparing the phenotypic outcomes between IPC-Col I and Col I 
hydrogels (Fig. 12B), relative to pellet culture , the former pair downregulated the expression of 
Col I and PRG-4, whereas no significant differences were observed in the expression of the 
middle zone marker, CILP.  Expression of hypertrophic marker collagen type X (Col X) was 
upregulated in IPC-Col I hydrogel, in comparison with both IPC-control and Col I hydrogels, 
suggesting early induction of hypertrophy. However, when normalized with Col II expression, 
it was obvious that expression levels of Col X were strongly suppressed when MSCs were 
cultured in all hydrogels, in comparison with MSC pellet culture (Fig. 12B). In contrast to the 
phenotypic differences brought about by IPC-control and IPC-Col I hydrogels, the control pellet 
culture resulted in neocartilage of inferior quality, with lower expression levels of Col II, 
aggrecan, CILP, COMP and Col IX, but with upregulation of PRG-4, indicating formation of a 








Fig. 12 Expression analysis of cartilaginous genes in various hydrogel groups. (A) Real time PCR analysis of 
mRNA expression levels of cartilaginous genes in different hydrogel groups and MSC pellet at days 14 and 21 
of chondrogenic differentiation. Expression was normalized to their respective GAPDH expression and 
expressed as fold changes relative to undifferentiated MSCs. n≥4 per group, mean ±SD. (B) Expression of 
zonal cartilage markers in different hydrogels and MSCs pellet as a function of their ratios with respective to 
Col II expression. * denotes p<0.05 between IPC-Col I and IPC–control, Col I hydrogel, pellet at same time 
point. # denotes p<0.05 between IPC-Col I and IPC-control, Col I hydrogel at same time point denotes. @ 
denotes p<0.05 between  IPC-control and IPC-Col I at same time point.  
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5.2.2 Influence of Col I on cell proliferation and chondrogenic outcomes in hydrogel 
constructs 
Histological evaluation of the neocartilage generated in the IPC hydrogels after 3 weeks 
of chondrogenic differentiation revealed that IPC-Col I hydrogel facilitated superior MSC 
chondrogenesis in comparison with IPC-control hydrogel. Uniform staining of cartilaginous 
proteoglycan components and Col II was observed in IPC-Col I hydrogel compared to localised 
staining of smaller tissue clusters in IPC-control hydrogel (Fig. 13). The homogenous 
distribution of ECM components was indicative of the ability of IPC-Col I hydrogel to facilitate 
uniform MSC differentiation throughout the entirety of the hydrogel, resulting in a stable ECM 
matrix.  
 
 Fig. 13 Histological analysis of chondrogenic outcomes in the various hydrogel groups.Histological analysis 
of chondrogenic outcomes in IPC–control, IPC-Col I hydrogels and Col I hydrogel at day 21 by Alcian blue, 
Safranin-O and Col type II immunohistochemical staining. (Scale bar 200µm). 
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Cell proliferation in different hydrogels was studied by evaluating the total DNA 
content. IPC-Col I hydrogel was found to enhance the proliferation of chondroprogenitor cells 
significantly, in comparison with IPC-control, Col I hydrogel and pellet culture (Fig. 14A). 
Quantification of sGAG and Col II in neocartilage tissue showed that MSCs encapsulated in 
IPC-Col I hydrogel deposited significantly higher levels of these ECM components during 
chondrogenesis, relative to IPC-control and Col I hydrogel (Fig. 14B, 14C). In comparison with 
all hydrogel groups, the ECM content of MSC pellet culture was the least (Fig. 14B, 14C), 
despite having similar cell proliferation rates as that of IPC-control hydrogel (Fig. 14A), 
suggestive of the need for 3D hydrogel culture of MSCs for efficient chondrogenic 
differentiation. 




Fig. 14 Cell Proliferation, ECM quantification and histological analysis of chondrogenic outcomes in various 
hydrogel groups. (A) Total DNA content in different hydrogels and MSC pellet at days 14, 21, n≥4 per 
group, mean ±SD. (B) Total sGAG and (C) Col type II content normalized with total DNA content of the 
samples. n≥4 per group, mean ±SD. * denotes p<0.05between IPC-Col I and IPC-control, Col I hydrogel, 
pellet at same time point. # denotes p<0.05 between Col I hydrogel and IPC-control at same time point. @ 
denotes p<0.05 between IPC-Col I and pellet control, at same time point. 
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5.2.3 Cell-matrix and cell-cell interactions in hydrogel constructs 
To investigate the mechanism underlying the enhanced MSC chondrogenesis observed 
in IPC-Col I hydrogel, changes in early cell morphology were studied by F-actin staining of the 
MSCs at days 1, 4 and 7 under chondrogenic induction (Fig. 15A). MSCs in IPC-control 
hydrogel formed small, local clusters throughout the length of the fibers by day 1, which 
continued to grow in size and number throughout the course of study, with no other significant 
changes (Fig. 15A). In contrast, encapsulated MSCs in the IPC-Col I hydrogel appeared as 
elongated cells exhibiting fibroblastic morphology, linearly stacked in rows. MSCs were found 
to be adjacent and aligned to the incorporated Col I at day 1 (as demonstrated by proximity of 
F-actin and FITC-Col I signals in Fig. 15A). A shift from elongated to a rounded cell 
morphology was seen with the initiation of cell condensation and clustering by day 4 in IPC-
Col I hydrogels. By day 7, more clustering and contraction was seen with remodeling of the 
microenvironment in IPC fibers by the encapsulated MSCs. in IPC-Col I hydrogels.  
Immunofluorescence analyses of N-cadherin and β-catenin staining were carried out at 
days 4 and 7 to address the onset of precartilage condensations (Fig. 15B). Stronger, cellular 
junction expression of N-cadherin was detected at day 4 in the IPC-Col I hydrogel, whereas 
expression of N-cadherin was only detected in the peripheral cells of the cell clusters formed in 
IPC-control hydrogel, suggestive of  uniform onset of precartilage condensation in the former 
system. β-catenin expression was largely membrane-bound in both the hydrogels at day 4, 
whereas translocation of β-catenin from membranous region to the cytoplasmic space and the 
nucleus was observed at day 7 in the IPC-Col I hydrogel (indicated by an arrow in merged 






Fig. 15  Early cellular and molecular events during chondrogenic commitment of MSCs.  (A) Differences in cell 
morphology of the encapsulated MSCs in IPC-control hydrogels (a,b,c) and FITC-conjugated IPC-Col I (green) 
hydrogels  (d,e,f) at days 1 (a,d), 4(b,e) and 7(d,f), as seen by F-actin staining (red). (B) Temporal changes in 
expression of markers for chondrogenic condensation, N-cadherin (green) and β-catenin (red), in IPC-control 




β-catenin expression in the IPC-control hydrogels remained predominantly in the 
membranous regions at both days 4 and 7 (indicated by arrowheads, Fig. 15B), suggestive of a 
lack of transcriptional β-catenin activation in these MSCs. The reduction of the strong N-
cadherin expression in regions of IPC-Col I fibers at day 7, could be correlated to intracellular 
translocation of β-catenin (indicated by arrows in N-cadherin channel in Fig. 15B), suggestive 
of progression in MSCs chondrogenesis from precondensation to chondrogenic commitment, 
and activation of chondrogenic gene expression. Immunofluorescence staining of Col II and 
Sox9 at days 4 and 7 provided further evidence (Fig. 16), where IPC-Col I hydrogel was found 
to induce higher deposition of Col II by the differentiating MSCs and intensified nuclear 
localization of Sox9 (indicated by arrows in Fig. 16).  
 
A morphological study of cells undergoing chondrogenesis in Col I hydrogel at day 4 
revealed that MSCs in the periphery of the hydrogels (Region a, Fig. 17A) displayed an 
elongated morphology, with substantial cell-cell interactions similar to that observed in IPC-Col 
I hydrogel. In contrast, the inner regions of the Col I hydrogel (Region b, Fig. 17A) were 
populated by mostly single cells, displaying rounded morphology with minimal cell-cell 
contacts. Such differences in cell morphology in the peripheral and inner regions of the Col I 












Fig. 16 Analysis of early onset of chondrogenic differentiation in IPC hydrogels.Expression of chondrogenic 
markers Col II (green) and Sox9 (red) in IPC-control hydrogels (a-d, i-l) and IPC-Col I hydrogels (e-h, m-p) at day 







Fig. 17 MSC morphology and early molecular events during chondrogenic commitment in Col I hydrogels. 
(A) MSCs morphology and distribution in different regions of Col I hydrogel, under chondrogenic induction at 
days 1, 4, 7, observed by F-actin staining (red) of MSC in peripheral (Region a) and inner regions (Region b) 
of the hydrogel. Nucleus was stained by DAPI in blue. (B) Changes in expression and localization of N-
cadherin (green) and β-catenin (red) was shown in the peripheral (Region a) and inner regions (Region b) of 
the hydrogel at day 4. (Scale bar: 50 um) 
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Expression of N-cadherin was much more pronounced in the peripheral regions (Region 
a, Fig. 17B) in comparison with the inner regions (Region b, Fig. 17B), indicative of non-
uniform cell-cell interactions in these different regions of the Col I hydrogel. β-catenin staining 
also demonstrated differences in the two regions of the Col I hydrogel, where cells in the inner 
regions of the hydrogel had a more  membranous expression of β-catenin.  Translocation of β-
catenin expression from membranous to cytoplasmic and near nuclear regions was observed in 
cells from the peripheral regions of hydrogel (as shown in Region a, Fig. 17B) suggestive of 
active β-catenin mediated MSCs chondrogenic differentiation in this region. This was validated 
by the enhanced expression of chondrogenic markers, Col II and Sox9 in the peripheral regions 
(Region a, Fig. 18A), relative to the inner regions of the Col I hydrogel (Region b, Fig. 18A).   
Quantification of Col II immunofluorescence signals in samples from these two regions 
demonstrated significantly higher Col II expression in the peripheral regions (Fig. 18B). These 










Fig. 18 Analysis of the early onset of chondrogenic differentiation in Col I hydrogel (A) Differences in 
expression of chondrogenic markers Col II (green) and sox9 (red) observed between the peripheral (a) and inner 
regions (b) of the hydrogel. (B) Fluorescence quantification of Col II expression in peripheral and inner regions 




5.2.4 Inhibition of cell-matrix interaction in IPC-Col I hydrogels  
As earlier studies indicated significant differences in cell morphology and cell-cell contacts in 
the hydrogel groups, we investigated the role of cell-matrix interactions in MSC chondrogenesis 
in the IPC-Col I hydrogel. As MSCs are known to engage Col I through β1integrin (Gronthos et 
al., 2001), MSCs were treated with anti-β1 integrin antibody before encapsulation in IPC-Col I 
hydrogels. MSCs pre-treated with an isotype control antibody served as the controls. Live/dead 
staining showed that cell viability was not significantly affected by pre-treatment with the 
antibodies, although cell proliferation appeared to be hampered by integrin inhibition (Fig. 
19A).            
F-actin staining analysis showed that anti-β1 integrin treated cells in IPC-Col I hydrogel 
were unable to acquire the fibroblastic morphology, neither at day 1, nor at day 7 (Fig. 20A, a-
c). Cells in the isotype control group aligned with fibroblastic morphology at day 1, and went 
on to condense and remodel the fibers by day 7 (Fig. 20A, d-f), akin to the behaviour of 
untreated MSCs in IPC-Col I hydrogel (Fig. 15A). Concomitantly, a reduced degree of hydrogel 
contraction was observed in anti-β1integrin treatment group (<30%), while contraction of the 
control group was in line (>45%) with that observed in untreated MSCs IPC-Col I hydrogel 
(Fig. 19B). In MSCs pre-treated with anti-β1 integrin, N-cadherin expression was found to be 
abrogated at days 4 and 7 (Fig. 20B, a-d, i-l), while N-cadherin expression was not affected in 
the control isotype group (Fig. 20B, e-h, m-p). β-catenin expression remained largely 
membranous in the anti-β1 integrin-treated MSCs in IPC-Col I hydrogel at days 4 and 7 (Fig. 
20B), while its translocation was observed at day 7 in the control isotype group (as shown by 












Fig. 19 Inhibiting cell-matrix interactions by β-1 integrin inhibition. (A) Live-dead staining images of untreated 
IPC – control (a,b), IPC-Col I hydrogels (c,d), β-1 integrin antibody treated IPC-Col I hydrogels (e,f) and 
control antibody treated IPC-Col I hydrogels (g,h) at day 14. (B) Differences in contraction of untreated IPC - 
control, IPC-Col I hydrogels, β-1 integrin antibody treated IPC-Col I hydrogels and control antibody treated 
IPC-Col I hydrogels at days 7, 14. (Scale bar: 500 um) * denotes p<0.05 betweenuntreated IPC-Col I hydrogels 
and IPC – control hydrogels, β-1 integrin antibody treated IPC-Col I hydrogels at same time point. # denotes 
p<0.05 between untreated IPC – control hydrogels and untreated IPC-Col I hydrogels, control antibody treated 
IPC-Col I hydrogels at same time point. @ denotes p<0.05 between β-1 integrin antibody treated IPC-Col I 







Fig. 20 Effect of blocking cell-matrix interactions by β1-integrin inhibition on MSC chondrogenesis in IPC-Col I 
hydrogels. (A) Differences in MSC morphology in IPC-Col I hydrogels treated with anti-β1 integrin (a-c) and 
control antibody (d-f) at days 1(a,d) , 4 (b,e) and 7 (c,f), as seen by F-actin staining (red). (B) Temporal changes 
in expression of N-cadherin (green) and β-catenin (red) in IPC-Col I hydrogels treated with anti-β1 integrin (a-d, 
i-l) and control antibody (e-h, m-p) at days 4 and 7.  Nucleus was stained by DAPI as blue. (Scale bar: 50 µm).  
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RT-PCR analysis of the chondrogenic outcomes in these two groups demonstrated that 
the early and robust chondrogenesis in the anti-β1integrin group was significantly reduced, to 






Fig. 21  Analysing the effect of blocking cell-matrix interactions on chondrogenic outcomes. Comparative 
analysis of chondrogenic outcomes by real time PCR analysis. Samples n≥4 per group, mean ±SD. * denotes 
p<0.05 between untreated IPC-Col I hydrogels and IPC-control hydrogels, β-1 integrin antibody treated IPC-
Col I hydrogels at same time point. # denotes p<0.05 between β-1 integrin antibody treated and control antibody 
treated IPC-Col I hydrogels at same time point. 
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In contrast, the control isotype group exhibited comparable expression levels of the 
chondrogenic markers to that of  untreated MSCs in IPC-Col I hydrogel. Notably, the 
phenotypic outcome of neocartilage generated was also reversed in the anti-β1 integrin treated 
group. Expression levels of Col I and PRG4 were up-regulated, while Col X, Col IX and COMP 
decreased significantly, to levels comparable with that of IPC-control hydrogel. 
 
5.3 Discussion 
5.3.1 IPC-Col I hydrogel supported superior MSC chondrogenesis 
The unique formation of submicron size nuclear fibers in IPC-based 3D fibers (Fig. 4B), and 
Col I presentation on such aligned fibers, directed uniform alignment of MSCs with an 
elongated, fibroblastic morphology (Fig. 4F). This resulted in extensive cell-matrix and cell-cell 
interactions in IPC-Col I hydrogels, as early as within 24 h post cell encapsulation (Fig. 15A).  
Temporal changes in cell morphology of the encapsulated MSCs in IPC-Col I hydrogel 
mimicked the sequential changes in cell morphology that are observed during in vivo 
chondrogenic process (DeLise et al., 2000). On the other hand, MSC encapsulated in IPC-
control constructs formed localised cell clusters throughout the length of the fibers, suggesting 
relatively less cell-ECM interactions. Analysis of the functional outcome after MSC 
differentiation showed that Col I incorporation in the IPC constructs facilitated both an early 
onset of chondrogenic differentiation (Figs. 15, 16) and robust chondrogenesis (Figs. 12, 13, 14) 
over that of IPC-control, Col I hydrogel and the pellet culture control. Significant up regulation 
of the chondrogenic genes, Sox9, aggrecan and Col II (Fig. 12) was observed, relative to IPC-
control, Col I hydrogel and the pellet control. IPC-Col I hydrogels facilitated uniform MSC 
differentiation throughout the entirety of the hydrogel, resulting in better matrix integrity, 
93 
 
evidenced by the resulting larger tissue size post processing for histological analysis (Fig. 13). 
Not only was a higher sGAG and Col II expression observed in IPC-Col I hydrogel, but was 
accompanied with significant upregulation of chondrogenically differentiated cells (Fig. 14), 
suggesting superior chondrogenic outcomes with higher cell number. The robustness of the 
neocartilage generated in the IPC-Col I hydrogel was demonstrated by the highly upregulated 
mRNA expression of COMP and Col IX (Fig. 12). This is of great significance as COMP and 
Col IX are implicated in matrix assembly, maturation, and mechano-responsiveness of articular 
cartilage. Both COMP and Col IX mediate enhanced collagen fibril assembly (Blumbach et al., 
2009, Haleem-Smith et al., 2012), and regulate the anchorage and organisation of other matrix 
macromolecules such as proteoglycans (Haleem smith et al., 2012), which are associated with 
the maturation (Opolka et al., 2007) and enhanced mechanical properties (Amanatullah et al., 
2012) of the cartilage tissues.  
 
5.3.2 IPC-Col I hydrogels enhanced MSC chondrogenesis by promoting early and uniform 
cell-matrix and cell-cell interactions 
Significant hydrogel contraction was observed by day 4 in IPC-Col I hydrogel (Fig. 11), which 
was likely to have arisen from MSCs undergoing precartilage condensation, where strong cell-
Col I interactions caused the fibers to be pulled in the direction of contraction.  MSCs in IPC-
control hydrogel exhibited less hydrogel contraction in comparison with IPC-Col I hydrogel, 
suggesting relatively inferior cell-ECM interactions (Fig. 15A). Such observations were 
consistent with studies correlating the degree of hydrogel contraction with chondrogenic 
differentiation (Ng et al., 2011), as IPC-Col I hydrogel facilitated superior chondrogenic 
outcomes in this study. Immunofluorescence analysis of markers of precartilage condensation 
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validated the observed hydrogel contraction to be reflective of the onset and progression of 
precartilage condensation. Stronger and more consistent expression of N-cadherin at cell 
junctions was detectable in the IPC-Col I hydrogels, followed by translocation of β-catenin 
from membranous region to the cytoplasm and nucleus of encapsulated MSCs, which was not 
detected in the IPC-control hydrogel (Fig. 15B). A recent study involving a modified hyaluronic 
acid hydrogel functionalized with N-cadherin mimetic peptides established its significance in 
regulating onset of chondrogenesis and cartilage matrix deposition by the encapsulated MSCs 
(Bian et al., 2013). Further, in TGF-induced chondrogenesis of human MSCs, activation of N-
cadherin expression and the accumulation of -catenin in the nucleus, and subsequent 
promotion of -catenin activated transcriptional activity, are strongly implicated in the 
commitment of MSCs to the chondrogenic lineage (Modarresi et al., 2005, Ng et al., 2008, Tuli 
et al., 2003, Yang et al., 2012b, Zhou et al., 2004).  Such concomitant temporal activation 
profiles, together withthe localization dynamics of N-cadherin and -catenin for chondrogenic 
condensation, underscore the efficacy of chondrogenic differentiation in the IPC-Col1 hydrogel, 
reflected also by the heightened nuclear localisation of Sox9 (Fig. 16), and the subsequent 
enhancement in chondrogenic gene expression (Fig. 12).     
The differences in spatio-temporal expression of N-Cadherin/-catenin during 
chondrogenesis in the two IPC hydrogel groups might also account for the differential 
expression pattern of cartilage phenotypic markers. We detected specific up-regulation of 
superficial zone markers (Col I, PRG-4), and middle zone marker (CILP) in the IPC-control 
hydrogel (Fig. 12). In contrast COMP, Col IX and Col X were highly up regulated in IPC-Col I 
hydrogel, whereas their expression in IPC-control hydrogels was barely detected. In TGF-
induced MSC chondrogenesis, involvement of Smad-dependent and Smad-independent 
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mitogen-activated protein (MAP) kinases pathways are reported (Augello and De Bari, 2010). 
Further, substrate-dependent regulation of N-cadherin expression and intracellular -catenin 
signaling, and their cross-talk with other pathways such as ERK1/2 or Smad2/3 was recently 
reported in MSCs spheroids cultured on chitosan or chitosan grafted with hyaluronan (Hsu and 
Huang, 2013). It is thus likely that the spatio-temporal expression of N-Cadherin/β-catenin, 
brought about by the microenvironmental differences between the two groups of IPC hydrogel, 
might have resulted in differential activation of intracellular pathways, so influencing 
differential expression of cartilaginous genes.   
 
5.3.3 Enhanced chondrogenic outcome in IPC-Col I hydrogels is initiated by cell-matrix 
interaction-mediated molecular events 
It was speculated that the early onset of elongated MSC morphology and higher cell packing 
densities in IPC-Col I hydrogel were pivotal in initiating an early and robust chondrogenic 
differentiation. Activation of integrin dimers, caused by binding of ligands such as Col I to their 
extracellular domains, is known to result in the association of their cytoplasmic domains with 
the actin cytoskeleton (Bershadsky et al., 2003).  Such integrin-driven changes in cell 
morphology facilitate enhanced cell-cell interactions, through N-cadherin expression during 
condensation events.  Activation of N-cadherin in the initiation of cell-cell junctions is also 
known to be stabilized by the actin cytoskeleton, to coordinate junction development with cell 
movement and polarization, and to maintain junction integrity (Bershadsky, 2004). Such actin 
links involve both  α- and β-catenins  (Ganz et al., 2006, Yap et al., 1997) through a conserved 
region in cytoplasmic domains of N-cadherins, who’s specific function is to form strong actin 
linkages (Bershadsky, 2004).  Thus it could be postulated that the interplay of such cellular-
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molecular events strengthened the role of cell-ECM interactions in MSC chondrogenesis. This 
relationship between cell-ECM interaction (through integrin engagement) driven morphological 
changes, and subsequent effects on condensation and chondrogenic commitment (N-cadherin/β-
catenin translocation), was validated by inhibiting early cell-ECM interactions in IPC-Col I 
hydrogel by using anti-β1 integrin antibodies. Not only was the cell morphology affected, 
concomitant precartilage condensation was also delayed with no observable expression of N-
cadherin even up to day 7 after differentiation induction (Figs. 20A, 20B). Also consistent was 
the reduced degree of MSC-mediated hydrogel contraction (Fig. 19B), suggesting weaker MSC 
chondrogenesis, which was validated by RT-PCR analysis showing a reduction in 
chondrogenesis to levels similar to that seen in IPC-control (Fig. 21). Although significant 
cytotoxicity was not observed with anti-β1 integrin treatment (Fig. 19A), reduced cell 
proliferation and cell-cell interaction dynamics were noted which could have arisen due to 
inhibition of other biological functions of β1 integrins (Darribere et al., 2000). Notably, 
blocking integrin-mediated cell-matrix interactions completely reversed the neocartilage 
phenotype (Fig. 21), further implicating cell-ECM driven intracellular signalling events as 
phenotypic fate determinants.  
The coupling of ECM-mediated morphological dynamics with cell-cell interactions in 
the initiation of MSC chondrogenesis was further evidenced with the cellular events in the 
conventional Col I hydrogel. MSCs in Col I hydrogels did not exhibit a uniform cell 
morphology, cell-cell interaction, and temporal profile of chondrogenic commitment (Fig. 
17A).  In comparing the chondrogenic outcomes between Col I and IPC-Col I hydrogels, in 
addition to weaker chondrogenesis, the expression of matrix maturation makers, COMP and Col 
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IX was barely detectable in the Col I hydrogel (Fig. 12). This outcome also correlates with the 
reduced contraction observed in Col I hydrogel during chondrogenesis (Fig. 11).  
Phenotypically, an enhanced superficial zone like (PRG-4), fibrocartilaginous (Col I) 
tissue was generated in the Col I hydrogels, albeit with lesser cartilage hypertrophy (Col X) 
when compared to IPC-Col I hydrogels (Fig. 12). Given the equivalent cell seeding density and 
initial Col I concentration in the IPC-Col I and Col I hydrogels, the different outcomes were 
likely to have arisen from the different presentation of Col I in the two systems. IPC fibers 
presented Col I on aligned, submicron nuclear fibers (Tai et al., 2010, Wan et al., 2004) while 
Col I hydrogels are reported to have a random collagen fibril distribution (Chen et al., 2012), 
resulting in differential cell-cell interactions in the two systems, which consequently affects the 
extent of MSC chondrogenesis. The submicron Col I alignment in IPC-Col I constructs 
facilitated uniform, and enhanced  cell-ECM interactions.  Since encapsulated cells were found 
to cluster and form aggregates in IPC-control hydrogels, a phenomenon not observed in the 
large part of the Col I hydrogel, it is suggested that IPC hydrogels could possibly be more 
amenable to cell induced local remodeling, owing to their hydrophilic chitin backbone. Our 
results implicate the need to not only create a niche biochemical microenvironment for MSC 
chondrogenesis, but also the importance of spatial orientation of the chosen biochemical cue. 
By facilitating robust cell-matrix interactions and achieving better cell-cell interactions, Col I 
incorporation in IPC hydrogels promoted those dynamic changes in cellular morphology and 
precartilage condensation needed for optimal chondrogenesis. 
 
In summary, this study demonstrated that IPC hydrogels can offer favorable 3D niches 
for facilitating MSC chondrogenesis, while also offering a conducive microenvironment that 
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sustains the proliferation of the chondro-differentiated MSCs. IPC mediated Col I incorporation 
was superior to Col I hydrogels and enhanced the chondrogenic outcome, with the observed 
upregulation of markers for matrix maturity (Col IX, COMP) and downregulation of 
fibrocartilaginous marker (Col I). IPC-Col I hydrogels  promoted uniform cell spreading and 
differentiation through enhanced cell-ECM (integrin), and cell-cell interaction, likely through 
N-cadherin/β-catenin mediated intracellular signaling events. Such results demonstrated the 
significance of oriented ligand presentation for MSC chondrogenesis, and underscore the 
importance of facilitating proximal interactions between MSCs and local microenvironment, to 
drive subsequent cellular and molecular events for robust neocartilage formation. Further 
studies contained in this thesis addressed the need to better understand the influence of different 










6. STUDYING THE INFLUENCE OF CS, HA ON MSC CHONDROGENESIS AND 
ANALYSIS OF ZONAL PHENOTYPIC OUTCOMES 
 
6.1 Background 
 Further to the studies analyzing the influence of Col I on MSC chondrogenesis, this chapter 
addresses the influence of different biochemical cues in modulating zonal chondrogenic 
phenotypes.  In addition to Col I, matrix microenvironmental cues, CS and HA were considered 
in this study due to their reported influence on stem cell based chondrogenic outcomes (Coates 
et al., 2012, Hwang et al., 2011, Nguyen et al., 2011a, Nguyen et al., 2011b, Varghese et al., 
2008). CS and HA are also reported to be important components of musculoskeletal tissue 
matrices and modulate tissue properties and function by cell-ECM interactions (Coates et al., 
2012, Goldring et al., 2006). A comparative account on the influence of CS and HA on MSC 
differentiation and the derivation of zonal cartilage phenotypes is presented. The cell 
encapsulating density (1 x 10
4
 cells per µl), total cell number per hydrogel (25 x10
4
 cells per 
hydrogel) and the final concentration of  biochemical cues, CS (0.25%) and HA (0.25%), were 
kept the same as in IPC-Col I hydrogel and IPC-control to facilitate comparative studies.  
 Analyses of the varying influence of different biochemical environments on the 
induction of chondrogenic differentiation were also performed at two levels, namely early, 
cellular and molecular events, and consequent functional phenotypic outcomes. Analyses of 
early events by immunofluorescence included F-actin staining to study cell morphology 
(Methods: 3.6.1), together with expression of chondrogenic differentiation marker, Col II, by 
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immunofluorescence staining (Methods: 3.6.1), at days 4 and 7. Analysis of chondrogenic 
outcomes was carried out at days 14, and 21 by studying chondrogenic gene expression using 
RT-PCR analysis (Methods: 3.8), quantification of chondroprogenitor population by picogreen 
assay, and ECM deposition by Blyscan assay for sGAG, and ELISA for Col II protein 
expression (Methods: 3.7), with sample size of n=6. Histological analysis for studying ECM 
organisation and distribution of secreted ECM components by Safranin-O and Col II 
immunohistochemistry (Methods: 3.5)  was carried out at day 21. The choices of experimental 
design and protocols, and the time points for aforementioned studies follow the same rational as 
in section 5.1. Lastly, the novelty of this study lies in evaluating the expression of a panel of 
zonal cartilage markers, at gene (by RT-PCR) and protein expression levels (by histological 
analysis), to better characterise the functional phenotype of resultant neocartilage. Also, the 
mRNA expression levels of the zonal markers  in the different hydrogel groups were 
normalized to their respective degree of differentiation, as indicated by their Col II mRNA 




6.2.1 Studying early morphological changes and onset of chondrogenic differentiation in 
IPC-CS and IPC-HA hydrogels 
Studies addressing the early dynamics of MSC morphology and the onset of chondrogenic 




   
 
 
Fig. 22  Influence of CS and HA on cell morphology and early chondrogenic differentiation of encapsulated 
MSCs in IPC hydrogels. Morphological dynamics of differentiating MSCs, and onset of chondrogenesis was 
analysed by staining for F-actin (red), and chondrogenic marker, Col II (green), respectively at days 1,4,7 for 
MSCs encapsulated in IPC-CS hydrogels (A) and IPC-HA hydrogels (B). (C) Immunofluorescence staining of 
Col II expression (green) in IPC-control and IPC-Col I hydrogels at days 4 and 7. (Scale bar: 50 µm). (D) 
Fluorescence quantification of Col II signals at days 4, 7 from immunofluorescent Col II staining images of 
MSCs encapsulated in IPC-control, IPC-Col I, IPC-CS, and IPC-HA, normalised to cell number in the respective 




Analysis of early changes in cell morphology of encapsulated MSCs in IPC-CS and 
IPC-HA hydrogels, under chondrogenic differentiation conditions, was done by F-actin 
staining at days 1, 4 and 7. Such studies revealed that MSCs in both IPC-CS (Fig. 22A) and 
IPC-HA hydrogels (Fig. 22B) assumed a rounded morphology and formed local aggregates. 
Such aggregates  grew in size and number with onset of chondrogenic differentiation, evidenced 
by increasing Col II deposition around such clusters (Fig. 22). Encapsulated MSCs in IPC-CS 
hydrogels formed larger clusters as early as day 4, relative to differentiating MSCs in IPC-HA 
hydrogel.  Semi-quantitative analysis of immunofluorescent Col II expression levels (Fig. 22D) 
in samples from IPC-CS (Fig. 22A), IPC-HA (Fig. 22B), IPC-Col I (Fig. 22C) and IPC-
control (Fig. 22C) at days 4 and 7 revealed that IPC-Col I hydrogels brought about the highest 
upregulation, followed by IPC-CS, relative to IPC-HA and IPC-control hydrogels (p<0.05). 
However, no significant differences in the early onset of Col II expression were observed 
between the IPC-CS and IPC-HA hydrogels in the time points that were studied. 
 
6.2.2 MSC chondrogenesis in IPC-CS and IPC-HA hydrogels 
Since significant differences in the early onset of chondrogenic differentiation were not 
observed between IPC-CS and IPC-HA hydrogels, studies analysing the chondrogenic 
outcomes after 21 days of in vitro culture  were performed. Unlike with IPC-Col I, no 
significant macroscopic changes were observed in MSCs encapsulated IPC-CS and IPC-HA 
hydrogel constructs, through the three week culture period under chondrogenic conditions (Fig. 
23). As observed by F-actin staining analysis (Fig 22), encapsulated MSCs in IPC-CS and IPC-
HA hydrogels remained as local aggregates, distributed uniformly throughout the IPC hydrogel 






Quantitative real time PCR analysis of chondrogenic differentiation in IPC-CS and IPC-
HA hydrogels was performed and compared with IPC-control and IPC-Col I hydrogels. Gene 
expression analysis of Sox9 and aggrecan indicated that incorporation of biochemical cues (CS, 
HA, Col I) favoured their upregulation relative to IPC-control hydrogels, with statistically 
significant differences.  But such significant differences were not observed in the expression 
levels of Sox9 and aggrecan, in comparing the hydrogels with different cues, with one another. 
IPC-HA hydrogel was found to facilitate the highest upregulation of Col II mRNA expression 
Fig. 23 Macroscopic changes of different IPC hydrogels with encapsulated MSCs, during chondrogenesis. 
Phase contrast images of IPC-control, IPC-Col I, IPC-CS, IPC-HA hydrogels under chondrogenic 
differentiation conditions at days 1, 7, 21. (Scale bar: 1 mm).  
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(Fig. 24A), followed by IPC-Col I and IPC-CS, with no significant differences between the 





Histological evaluation of the neocartilage generated in the IPC-CS and IPC-HA hydrogels after 
3 weeks of chondrogenic differentiation revealed that IPC-HA hydrogel facilitated superior, yet 
localised MSC chondrogenesis in comparison with IPC-CS hydrogel (Fig. 24B). Although HA 
incorporation brought about a superior chondrogenic outcome, CS incorporation facilitated 
uniform MSC differentiation throughout the entirety of the hydrogel, resulting in better matrix 
Fig. 24  Real time PCR and histological analysis of chondrogenic outcomes in IPC hydrogels. (A) Real time 
PCR analysis of mRNA expression levels of cartilaginous genes in different hydrogel groups at day 21 of 
chondrogenic differentiation. Expression was normalized to their respective GAPDH expression and expressed 
as fold changes relative to undifferentiated MSCs. n≥4 per group, mean ±SD. * denotes  p<0.05 between IPC-
control and IPC-Col I, IPC-CS, and IPC-HA hydrogels. # denotes  p<0.05 between IPC-HA and IPC-Col I, IPC-
CS hydrogels. (B) Histological analysis of chondrogenic outcomes in IPC–CS and IPC-HA hydrogels at day 21 
by Alcian blue, Safranin-O and Col type II immunohistochemical staining. (Scale bar 200µm). 
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integrity, evidenced by the resulting larger tissue size post-processing for histological analysis 
(Fig. 24B). On the other hand, localised clustering of cell aggregates and non-uniform 
formation of cartilage tissue in IPC-HA was observed, despite more intense ECM and Col II 
staining. 
 
6.2.3 Influence of CS and HA on cell proliferation and ECM formation in hydrogel 
constructs 
Cell proliferation in different hydrogels was studied by evaluating the total DNA content. DNA 
quantification after 21 days of chondrogenic differentiation suggested that CS and HA 
incorporation did not bring about significant differences in cell number, relative to IPC-control 
(Fig. 25A). Col I incorporation supported the highest cellular proliferation, with statistically 
significant differences in comparison with IPC-control, IPC-CS and IPC-HA hydrogels. 
Quantification of sGAG and Col II in neocartilage tissue showed that MSCs encapsulated in 
hydrogels with different cues resulted in higher levels of sGAG and Col II expression, after 21 
days of chondrogenic differentiation (Fig. 25B, 25C). Among the different cues studied, Col I 
and HA facilitated significant higher sGAG expression, to that in IPC-CS hydrogels. Although 
IPC-Col I hydrogel was observed to have highest sGAG expression, no statistically significant 
difference was observed with IPC-HA hydrogels. IPC-HA hydrogel was found to facilitate the 
highest Col II expression, with statistically significant differences when compared with all the 
other hydrogel groups. IPC-Col I and IPC-CS were found to facilitate similar upregulation of 





6.2.4 Gene expression analysis of zonal cartilage markers in IPC hydrogels with different 
cues 
As earlier studies suggested that incorporation of biochemical cues, Col I and HA, facilitated 
superior chondrogenic outcomes in comparison with IPC-CS and IPC-control hydrogels, further 
studies addressed the zonal phenotypic outcomes brought about in such hydrogels. Quantitative 
real time PCR analysis of zonal cartilage markers for the superficial, middle, and deep zones 
was performed in IPC hydrogels with different cues and IPC-control hydrogels, after 21 days of 
chondrogenic differentiation (Fig. 26). In general, incorporation of Col I, CS, HA resulted in 
statistically significant differences in comparing the expression levels of zonal markers with 
Fig. 25 Cell proliferation and ECM quantification of IPC hydrogels with different cues. (A) Total DNA content 
in IPC-control, IPC-Col I, IPC-CS, IPC-HA hydrogels at day 21, n≥4 per group, mean ±SD. (B) sGAG and (C) 
Col type II content normalized with respective DNA content of  samples from IPC-control, IPC-Col I, IPC-CS, 
IPC-HA hydrogels at day 21. n≥4 per group, mean ±SD. *  denotes p<0.05 between IPC-control and IPC-Col I, 
IPC-CS, and IPC-HA hydrogels. &  denotes p<0.05 between IPC-Col I and IPC-CS, IPC-HA. @  denotes 
p<0.05 between IPC-CS and IPC-Col I, IPC-HA.  #  denotes p<0.05 between IPC-Col I and IPC-HA. 
107 
 
IPC-control hydrogel, with the exception of matrix maturity marker Col IX, wherein HA 
incorporation did not alter its expression. Also, the patterns of zonal cartilage marker 
expressions in IPC-control and IPC-Col I hydrogels were consistent with results obtained in 
earlier studies in chapter 4.2, wherein MSC chondrogenesis in IPC-control hydrogels resulted in 
a superficial zone like phenotype and IPC-Col I facilitated a more mature, mid-deep zone like 
neocartilage tissue.  
 
In analysing the influence of CS on zonal chondrogenic markers, it closely followed 
IPC-Col I hydrogel in down regulating expression of superficial zone markers, Col I and PRG-
4, in comparison with IPC-control. Expression levels of middle zone markers, CILP and COMP 
were positively influenced in IPC-CS hydrogels, resulting in their highest upregulation, in 
comparison with all other hydrogel groups studied, with statistical significance. Together with 
the high upregulation of matrix maturity marker Col IX, second only to IPC-Col I, and a lower 
Col X expression, in comparison with IPC-Col I and IPC-HA, the phenotypic outcome 
following CS incorporation was consistent with a middle zone cartilage phenotype. In analysing 
the effect of HA incorporation on zonal chondrogenic markers, IPC-HA hydrogels facilitated 
the highest upregulation of fibrocartilaginous marker, Col I, with statistical significance in 
comparison with all other hydrogel groups. But it demonstrated a much lower expression of the 
other superficial zone marker, PRG-4, similar to that observed in IPC-CS and IPC-Col I 
hydrogels. Expression of middle zone marker, CILP, in IPC-HA hydrogels was significantly 








Fig. 26 Expression analysis of zonal cartilage markers in IPC hydrogels with different cues. Real time PCR 
analysis of mRNA expression levels of zonal  cartilage markers in IPC-control, IPC-Col I, IPC-CS, IPC-HA 
hydrogels at day 21 of chondrogenic differentiation. Expression was normalized to their respective GAPDH 
expression and expressed as fold changes relative to undifferentiated MSCs. n≥4 per group, mean ±SD. * 
denotes p<0.05 between IPC-control and IPC-Col I, IPC-CS, and IPC-HA hydrogels. #  denotes p<0.05 between 
IPC-HA and IPC-Col I, IPC-CS. @ denotes p<0.05 between IPC-CS and IPC-Col I. 
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IPC-HA hydrogels positively upregulated COMP, but did not alter Col IX, when 
compared with IPC-control. Notably, IPC-HA hydrogels demonstrated highest upregulation of 
hypertrophic marker, Col X, when compared with all other hydrogel groups studied. Taken 
together, these results suggested that HA incorporation primed a deep zone cartilage phenotype, 
with the notable exception of the high Col I expression. 
When expression levels of the aforementioned zonal markers in the different hydrogel 
groups were normalized to their respective degree of differentiation, as indicated by their Col II 
mRNA expression level, the phenotypic differences were maintained and more pronounced 
between IPC-Col I, IPC-CS, IPC-HA and IPC-control hydrogels (Fig. 27). IPC-control 
hydrogels facilitated the derivation of a superficial zone phenotype, evidenced by high 
expression of both Col I and PRG-4. IPC-CS hydrogels favoured the transition from superficial 
to middle zone phenotype, demonstrating higher upregulation of Col I and CILP, in comparison 
with IPC-Col I, and seconded by IPC-Col I in COMP expression. IPC-Col I hydrogels were 
found to derive a mature, mid-deep zonal phenotype, evidenced by higher expression of COMP, 
Col IX and col X and concomitant lower expression of Col I, PRG-4 and CILP, in comparison 
with IPC-CS and IPC-control hydrogels. IPC-HA hydrogels were found to favour a deep zone 
phenotype, evidenced by highest Col X expression, and lowest PRG-4, CILP, Col IX 
expression, in comparison with all the other hydrogel groups.  Although IPC- HA hydrogels 
facilitated comparable COMP upregulation with IPC-CS, second only to IPC-Col I and highest 
Col I upregulation amongst all other hydrogels groups, when taken together with the 
unequivocal differences in expression patterns of superficial (PRG4) and deep zone maker (Col 











Fig. 27 Col II normalised gene expression of zonal cartilage markers in IPC hydrogels with different cues.  Real 
time PCR analysis of zonal cartilage markers in IPC-control, IP-Col I, IPC-CS, IPC-HA expressed as a function 
of their ratios with respective Col II expression. n≥4 per group, mean ±SD. .* denotes p<0.05 between IPC-
control and IPC-Col I, IPC-CS, and IPC-HA hydrogels. #  denotes  p<0.05  between IPC-HA and IPC-Col I, 
IPC-CS. @ denotes p<0.05 between IPC-CS and IPC-Col I. &  denotes p<0.05 between IPC-Col I and IPC-CS, 
IPC-HA. $  denotes p<0.05 between IPC-CS and IPC-Col I, IPC-HA. 
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6.2.5 Immunohistological evaluation of zonal phenotype generation in IPC hydrogels with 
different cues 
To validate the influence of different biochemical cues in generating phenotypically distinct 
neocartilage, immunohistological staining analysis was performed to examine the protein 
expression profiles of the various zonal cartilage markers. Immunohistological staining analysis 
of superficial zone markers, Col I and PRG-4, clearly indicated the differences in the 
phenotypic outcomes in the different hydrogel groups (Fig. 28). IPC-control hydrogel was 
found to upregulate both Col I and PRG-4 protein expression. Upregulation of PRG-4 protein 
expression in IPC-control, not only followed its mRNA expression profile (Fig. 26), but also 
indicated the predisposition of  a superficial zone phenotype. The staining pattern of Col I 
protein expression in IPC hydrogels with different cues, did not demonstrate clear differences in 
comparison with IPC-control hydrogels. Notably, the higher mRNA expression profile of Col I 
in IPC-HA hydrogel (Fig. 26) was inconsistent with its protein expression pattern, suggesting 
IPC-control hydrogels exclusively favour neocartilage tissues with superficial zone like 
phenotype. Immunohistological staining of middle and deep zone markers in the different 
hydrogels also yielded significant results (Fig. 29). Expression patterns of COMP protein in 
IPC-Col I and IPC-CS hydrogels were reflective of the high mRNA expression observed in the 
PCR analysis at day 21 (Fig. 26). While IPC-Col I demonstrated a highly localised expression 
of COMP in the periphery of the construct, with intermittent staining in the interior regions of 
the hydrogel, IPC-CS hydrogels demonstrated equally intense staining, distributed throughout 
the entirety of the hydrogel. IPC-HA hydrogels demonstrated a weaker, albeit uniform, staining 
of COMP, which also followed the lower RNA expression profile at day 21, relative to IPC-Col 






Immunostaining analysis of Col IX (Fig. 29) demonstrated a striking difference between 
the different IPC hydrogels, wherein IPC-Col I demonstrated the strongest protein expression, 
with very little expression in IPC-control, IPC-CS, and IPC-HA hydrogels, at day 21. Although 
such protein expression profile was in contrary to the higher mRNA expression observed in 
IPC-CS, and IPC-HA hydrogels, relative to IPC-control hydrogels at day 21 (Fig. 26), it indeed 
correlated with the normalised Col IX expression profile of different IPC hydrogels (Fig. 27), 
with IPC-Col I hydrogel alone demonstrating a clear mRNA upregulation.  
Fig. 28 Immunohistology of superficial zone markers in IPC hydrogels with different cues. Immunohistological 







Immunostaining analysis of Col X (Fig. 29) in different IPC hydrogels demonstrated 
differences between IPC-HA and IPC-CS hydrogels, showing the most and least intense 
staining for Col X protein, similar to their respective mRNA expression profiles. Although IPC-
Fig. 29 Immunohistology of middle and deep zone markers in IPC hydrogels with different cues. 
Immunohistological staining of COMP, Col IX, and Col X in IPC-control, IP-Col I, IPC-CS, IPC-HA hydrogels 
at day 21. (Scale bar 200µm). 
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Col I hydrogels demonstrated second highest upregulation of Col X mRNA expression (Fig. 
26), its protein expression was found to be much less in comparison with IPC-HA, and IPC-
control hydrogels (Fig. 29). On the other hand, although IPC-control hydrogels demonstrated 
relatively lower mRNA expression of Col X (Fig. 26), it was found to stain intensely relative to 
IPC-Col I and IPC-CS, second only to that observed in IPC-HA hydrogels (Fig. 29).  
 
6.3 Discussion  
 
6.3.1 Differential influence of biochemical cues on early cellular and molecular events 
during chondrogenic differentiation 
Analysis of early changes in cell morphology of encapsulated MSCs in IPC-CS and IPC-HA 
hydrogels revealed that they assumed a rounded morphology at day 1 in both hydrogels (Fig. 
22A, 22B). But IPC-CS hydrogels facilitated larger aggregates of MSC, as early as day 4 (Fig. 
22A), which grew with the onset of chondrogenic differentiation, relative to IPC-HA and IPC-
control hydrogels (Fig. 22B, 22C). Such observations are in-line with the reported ability of CS 
to promote larger aggregates, and enhance cartilage ECM assembly during MSC 
chondrogenesis (Hwang et al., 2011, Nguyen et al., 2011a, Nguyen et al., 2011b). IPC-HA 
hydrogels were found to facilitate smaller MSC aggregates, relative to IPC-CS,  although 
similar to that observed in IPC-control hydrogels (Fig. 22B). It is known that interaction of high 
molecular weight HA molecules (such as that used in this study) results in engagement of 
multiple CD44 receptors, leading to receptor clustering on the cell surface (Responte et al., 
2012). Although receptor clustering resulted in strong cell-ECM networks, such cells 
consequently formed smaller cell clusters.  This offers a possible explanation for the differences 
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observed in MSC morphology between this study and others studies incorporating HA. Studies 
(Assmann et al., 1999, Lee and Spicer, 2000)  have  reported differences in focal adhesions of 
MSCs, with protrusions of microvilli like structures under the influence of HA (Hwang et al., 
2011). But such alterations in focal adhesions and F-actin are reported to be characteristic of 
CD44 independent mechanisms, involving another class of hyaladherin molecule called 
RHAMM (receptor for hyaluronic acid mediated motility) (Assmann et al., 1999, Hall et al., 
1994, Lee and Spicer, 2000). Thus the observations of MSC morphology in IPC-HA hydrogels 
was suggestive of CD44 dependent mechanisms for HA interaction. 
 Quantification of Col II deposition levels from immunofluorescence staining images of 
differentiating MSCs in IPC hydrogels suggested IPC-Col I hydrogels to facilitate superior Col 
II deposition, as early as day 4 (Fig. 22D). IPC-Col I hydrogels were found to facilitate dynamic 
morphological changes in MSCs (Fig. 15A) and involved N-cadherin/β-catenin mediated 
downstream signaling events (Fig. 15B), which might account for the observed Col II 
upregulation. IPC-CS hydrogels demonstrated only moderate upregulation of Col II, relative to 
IPC-control which was in-line with reports implicating moderate Col II expression in CS based 
scaffolds (Hwang et al., 2011, Nguyen et al., 2011a, Nguyen et al., 2011b). Although IPC-
control hydrogels demonstrated the least upregulation of Col II relative to other IPC hydrogels, 
they better facilitated matrix remodeling and cellular migration during tissue morphogenesis, 
owing to their  hydrophilic chitin backbone, in comparison with other reported hydrogel 
approaches (Fig. 11A). This was in contrast to other unmodified hydrogels such as PEG, HA, or 
alginate (Chung et al., 2009, Hwang et al., 2011, Coates et al., 2012), wherein cell migration 
and clustering was found to be very minimal, with localized clusters of 1-2 cells, even after 6 




6.3.2 Biochemical cue incorporation influenced MSC derived chondrogenic outcomes  
Phase contrast images of MSC undergoing chondrogenesis in IPC hydrogels with different 
biochemical cues showed differences across the time points studied (Fig. 23). IPC-control and 
IPC-Col I hydrogel behavior was similar to that discussed in chapters 4.2 and 5.2. IPC-HA 
hydrogels did not exhibit hydrogel contraction and appeared to be more hydrated, in-line with 
their swelling ratio analysis (Fig. 6B) and earlier studies demonstrating significant matrix 
hydration (Nguyen et al., 2011a, Nguyen et al., 2011b). IPC-CS hydrogels displayed 
noteworthy contraction, relative to day 1, and to IPC-HA and IPC-control hydrogels at later 
time points (Fig. 23). This might arise from the role of CS in mediating enhanced cartilage 
ECM assembly (Nguyen et al., 2011a, Nguyen et al., 2011b).  
Analysis of chondrogenic outcomes under the influence of different biochemical cues by 
real time PCR, histological analysis, and ECM quantification studies suggested significant 
differences between them. Analysis of chondrogenic gene expression showed a general increase 
in Sox9 expression with biochemical cue incorporation (Fig. 24A). IPC-HA hydrogels 
facilitated greatest upregulation of aggrecan and Col II gene expression, relative to all other IPC 
hydrogels, seconded by IPC-Col I hydrogels (Fig. 24A). Histological evaluation of 
chondrogenic differentiation was in-line with PCR analysis in general, with IPC-HA facilitating 
higher sGAG and Col II deposition (Fig. 24B). Yet, IPC-CS facilitated better matrix assembly, 
albeit with reduced  Col II deposition, with localized distribution of cell aggregates resulting in 
non-uniform, neocartilage formation in IPC-HA hydrogels. Of the three biochemical cues 
tested, only Col I incorporation in IPC hydrogels facilitated significant chondroprogenitor 
proliferation, whereas the presence of CS and HA did not exert a proliferative effect (Fig. 25A). 
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The influence of Col I in upregulating chondroprogenitor population to HA was opposite to that 
reported by Hwang et al., 2011, using the PEG hydrogels where HA resulted in increased 
proliferation, relative to Col I. This was also thought to be related to the differences in cell 
morphology observed between IPC-HA and PEG-HA hydrogels, with differential receptor 
mechanisms altering cellular processes such as proliferation.  
To summarise, the chief differences in the chondrogenic outcomes mediated by IPC 
hydrogels and earlier studies, are as follows: (i) IPC-HA hydrogels facilitated significant Col II 
protein expression, relative to IPC-Col I and IPC-CS hydrogels; (ii) this was accompanied with 
similar upregulation of sGAG levels to that in IPC-Col I hydrogels; and lastly (iii) IPC-HA 
hydrogels did not upregulate significant cellular proliferation relative to IPC-control hydrogels. 
Such outcomes differ from observations made by Hwang et al  (2011), demonstrating 
superiority of Col I incorporation over HA in PEG hydrogels, in sGAG and Col II protein 
expression. Further, the same report demonstrated increase in MSC proliferation during 
chondrogenesis in PEG-HA matrices, relative to PEG-Col I hydrogels, which was not observed 
in IPC hydrogel systems. Differences in receptor mechanism that facilitated HA interaction 
with encapsulated MSCs in these two systems might be among the primary causes, since the 
reported protrusions in MSC morphology in PEG-HA hydrogels (Hwang et al., 2011), are 
known to be associated with RHAMM mediated interactions (Assmann et al., 1999, Hall et al., 
1994). In contrast, MSC in IPC-HA hydrogels were found to aggregate, in which a CD44 
receptor mediated interaction might have occurred (Responte et al., 2012). As CD44 and 
RHAMM are known to implicate different downstream signaling events that alter several 
cellular processes, including actin cytoskeleton, proliferation and migration, (Assmann et al., 
1999, Lee and Spicer, 2000, Responte et al., 2012, Underhill, 1996), the different cellular 
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outcomes might have stemmed from the differential receptor engagement, hence triggering 
different intracellular signaling. This might also hold true for the reported inferior Col II 
expression in PEG-HA hydrogels relative to IPC-CS hydrogels (Nguyen et al., 2011a, Nguyen 
et al., 2011b). 
 
6.3.3 Derivation of zonal cartilage phenotypes by IPC hydrogels with different 
biochemical cues  
The following table (Table 2) summarizes the reported zonal variations in articular cartilage, 
with regards to the varying expression levels of sGAG, Col II, Col X and other molecular 
markers between the different zones and the associated mechanical properties (Aigner and 
Stove 2003, Coates et al., 2010,  Little et al., 2011, Keeney et al., 2011). 
 
Of the elements listed in the table above, the expression of clusterin and decorin were 
not studied, nor were the measurement of compressive modulus of the various IPC hydrogels. 
Measuring mechanical properties of the IPC hydrogels presented significant challenges for  
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handling and sample preparation, with their fiber-assembled nature causing  stickiness under 
testing conditions, thus hampering measurement. With the background of zonal variations in   
ECM composition known to occur in articular cartilage (Table 2), the following table (Table 3) 
summarizes the findings of this study (Figs. 24-29), and thus the potential of IPC hydrogels 
with different biochemical cues for  engineering zonal cartilage phenotypes. 
   
 
IPC-control hydrogels were found to prime superficial zonal phenotypes, owing to high 
PRG-4 expression, with moderate Col II expression accompanied by lowest sGAG expression. 
Higher  PRG-4 expression observed in IPC-control hydrogels is of great significance, as its 
upregulation has not been observed in previous studies that sought to modulate biochemical 
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compositions in order to alter chondrogenic outcomes (Coates et al., 2012). PRG-4 is expressed 
in the superficial zone of articular cartilage, where it facilitates biochemical joint lubrication 
(Chan et al., 2010, Chang et al., 2008, Greene et al., 2011) by forming complexes with HA 
molecules,  both on the surface of articular cartilage (Nugent‐Derfus et al., 2007), and in 
synovial fluid  (Jay et al., 2007). Provision of lubricative (frictionless) properties is as equally 
important, as the development of a neocartilage tissue with compressive properties (Keeney et 
al., 2011, Kock et al., 2012), since  cartilage accounts for the  low coefficient of friction of 
joints, enabling smooth articulation (Gleghorn et al., 2007).  Although IPC-control hydrogels 
exhibited only moderate Col X expression here, it has been  a widely reported characteristic 
feature of TGF-β3 driven MSC chondrogenesis, due to the tendency to enter cartilage 
hypertrophy, characterized by Col X expression (Bian et al., 2011, Keeney et al., 2011, Kock et 
al., 2012).  
IPC-CS hydrogels appeared to prime  the derivation of a middle zone cartilage 
phenotype, as evidenced by high CILP and COMP expression, together with moderate sGAG 
and Col II expression, and  relatively low PRG-4 and Col X expression. The higher CILP 
expression observed in IPC-control hydrogels might aid the transition from a superficial to a 
more middle zone phenotype derivation. This might also be engineered by assembling spatially 
stratified IPC-control and IPC-CS fibers.  Both IPC-Col I and IPC-HA hydrogels demonstrated 
significant Col II, COMP, Col X and sGAG expression, but differed in IPC-Col I mediated 
COMP and Col IX expression, in contrast to the enhanced Col I and Col IX expression seen in 
IPC-HA hydrogels. The elevated COMP and Col IX protein expression observed in IPC-Col I 
hydrogels, relative to IPC-HA hydrogels, is very significant as COMP and Col IX are involved 
in matrix assembly, maturation, and the overall mechano-responsiveness of articular cartilage. 
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They also mediate the enhanced collagen fibril assembly  (Blumback et al., 2009, Haleem-
Smith et al., 2012) of other matrix macromolecules such as proteoglycans (Haleem-Smith et al., 
2012), which are associated with the maturation  (Opolka et al., 2007) and enhanced 
mechanical properties (Amanatullah et al., 2012) of the cartilage tissues.  
A deep zone cartilage phenotype is known to result when the developing neocartilage 
tissue enters maturation phase, particularly when the sGAG deposited by differentiating cells 
reaches a threshold CS6:CS4 ratio of 4 (Barry et al., 2001). Cessation of sGAG and Col II 
expression follows, with increase in Col IX and Col X expression. As our results indicated that 
sGAG levels in all the IPC hydrogels continuously increased even at day 21 (Fig. 25B), it 
suggests that the neocartilage tissue had not entered the maturation phase. Although heightened 
col IX expression was observed in IPC-Col I hydrogels, it suggests only an initiation of 
neocartilage maturation, and not  a  terminal state. As chondroprogenitors  in vivo are under the 
influence of both biochemical and mechanical stimuli, mechanical loading might aid in the 
further refinement of zonal cartilage phenotypes generated in vitro. An ideal hyaline cartilage 
phenotype might result from IPC-Col I hydrogels subjected to  mechanical stimulation, due to a   
 synergistic effect with the observed lower Col I (fibrocartilaginous marker), and high COMP, 
Col IX expression (mature, hyaline phenotype markers). While IPC-HA hydrogels could also 
facilitate a deep zone cartilage phenotype, Col IX mediated crosslinking of Col II fibrils, as 
observed in IPC-Col I hydrogels, is known to confer better structural and mechanical properties 





6.3.4 Possible mechanisms underlying the differential influence of biochemical cues on 
MSC chondrogenesis 
While the different phenotypic outcomes resulting under the influence of various 
biochemical cues have been discussed, the possible mechanisms underlying such differences are 
addressed in this section. In general, the results of this study are most likely to arise from 
differences in the mode of biochemical cue presentation (submicron cell/ECM interactions) and 
differential perturbation of cellular processes and consequent downstream signaling events, 
under the influence of different biochemical cues. 
PRG-4 upregulation in IPC-control hydrogels might stem from the influence of chitin-
alginate backbone, and lesser cell-ECM interactions, due to lack of adhesive cues. Such 
speculation is supported by recent reports, where MSCs encapsulated in alginate hydrogels 
undergoing chondrogenic differentiation were found to upregulate PRG-4 expression (Coates et 
al., 2012, Gleghorn et al., 2007). The report by Coates et al  (2012) involved 2% alginate 
hydrogels demonstrating upregulated Col I and PRG-4 gene expression by chondro-
differentiating MSCs, which was not observed in the CS- and HA-incorporated alginate 
hydrogels. However, a notable difference between the two studies was the positively stained 
pericellular matrix of MSCs for PRG-4 protein, in CS and HA incorporated alginate hydrogels, 
albeit such hydrogels downregulating PRG-4 mRNA expression. Factors contributing to such 
differences could include differences in alginate concentration and material backbone 
constituting the hydrogels, and chiefly, the concentration of CS and HA employed. As  a  higher 
concentration of HA (5%) and CS (1%) was used by Coates et al  (2012), relative to the lower 
(0.25%) concentration of CS and HA in this study, it is likely that the higher CS and HA 
concentration significantly enhanced their binding to cells and secreted products, such as 
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proteins, due to increasing charge density of such biomolecules. Differentiating MSCs in 
hydrogels lacking adhesive cues have been extensively reported to enter cartilage hypertrophy, 
known to be mediated by Runx2 expression and involving P38 MAPK pathways (Zhen et al., 
2001, Stanton et al., 2004, Goldring et al., 2006). As mechanical loading is known to prevent 
hypertrophic development and arrest chondroprogenitors in hyaline fates, mechanical loading 
can play a beneficial role in  downplaying Col X expression, to maintain superificial zone 
phenotype (Afizah et al., 2007, Bian et al., 2011, Erickson et al., 2012, Zhang et al., 2013).  
The role of CS in mediating a middle zone phenotype is reported to stem from its charge 
property, (Hwang et al., 2011, Nguyen et al., 2011a, Nguyen et al., 2011b) whereby it 
facilitates association of chondroprogenitor secreted PGs, forming a stable and uniform 
cartilage ECM.  Such effects could arise from the property of CS to create morphogenetic 
gradients by its binding with PGs and cytokines including growth factors,  especially members 
of the TGF-β superfamily (Hubbell, 2003). It could act as a reservoir for bio-actives, increasing 
their shelf life and local retention that influence cellular processes and differentiation outcomes. 
The larger cell cluster observed in this study, in comparison with other reports involving PEG-
CS hydrogels even after prolonged  in vitro  culture, might result from better facilitation of 
differentiation associated, cellular remodeling of local microenvironment by encapsulated cells 
in IPC hydrogels. This is elucidated in the observation that, despite employing much higher CS 
concentrations (9% and 10%) (Nguyen et al., 2011a, b), with associated increase in charge 
property aiding retention and assembly of cell secreted PGs, only smaller cell clusters were 
observed in such matrices, even after prolonged  in vitro  culture for 6 weeks. Such a 
comparison is significant since larger cell clusters in IPC-CS hydrogels were observed even by 
day 4, relative to that observed in studies by Nguyen et al  (2011a&b). This suggested the 
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aforementioned observations to stem from  efficient biochemical cue presentation in IPC 
hydrogels, where its  permissiveness to cellular remodeling could have  aided such dynamic cell 
induced outcomes. 
 IPC-Col I hydrogels were found to involve the β-1 integrin mediated N-cadherin/β-
catenin pathway, which can influence the TGF-β  dependent Smad or non-Smad pathways to 
drive chondrogenic differentiation. Although the precise mechanism and downstream signaling 
events have not been addressed in this study, the Col I mediated dynamic morphological 
changes may play a vital role. Such dynamic morphological events are known to mimic 
morphological changes of limb bud cells in the condensing mesenchyme in vivo (DeLise et al., 
2000, Sandell 1994). This is especially relevant in addressing the early and robust onset of Col 
II expression (Fig. 22D) and the marked  upregulation of Col IX protein expression in IPC-Col I 
hydrogels (Figs. 27, 30), observed before  any mechanical stimulation. Changes in actin 
cytoskeleton are known alter nuclear morphology, modulating the expression of different 
regions of the chromosome (Shivashankar, 2011). As dynamic changes in MSC morphology 
also accompanied changes in size and shape of nuclei during the early time points studied (Figs. 
15, 16), such cellular and molecular events may account for the robust and mature chondrogenic 
differentiation observed in IPC-Col I hydrogels. 
 As discussed earlier in 6.3.1, interactions of encapsulated MSCs in IPC-HA hydrogels 
may involve CD44 receptor mediated mechanisms (Bian et al., 2013, Responte et al., 2012).   
CD44 is known to be associated with F-actin through ERM  and ankyrin (Isacke and Yarwood, 
2002, Underhill, 1996), which influence downstream signaling events such as cell migration 
and proliferation  (Chung et al., 2009, Underhill, 1996). Further, CD44 mediated HA 
interaction is known to upregulate N-CAM and N-cadherin expression (Bian et al., 2013), 
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which is in agreement with the report of Rac1 activation following CD44 engagement (Lee and 
Spicer 2000); as Rac1 is also known to be a positive regulator of mesenchymal condensation 
(Woods et al., 2007). Furthermore, CD44 mediated Rac1 activation is known to activate MAPK 
pathways (Lee and Spicer 2000), which suggests a possible role of p38 MAPK pathways in 
bringing about the upregulated Col X expression (Goldring et al., 2006, Zhen et al., 2001) in 
IPC-HA mediated MSC chondrogenesis. Thus, even the similar chondrogenic outcomes 
observed with HA and Col I can result from activation of very different extracellular receptors, 
which  may consequently alter various intracellular pathways, thereby modulating  such cellular 
processes. 
 
In conclusion, IPC hydrogels with different biochemical cues brought about distinct 
phenotypic differences in chondrogenic outcomes. Although earlier reports have indicated the 
potential of biochemical cues in modulating chondrogenesis, the varied phenotypic differences 
observed and zonal markers studied in this study are unique and significant, since such distinct 
effects were facilitated employing similar concentrations (0.25%) for all the biochemical cues 
studied, validating the potential of IPC mediated cue presentations in modulating cellular 
processes. In comparison, earlier efforts using engineered PEG hydrogels (Hwang et al., 2011, 
Nguyen et al., 2011a, Nguyen et al., 2011) have varied the concentrations of biochemical cues, 
typically employing higher concentrations, to bring about phenotypically different 
differentiation outcomes. Notwithstanding a much lower concentration (0.25%) of different 
biochemical cues employed in this study, we speculate that the cell/ECM alignment and high 
cell packing density were positive  factors in bringing about the augmented chondrogenic 
outcomes. IPC hydrogels were perceived to better facilitate cellular remodeling during 
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chondrogenesis, resulting in more homogenous and uniform differentiation, relative to other 
hydrogel based approaches. Thus the underlying hypothesis of this study was supported by such 








7. STUDYING CHONDROCYTE BEHAVIOR IN IPC HYDROGELS 
 
7.1 Background 
Recent studies have reported significant differences in functional phenotypic outcomes, when 
MSCs or culture-expanded chondrocytes were cultured in similar three-dimensional, matrix 
microenvironments.  Significant differences in chondrogenic gene expression and ECM 
production were reported in 3D, agarose matrices  (Erickson et al., 2008, Huang et al., 2010b), 
and alginate matrices incorporated with CS and HA (Coates et al., 2012). Since results from 
earlier chapters  of this  thesis (Chapters 5 and 6) indicated  that   IPC-Col I hydrogels 
facilitated a robust chondrogenic outcome using MSCs, comparative studies to investigate MSC 
and chondrocyte  based  phenotypic  outcomes in using  IPC-Col I and IPC-control hydrogels 
were performed. This  comparison was especially relevant since MSC based approaches for 
cartilage regeneration are reported to result in inferior outcomes, in comparison with 
chondrocytes based outcomes (Erickson et al., 2008, Zscharnack et al., 2010). Further, given 
the strong correlation between cell shape and phenotypic fate with regards to chondrocytes, 
wherein loss of rounded morphology alters chondrogenic fate (Benya and Padilla 1993, Wang 
et al., 2004, Woods et al., 2007), employing Col I incorporated IPC hydrogel presented an 
interesting proposition. Thus the main objective of this chapter was to examine the suitability of 
widely reported application of similar 3D matrix environments, for both MSC and chondrocyte 
based approaches.  
Analyses of chondrogenic outcomes in taking chondrocyte based approaches were also 
performed at two levels, namely early, cellular and molecular events, and consequent functional 
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phenotypic outcomes. Firstly, analysis of chondrogenic outcomes in chondrocyte laden IPC-
control and IPC-Col I hydrogels (n=5) was carried out by studying chondrogenic gene 
expression using  RT-PCR analysis, at days 7, and 14 (Methods: 3.8). Such time points were 
chosen to observe any early differences in gene expression profile, between encapsulated 
chondrocytes in IPC-control, and IPC-Col I hydrogels. Further, histological analysis for 
studying  differences in ECM organisation and distribution by Safranin-O and Col II 
immunohistochemistry (Methods: 3.5)  was carried out at day 21 (n=4), to evaluate if trends 
observed in mRNA expression correlated with functional chondrogenic outcomes. Similarly, 
gene (RT-PCR) and protein expression (histological analysis) of zonal cartilage markers by 
encapsulated chondrocytes in IPC-control, and IPC-Col I hydrogels (n=5), was also performed 
at aforementioned time points, to facilitate comprehensive analyses of phenotypic outcomes. 
Also, quantification of chondrocytic population by picogreen assay, and ECM deposition by 
Blyscan assay for sGAG, and ELISA for Col II protein expression (Methods: 3.7) were 
performed at days 14, and 28 (n=5), to correlate if early differences in gene expression 
(observed at days 7, 14) were sustained at later time points (at day 28), in terms of functional 
differentiation outcomes.  
To validate the significance of ECM driven changes in influencing cell morphology and 
associated functional outcomes, F-actin polymerization was disrupted by cytochalasin D (CytD) 
treatment. CytD treatment prevented changes in rounded chondrocyte morphology, when 
encapsulated in IPC-Col I hydrogels.  Effects of CytD treatment on early cellular events was 
performed by F-actin staining to study cell morphology (Methods: 3.6.1), together with 
expression of articular cartilage phenotypic marker, Col II, by immunofluorescence staining 
(Methods: 3.6.1), at days 1, 4, and 7 (n=4). Further, analyses of phenotypic outcomes in IPC-
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Col I hydrogels encapsulating CytD treated chondrocytes, was performed by evaluating gene 
expression of articular cartilage markers, Sox9 and Col II, together with expression of 
fibrocartilaginous  marker  Col I, at day 14 (n=5). Such studies involving CytD treatment were 
also performed in parallel with MSCs, wherein CytD  treated  MSC  were encapsulated in IPC-
Col I hydrogels (n=5), to  facilitate valid comparisons between the two cellular approaches. In 
all studies involving CytD treatment, a control group constituted by untreated cells, 
encapsulated in IPC-Col I hydrogels, and conventional IPC-control hydrogels were maintained, 
in both MSC and chondrocyte based studies. 
 
7.2 Results 
7.2.1 Analysing chondrogenic outcomes in IPC-control and IPC-Col I hydrogels 
Differences in the macroscopic changes of chondrocyte encapsulated IPC-control and IPC-Col I 
hydrogels were observed through the course of chondrogenic differentiation (Fig. 30A). 
Chondrocytes in IPC-control hydrogels formed local aggregates in IPC-control hydrogels by 
day 7 (Fig. 30B). On the other hand, cells in IPC-Col I hydrogel did not exhibit such clustering, 
suggesting Col I engagement (Fig. 30B), to  result in hydrogel contraction by day 7 (Fig. 30A). 
Such difference was more pronounced by day 14 of chondrogenic differentiation, where 
quantification of hydrogel contraction (Fig 30C) brought about by encapsulated chondrocytes 






Quantitative real time PCR analysis of chondrogenic differentiation in IPC-control and 
IPC-Col I hydrogels was performed. Gene expression analysis of Col II and aggrecan (Fig. 
31A) indicated that Col I incorporation downregulated their expression, relative to IPC-control 
hydrogel.  
Fig. 30 Macroscopic changes of different IPC hydrogels with encapsulated chondrocytes during 
chondrogenesis. (A) Phase contrast images of IPC-control and IPC-Col I hydrogels under chondrogenic 
differentiation conditions at days 1, 7, 14. (Scale bar: 1 mm). (B) Magnified images of encapsulated 
chondrocytes in IPC-control and IPC-Col I hydrogels at day 7. (Scale bar: 500µm).  (C) Analysis of 
chondrocytes mediated hydrogel contraction during chondrogenesis in IPC-control and IPC-Col I 
hydrogels. n≥4 per group, mean ±SD. * denotes p<0.05 between IPC-control and IPC-Col I hydrogels.  
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Fig. 31 Histological and real time PCR analysis of chondrogenic outcomes in IPC-control and IPC-Col I 
hydrogels. (A) Real time PCR analysis of cartilaginous genes by encapsulated chondrocytes in IPC-control and 
IPC-Col I hydrogels at days 7 and 14 of chondrogenic differentiation. Expression was normalized to their 
respective GAPDH expression and expressed as fold changes relative to undifferentiated chondrocytes. n≥4 per 
group, mean ±SD.*p<0.05 between IPC-control and IPC-Col I hydrogels, at the same time points. (B) 
Histological analysis of chondrogenic outcomes in IPC hydrogels with encapsulated chondrocytes at day 21 by 
Alcian blue, Safranin-O and Col type II immunohistochemical staining. (Scale bar 200µm). Regions a, b from 
Col II staining of IPC-control and IPC-Col I hydrogels are shown at a higher magnification. (Scale bar 50µm).  
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IPC-control hydrogels facilitate better maintenance of chondrogenic phenotype, which was 
evidenced by statistically significant upregulation of Col II and aggrecan expression. Yet, a 
common trend observed in both the hydrogels was the downregulation of chondrogenic markers 
by day 14, relative to their expression at day 7 of chondrogenic differentiation.  
Histological evaluation of the neocartilage generated in the IPC-control and IPC-Col I 
hydrogels after 3 weeks of chondrogenic differentiation was performed (Fig. 31B). IPC-Col I 
hydrogel facilitated uniform chondrocyte differentiation throughout the entirety of the hydrogel, 
resulting in better matrix integrity, evidenced by the resulting stable, and larger tissue size post 
processing for histological analysis (Fig. 31B). On the other hand, localised clustering of cell 
aggregates and non-uniform formation of cartilage tissue in IPC-control was indicated by the 
disintegration of IPC-control hydrogel construct during sample preparation for histology, 
despite intense ECM and Col II staining. Consistent with phase-contrast observations during 
chondrogenesis (Fig. 30), chondrocytes in IPC-control hydrogels formed local aggregates, with 
intense pericellular Col II staining (region a, Fig. 31B). Chondrocytes in IPC-Col I hydrogels 
were found to align, with less intense Col II deposition at same magnification (region b, Fig. 
31B). 
 
7.2.2 Influence of IPC hydrogels on chondrocyte proliferation and ECM deposition  
Chondrocyte proliferation in IPC-control and IPC-Col I hydrogels was studied by evaluating the 
total DNA content. DNA quantification at 14 and 28 days of chondrogenic differentiation 
suggested that IPC-control hydrogels supported higher cellular proliferation (Fig. 32A). Col I 
incorporation was found to limit cellular proliferation, with statistically significant differences 
in comparison with IPC-control hydrogels. Quantification of sGAG and Col II in neocartilage 
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tissue showed that chondrocytes encapsulated in IPC-control hydrogel resulted in higher levels 
of sGAG and Col II expression, at 14 and 28 days of chondrogenic differentiation (Fig. 32B, 
32C). Although upregulation of sGAG expression in IPC-control hydrogels was statistically 
significant only after 28 days of differentiation, upregulation of Col II expression was 
statistically significant at both 14 and 28 days of chondrogenic differentiation, relative to IPC-
Col I hydrogels. 
 
 
Fig. 32 Cell proliferation and ECM quantification of IPC hydrogels with encapsulated chondrocytes. (A) Total 
DNA content in IPC-control and IPC-Col I hydrogels at day 21, n≥4 per group, mean ±SD. (B) sGAG and (C) 
Col type II content normalized with respective DNA content of  samples from IPC-control and IPC-Col I 
hydrogels at day 21. n≥4 per group, mean ±SD. * denotes p<0.05 between IPC-control and IPC-Col I hydrogels.  
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7.2.3 Gene expression analysis of zonal cartilage markers in IPC hydrogels  
As earlier studies suggested differences in sGAG and Col II expression by encapsulated 
chondrocytes in IPC-control and IPC-Col I hydrogels, real time PCR analysis of zonal cartilage 
markers was performed to ascertain differences in phenotypic outcomes between the two 
hydrogels (Fig. 33). 
 
 
Fig. 33 Real time PCR analysis of zonal cartilage markers in chondrocyte encapsulated IPC hydrogels. Real time 
PCR analysis of mRNA expression levels of zonal cartilage genes in IPC-control and IPC-Col I hydrogels at 
days 7 and 14 of chondrogenic differentiation. Expression was normalized to their respective GAPDH 
expression and expressed as fold changes relative to undifferentiated chondrocytes. n≥4 per group, mean ±SD. * 
denotes p<0.05 between IPC-control and IPC-Col I hydrogels. 
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Expression of fibrocartilaginous marker Col I, and superficial zone marker PRG-4 was very 
high in IPC-Col I hydrogels, with statistically significant differences relative to IPC-control 
hydrogels at day 14 of chondrogenic differentiation. While Col I expression was almost nil at 
days 7 and 14 of chondrogenic differentiation in IPC-control hydrogels, moderate expression of 
PRG-4 was indeed observed, with little increase between days 7 and 14. Middle zone markers 
COMP, Col IX, which also signified matrix maturity were found to be highly upregulated in 
IPC-control hydrogel at day 7, with statistical significance relative to IPC-Col I hydrogel. But 
expression of these markers decreased in both the hydrogels by day 14 with no statistical 
significance between the two groups. Very little expression of deep zone and hypertrophy 
marker, Col X, was observed at day 7 in both IPC-control and IPC-Col I hydrogels. But the 
IPC-Col I hydrogel was found to have high upregulation of Col X expression at day 14, with a 
statistical significance relative to IPC-control hydrogel.  
 
7.2.4 Immunohistological evaluation of zonal phenotype generation in IPC hydrogels  
To validate the influence of different matrix microenvironments in generating phenotypically 
distinct neocartilage, immunohistological staining analysis was performed to examine the 
protein expression profiles of the various zonal cartilage markers. Immunohistological staining 
analysis of superficial zone markers, Col I and PRG-4, indicated differences in the phenotypic 
outcomes in IPC-control and IPC-Col I hydrogels (Fig. 34). Col I protein expression was 
observed in both the hydrogels, without any significant differences between them at day 21 of 
chondrogenic differentiation. This was found to be inconsistent with gene expression profile of 
Col I in IPC-control hydrogels, where no significant upregulation was observed at day 14 of 
chondrogenic differentiation (Fig. 33). But PRG-4 protein expression in IPC-Col I hydrogel was 
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in-line with gene expression analysis, demonstrating a significant upregulation, relative to IPC-




Further, differences in protein expression pattern of middle zone marker, COMP, was 
observed in the two hydrogel groups. While IPC-Col I hydrogel did not stain positively either 
for COMP, or the other middle zone marker, Col IX, IPC-control hydrogel demonstrated 
Fig. 34 Histological analysis of zonal cartilage markers in chondrocyte encapsulated IPC hydrogels. 
Immunohistological staining of Col I and PRG-4, COMP, Col IX and Col X in IPC-control and IPC-Col I 
hydrogels with encapsulated chondrocytes at day 21. (Scale bar 200µm). 
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COMP protein expression, but stained negatively for Col IX. Absence of Col IX protein 
expression followed its gene expression, since Col IX was found to downregulated at day 14 in 
both hydrogels (Fig. 33). Yet, when similar downregulation of COMP mRNA expression was 
observed at day 14 in both hydrogels (Fig. 33), IPC-control hydrogel stained positively for 
COMP protein at day 21, implicating that such matrix microenvironments better preserved its 
expression. Protein expression of deep zone marker, Col X, in IPC-control hydrogels (Fig. 34) 
followed its gene expression profile (Fig. 33), with negative staining at day 21. In IPC-Col I 
hydrogels, albeit a heightened Col X mRNA expression observed at day 14 (Fig. 33), its protein 
expression was found to be absent at day 21 of chondrogenic differentiation (Fig. 34). 
 
7.2.5 Inhibiting changes in cellular morphology and analysis of chondrogenic outcomes in 
IPC-Col I hydrogels 
As earlier results suggested change in chondrocyte morphology in IPC-Col I hydrogels under 
chondrogenic conditions (Figs. 30, 31), with associated changes in phenotypic outcomes (Figs. 
32, 33, 34), studies to understand the role of chondrocyte morphology in influencing phenotypic 
outcomes were performed. F-actin polymerization was disrupted by cytochalasin D (CytD) 
treatment, which prevents morphological changes in chondrocytes, such as the adoption of an 
elongated morphology under the influence of Col I. Preliminary studies to understand the 
cytotoxicity of CytD on chondrocytes was performed by testing various CytD concentrations 
under chondrogenic culture conditions for 7 days (Fig. 35A). Concentrations that were studied 
included 1µM, 0.5µM, 0.25µM and 0.1µM, with 0.1% DMSO carrier solution as the control, as 
CytD was prepared in DMSO, constituting a final concentration of 0.1% DMSO in the culture 
media. Since the objective of this study was to elucidate the differences in matrix 
138 
 
microenvironment requirements in using a MSC or chondrocyte based approach for cartilage 
regeneration, similar studies were also extended to IPC-Col I hydrogels with encapsulated 





Fig. 35 Cytotoxicity of various cytochalasin D concentrations on encapsulated cells in IPC-Col I hydrogels. 
(A) Live-dead staining images of encapsulated chondrocytes (A) and MSCs (B) in IPC-Col I hydrogels 
incubated with 1µM, 0.5µM, 0.25µM and 0.1µM concentrations of cytochalasin D, and 0.1% DMSO control 




In general, a concentration dependent cytotoxic effect of CytD was observed on both 
chondrocytes (Fig. 35A), and MSCs (Fig. 35B), with very little cytotoxicity elicited by DMSO 
control during the chondrogenic differentiation. While both 1µM and 0.5µM concentrations of 
CytD efficiently disrupted F-actin polymerization and subsequent IPC-Col I hydrogel 
contraction, high cytotoxic effect was observed with 1µM CytD. 0.5µM CytD concentration 
was used for subsequent experiments, for both MSCs and chondrocytes. Also noteworthy was 
the inverse relationship between decreasing CytD concentration and increasing IPC-Col I 
hydrogel contraction, validating the role of F-actin mediated morphological changes during 
chondrogenesis in IPC-Col I with encapsulated MSCs and chondrocytes (Fig. 35). IPC-Col I 
hydrogels with encapsulated MSCs and chondrocytes contracted the most in the DMSO control 
group, excluding any interference from DMSO in the hydrogel contraction. 
 
Analysis of early changes in cell morphology and chondrogenic outcomes with CytD 
treatment was performed for both MSC and chondrocyte encapsulated IPC-Col I hydrogels. 
Phalloidin staining of F-actin and immunofluorescence staining of Col II expression in MSC 
and chondrocyte encapsulated IPC-Col I hydrogels with CytD treatment (+CytD), was carried 
out during the first 7 days of chondrogenic differentiation. Cells treated with 0.1% DMSO 
solution served as controls (-CytD), while cell laden IPC-control hydrogels were also included 
in the study to appreciate the role of F-actin disruption and consequent changes in cellular 
processes. Striking differences were observed in CytD treated chondrocyte (Fig. 36) and MSC 
(Fig. 37) encapsulated IPC-Col I hydrogels during early chondrogenic differentiation, relative 





Fig. 36 Effect of F-actin disruption by Cytochalasin D treatment on chondrogenic differentiation of 
encapsulated chondrocytes in IPC hydrogels. Chondrocyte morphology was observed by F-actin staining (red) 




Untreated chondrocytes encapsulated in IPC-Col I hydrogels (-CytD) assumed a rounded 
morphology at day 1 (Fig. 36A), but displayed dynamic morphological changes by assuming an 
elongated morphology, at days 4 (Fig. 36B) and 7 (Fig. 36C). This was in contrast to the 
chondrocyte morphology in CytD treated IPC-Col I hydrogels (+CytD) and IPC-control 
hydrogels, wherein they maintained a rounded morphology at days 1 (Fig. 36A), 4 (Fig. 36B), 
and 7 (Fig. 36C). Chondrocytes in IPC-control hydrogels formed local aggregates, as early as 
day 4, during chondrogenic differentiation with associated Col II expression, whereas CytD 
treated chondrocytes did not readily form aggregates at day 4. Chondrocytes across the different 
treatment groups and hydrogels were found to express Col II, from day 1 until day 7 of 
chondrogenic differentiation in this study.  
CytD treated MSCs encapsulated in IPC-Col I hydrogels (+CytD) were also limited in 
their ability to undergo dynamic morphological changes, during chondrogenic differentiation 
(Fig. 37). Although they displayed an elongated morphology, similar to that observed in DMSO 
treated control IPC-Col I hydrogel (-CytD) at day 1(Fig. 37A), they assumed a rounded 
morphology and did not undergo subsequent morphological dynamics at days 4 (Fig. 37B), and 
7 (Fig. 37C), as observed in control IPC-Col I hydrogels (-CytD). The F-actin in CytD treated 
MSCs was found as aggregates at days 4 and 7, with CytD treatment disrupting F-actin 
polymerization, which was elucidated in comparing the cortical actin distribution of MSCs in 
IPC-control hydrogels. Furthermore, CytD treated MSCs were unable to form clusters and 
existed as single cells, which was in contrast to the local clusters observed in IPC-control 
hydrogel at the same time points. MSCs across the different treatment groups and hydrogels 
were found to express Col II, starting from day 4, with nil expression at day 1, which was in-





Fig. 37 Effect of F-actin disruption by Cytochalasin D treatment on chondrogenic differentiation of 
encapsulated MSCs in IPC hydrogels. MSC morphology was observed by F-actin staining (red) and 
chondrogenic differentiation by Col II expression (green) at days 1 (A), 4 (B) and 7 (C). (Scale bar: 50 µm). 
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To correlate the changes in cell morphology and their chondrogenic outcomes, 
quantification of Col II expression from immunofluorescence staining images of the different 
hydrogels in Figs. 36 and 37 was performed. Level of Col II expression in the CytD treated 
chondrocytes in IPC-Col I hydrogels at days 1, 4, and 7 was found to be statistically higher than 
that observed in the control group (-CytD) (Fig. 38A). Treatment with CytD reverted Col II 
expression to levels similar to that in IPC-control hydrogels, establishing an association 





Fig. 38 Fluorescence quantification of Col II expression by Cytochalasin D treated chondrocytes (A) and 
MSCs (B) encapsulated in IPC-Col I hydrogels, and untreated cells in IPC-control hydrogels. * denotes 




 In contrast to the inhibition of morphological changes in chondrocytes, and 
associated upregulation of Col II expression in CytD treated IPC-Col I hydrogels, inhibition of 
F-actin dynamics by CytD treatment downregulated Col II expression in MSC encapsulated 
IPC-Col I hydrogels (Fig. 38B).Levels of Col II expression at days 4 and 7 in the CytD treated 
IPC-Col I hydrogels was statistically lower in comparison with control IPC-Col I hydrogels (-
CytD). Col II expression levels in CytD treated IPC-Col I hydrogels was found to be similar to 
IPC-control hydrogels, suggesting the critical role of dynamic morphological changes in MSC 
chondrogenesis. 
  
 To unequivocally validate the role of morphological changes and concomitant 
effects on chondrogenic outcomes, real time PCR analysis of chondrogenic genes in CytD 
treated MSC and chondrocyte encapsulated IPC-Col I hydrogels was performed after 14 days of 
chondrogenic differentiation. DMSO treated cell laden IPC-Col I hydrogels (-CytD) served as 
controls and IPC-control hydrogels were included for comparative studies. Phase contrast 
images acquired in the due course of chondrogenic differentiation demonstrated significant 
differences between the CytD treated cell laden IPC-Col I hydrogels, relative to control IPC-Col 
I (-CytD) and IPC-control hydrogels (Fig. 39A, 39B). Analysis of hydrogel contraction at day 
14 showed significant reduction in contraction of CytD treated IPC-Col I hydrogel to levels 
similar to IPC-control group, for both MSCs (Fig. 39C) and chondrocytes (Fig. 39D). The effect 
of F-actin disruption brought about opposite outcomes between MSCs and chondrocytes, as 




Fig. 39  Macroscopic changes in IPC-Col I hydrogels encapsulated with Cytochalasin D treated MSCs and chondrocytes 
during chondrogenesis.  Phase contrast images of MSC (A) and chondrocyte (B) under chondrogenic differentiation 
conditions in different IPC hydrogels at days 1, 14. (Scale bar: 1 mm). Analysis of hydrogel contraction in MSCs (C) 
chondrocytes (D) encapsulated IPC-Col I hydrogels with and without Cytochalasin D treatment, and IPC-control hydrogels 
after 14 days of chondrogenic differentiation. n≥4 per group, mean ±SD. . * denotes p<0.05 between Cytochalasin D treated 








Fig. 40  Real time PCR analysis of chondrogenic outcomes in Cytochalasin D treated MSCs and chondrocytes encapsulated 
in IPC-Col I hydrogels. (A) Expression of cartilaginous genes in MSC (A) and chondrocyte (B) encapsulated IPC-Col I 
hydrogels with and without Cytochalasin D treatment, and IPC-control hydrogels at day 14 of chondrogenic differentiation. 
Expression was normalized to their respective GAPDH expression and expressed as fold changes relative to undifferentiated 
MSCs (A) and chondrocytes (B). n≥4 per group, mean ±SD.* denotes p<0.05 between Cytochalasin D treated and untreated 




 Inhibiting morphological changes in MSC encapsulated IPC-Col I hydrogels by 
CytD treatment was found to significantly downregulate Col II and aggrecan expression, 
relative to untreated control IPC-Col I hydrogels (-CytD) and IPC-control hydrogels (Fig. 40A). 
Sox9 expression was also significantly downregulated in CytD treated IPC-Col I hydrogels, but 
relative to untreated IPC-Col I hydrogels (-CytD) (Fig. 40A). In contrast, inhibiting 
chondrocyte elongation significantly upregulated Col II and aggrecan expression, relative to 
untreated IPC-Col I hydrogels (-CytD), and to similar levels similar observed in IPC-control 
hydrogels (Fig. 40B). Further, upregulated expression of fibrocartilaginous marker Col I in 
untreated IPC-Col I hydrogels (-CytD), was significantly reduced in CytD treated IPC-Col I 
hydrogels, to levels comparable with that observed in IPC-control hydrogels. These results 
established an association between morphological changes of chondrocytes in IPC-Col I 
hydrogels and the loss of hyaline cartilage phenotype. 
 
7.3 Discussion 
7.3.1 Comparing cell behavior and chondrogenic outcomes between MSCs and 
chondrocytes in IPC hydrogels 
Initial studies addressed differences in MSC and chondrocyte behavior in IPC-Col I and IPC-
control hydrogels. Chondrocyte behavior was similar to MSCs, wherein they adopted a rounded 
morphology and formed aggregates in IPC-control hydrogels, and adopted an elongated 
morphology in IPC-Col I hydrogels (Fig. 30). Similar to MSCs (Fig. 11), chondrocyte mediated 
hydrogel contraction in IPC-Col I hydrogels (Fig. 30), were in-line with other studies involving 
collagen based hydrogels (Berendsen et al., 2012, Rutgers et al., 2012). However, the 
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chondrogenic outcomes of chondrocytes in IPC-Col I when compared to IPC-control were 
found to be the opposite to those  of MSCs in the same IPC hydrogels. Despite not causing 
hydrogel contraction, IPC-control hydrogels facilitated higher upregulation of chondrogenic 
marker expression at day 7, relative to IPC-Col I hydrogels, although the expression levels 
decreased at day 14 in both systems (Fig. 31). Such downregulation of chondrogenic markers at 
later time points under 3D,  in vitro culture was in-line with the other reports (Berendsen et al., 
2012, Coates et al., 2012. This was thought to arise from relatively low metabolic activity and 
ECM turnover associated with terminally differentiated, mature chondrocytes (Chen et al., 
2013), in comparison with differentiating MSCs entering chondrogenic fate, where sustained 
upregulation was observed (Fig. 12). 
Histological evaluation (Fig. 31B) and ECM deposition (Fig. 32B, 32C) studies 
confirmed chondrocyte differentiation patterns in the two IPC hydrogels, with IPC-control 
hydrogels exhibiting higher and more intense Col II protein expression, relative to IPC-Col I 
hydrogels. Further, the observation that IPC-control hydrogels promoted the proliferation of 
encapsulated chondrocytes was significant, as  expanding chondrocyte numbers without loss of 
phenotype has been a severe shortcoming for the discipline (Keeney et al., 2011, Kock et al., 
2012). The morphology and behaviour of chondrocytes in the IPC hydrogels observed in 
histological analysis (Fig. 31B) were  consistent with phase contrast observations (Fig. 30). 
IPC-Col I hydrogels facilitated uniform matrix formation with better neotissue integrity, albeit 
with less ECM formation (Fig. 31B). Although IPC-control hydrogels facilitated the formation 
of local clusters in a manner similar to MSC (Fig. 13), the chondrogenic outcomes were quite 
different. High gene expression of Col II and aggrecan, with the low levels of Col I expression  
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 in IPC-control hydrogels indicated that the absence of Col I cues in IPC hydrogels favoured a 
better phenotype maintenance by chondrocytes relative to IPC-Col I hydrogels.  
 
7.3.2 Differences in biochemical environment altered phenotypic outcomes 
A strong correlation between cell shape and fate of chondrocytes has been previously reported, 
where the loss of rounded chondrocyte morphology is known to result in dedifferentiation of 
chondrocytes (Benya and Padilla, 1993, Wang et al., 2004, Woods et al., 2007). The expression 
of zonal cartilage phenotypic markers in chondrocyte encapsulated IPC-control and IPC-Col I 
hydrogels was further studied. Real time PCR and histological analysis of fibrocartilaginous 
marker Col I validated the cell shape and fate correlation, with Col I mRNA (Fig. 33) and 
protein expression (Fig. 34) being significantly upregulated by the elongated chondrocytes in 
IPC-Col I hydrogels. In addition, PRG-4, which is only expressed by the fibroblastic, 
superficial zone chondrocytes, was upregulated by the encapsulated chondrocytes in IPC-Col I 
hydrogels (Figs. 33, 34). On the other hand, the rounded chondrocytes in IPC-control hydrogels, 
in addition to higher expression of aggrecan and Col II, exhibited significant upregulation of the 
mature cartilage markers, COMP and Col IX, suggestive of a middle/deep zone cartilage 
formation in IPC- control.   The weak expression of COMP protein and absence of Col IX 
protein expression might have arisen from the absence of a mature ECM and mechanical 
stimulation during in vitro culture in IPC hydrogels. As chondrocytes in native articular 
cartilage tissue experience significant mechanical loading, such stimuli might be vital for 
protein expression and maintenance of mechanoresponsive elements such as COMP and Col IX 
(Chen et al., 2013, Goggs et al., 2003). The tendency of encapsulated chondrocytes in IPC-
control hydrogels to facilitate relative upregulation of COMP and Col IX, under 3D culture, 
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without mechanical stimuli is reflective of their potential for facilitating development of hyaline 
tissue properties in vivo. Although gene expression of the deep zone/hypertrophy marker, Col 
X, increased significantly in IPC-Col I hydrogels, Col X protein expression was not observed in 
IPC-Col I hydrogels. It suggested that encapsulated chondrocytes in IPC-Col I hydrogels have 
higher tendency to progress towards endochondral ossification. Taken together, the results 
establish that chondrocyte behavior was in direct contrast with that in MSC derived 
chondrogenic outcomes in IPC-Col I hydrogel. IPC-control hydrogels supported the 
development of a hyaline cartilage phenotype, whereas IPC-Col I hydrogels favoured an 
increase in fibrocartilaginous and hypertrophic marker expressions. 
 
7.3.3 Validating cell shape induced phenotypic changes in IPC-Col I hydrogels 
The relationship between Col I induced changes in cell morphology and phenotypic differences 
in chondrogenic outcomes, for both MSC and chondrocytes, was investigated by CytD 
treatment.  CytD induced changes in cell shape, by disruption of f-actin polymerization and 
reorganization, has been reported to have a positive correlation with maintenance of 
chondrogenic phenotype (Wang et al., 2004, Woods et al., 2007). Post optimization of 
cytocompatible CytD concentrations for the two cell types, both early changes and functional 
outcomes were studied. Studies analyzing cell morphology and concomitant chondrogenic Col 
II expression yielded striking observations. CytD treatment inhibited cell alignment of both cell 
types (Figs. 36, 37), which was evident by day 4, but resulted in differential chondrogenic 
commitment. Inhibiting cell elongation in chondrocytes resulted in increased Col II expression, 
to similar levels as in the rounded chondrocytes in IPC-control hydrogels (Fig. 38A). But CytD 
treatment had a negative influence on MSCs undergoing chondrogenesis, wherein it 
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downregulated Col II expression, to similar levels in IPC-control hydrogels (Fig. 38B). Such 
changes in cell morphology and consequent chondrogenic outcomes were maintained even at 
day 14, as evidenced by real time PCR analysis of chondrogenic markers (Fig. 40). The 
implications of F-actin disruption were especially significant for MSC chondrogenesis, wherein 
CytD treatment knocked down gene expression of sox9 and aggrecan, even in comparison with 
that in untreated IPC-control hydrogels. Given that cells remained largely as non-aggregated, 
single cells in the CytD-treated samples, compared to the aggregated cells in the IPC-control 
hydrogels, it may underscore the essential requirement of cell-cell interactions for chondrogenic 
commitment and differentiation of MSCs. These observations differ from the reported positive 
correlation between CytD mediated disruption of F-actin and cytoskeletal tension, and 
upregulation of chondrogenic commitment by MSCs in the presence of TGF-β3 (Gao et al., 
2010, Woods et al., 2005). It is noteworthy that such studies were carried out using fibronectin 
coated, micropatterned 2D substrates (Gao et al., 2010), or as high density micromass cultures 
(Woods et al., 2005) in which cell-cell interactions could have been facilitated. Further, the 
negative correlation observed here is in-line with the suggestion of context dependent 
differences in actin inhibition and involvement of RhoA/ROCK pathways on chondrogenic 
differentiation process of  MSCs (Woods et al., 2006), in comparing chondrogenic outcomes 
between micromass culture, 2D, and engineered 3D hydrogel approaches. Furtherstill, the very 
presence of adhesive cues, annulling differences in the biochemical cue  presented, or their 
mode of presentation, between such studies and our study may also have a significant influence 
in directing cellular processes. Interestingly, CytD treatment positively influenced chondrogenic 
gene expression in chondrocytes, in-line with earlier reports (Woods and Beier, 2006, Woods et 
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al., 2007), and reaffirming the importance of cell shape and fate correlation in chondrocytes, 
with a lesser dependence on cell-ECM interactions.  
 
7.3.4 Role of underlying mechanisms and its implications for cartilage tissue engineering 
This study demonstrated the significance of differential matrix requirements for the use of 
either a stem cell or chondrocyte based approach for cartilage tissue engineering. Whilst there is 
an abundance of reports concerning different types of biomaterials and forms of 3D scaffolds 
that have been employed for articular cartilage tissue engineering (Keeney et al., 2011, Kock et 
al., 2012), there is a clear need for a systematic analysis on the suitability of such approaches, 
with due considerations for the different cell types being pursued. Such a standpoint seems 
valid in considering that stem cells, such as MSCs, and terminally differentiated cells, such as 
chondrocytes, differ at more than one level. The optimal requirements for an artificial, 3D 
scaffold to either drive or promote maintenance of cell fate under  in vitro culture, entails 
differential perturbation of cell surface receptor expression, and ECM driven morphological 
adaptation and modulation of intracellular signaling pathways. Reports have identified the gene 
and cell surface receptor differences during MSC chondrogenesis, in comparison with that 
constitutively expressed by undifferentiated MSCs and those in terminally differentiated 
chondrocytes, and dedifferentiating chondrocytes  (Huang et al., 2010b, Stokes et al., 2002). 
Differences in integrin expression between  MSCs and chondrocytes are also known to 
modulate intracellular events and consequently cell fate (Docheva et al., 2007, LaPointe et al., 




A few recent studies have also noted that cellular differences play significant roles in 
engineering appropriate 3D matrices for articular cartilage repair. Coates et al  (2012) reported 
that MSC and chondrocyte based chondrogenic outcomes, in CS and HA incorporated alginate, 
and unmodified alginate, differed in their phenotypic outcomes. Seda Tigli et al  (2009) 
demonstrated that commonly reported matrices such as silk and chitsoan, also triggered    
 significant differences, reducing the chondrocytes chondrogenic properties of encapsulated 
chondrocytes, relative to MSCs studied in such hydrogels. Results discussed in earlier chapters 
(Chapters 5.3, and 6.3) also suggest that morphological changes can modulate different 
intracellular pathways in MSCs to bring about consequent phenotypic outcomes. Chondrocytes 
on other hand necessitate the provision of an optimal, sGAG rich ECM, with the resultant cell-
ECM interactions required for fate maintenance  entailing fewer  cell morphological changes 
(Seda Tigli et al., 2009, Chen et al., 2013). Achieving a critical cell density is also essential for 
chondrocytes to redifferentiate in 3D culture, post 2D expansion (Wang et al., 2006a). This is 
reflected in chondrocyte behavior in IPC-control hydrogels, where the chitin-alginate backbone 
offered a conducive microenvironment for chondrocytes to cluster, without losing their rounded 
morphology, leading to the formation of Col II rich pericellular and extracellular matrices (Fig. 
31B). Formation of such cell clustering and associated pericellular matrix formation was 
impaired in IPC-Col I hydrogels, where chondrocytes engaged the Col I and aligned resulting in 
an elongated morphology. Such morphological changes did not favour hyaline cartilage 





It is probable  that such morphological changes in chondrocytes are associated with 
Rho/ROCK mediated downstream signaling events, since CytD treatment was reported to 
inhibit RhoA/ROCK mediated events (Woods and Beier, 2006, Woods et al., 2007). 
Rho/ROCK signaling in chondrocytes has been reported to upregulate cyclin D1, enhancing 
chondrocyte proliferation (Beier, 2005, Woods et al., 2007), while concomitantly inhibiting 
hypertrophic development (Wang et al., 2004, Woods et al., 2007). Both these reports are in 
agreement with results obtained in chondrocyte encapsulated IPC-control hydrogels, where an 
enhanced proliferation was observed, with higher Col II and weaker expression of Col X. 
Although our study did not probe changes associated with integrin expressions during 
morphological changes, or the exact underlying downstream mechanisms, the literature on 
similar studies does suggest such changes to be involved in the aforementioned phenotypic 
differences (Docheva et al., 2007, LaPointe et al., 2013, Shakibaei and Merker, 1999). 
 Such findings have potential implications on co-culture studies that have been reported 
to augment chondrogenic outcomes. Co-culture of MSC and chondrocytes was reported to 
facilitate hyaline cartilage generation (Meretoja et al., 2012, Sabatino et al., 2012, Wu et al., 
2011, Wu et al., 2012).  Many of the co-culture studies have employed the same biomaterials, 
such as alginate or HA based hydrogels, for the encapsulation of both chondrocytes and MSCs. 
The current best understanding of a co-culture system  involving MSCs and chondrocytes 
suggests that MSCs secrete trophic factors that encourage chondrocyte proliferation, without 
themselves differentiating into chondrocytes, resulting in enhanced cartilage ECM deposition 
by chondrocytes (Wu et al., 2011, Wu et al., 2012). Although such studies have shown 
significant hyaline cartilage formation, with relatively lesser Col I and Col X expression, the 
cell type dependent matrix requirements, in either promoting dynamic morphological changes 
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in MSCs during chondrogenesis, or the maintenance of rounded chondrocyte morphology and 
hyaline phenotype have not been addressed. The results obtained from this  study and those 
reported by others (Seda Tigli et al., 2009, Coates et al., 2012) favour such assertions. Clearly, 
a careful consideration of biomaterial choice is warranted for establishing 3D matrices for co-
culture studies, to promote the desired morphological requirement of chondrocytes and MSC, 
and augment the functional outcome from each of these cell types. 
 
In summary, results from this study establish the differences in optimal matrix 
requirements,  in taking a MSC or chondrocyte based approach for restoration of hyaline, 
articular cartilage.  Col I induced early morphological changes in chondrocytes, resulted in loss 
of  rounded  morphology and  hyaline phenotype. CytD  treatment  of chondrocytes in IPC-Col 
I  hydrogels  reversed  such outcomes, restoring  morphology and  hyaline cartilage phenotype. 
This was  in  striking contrast  with  the  inferior chondrogenic outcomes in CytD treated MSCs, 
wherein abolition of early cell-cell, and cell-ECM interactions hampered robust chondrogenesis 
and functional hyaline phenotype in IPC-Col I hydrogels. Such observations underscore the 
need  for  cell-type and phenotype sensitive choice of biomaterial strategies for functional 
restoration. Thus systematic studies analyzing chondrogenic fates of each cell type under 
consideration, and associated matrix requirements, are critical to augment the current design of 
biomimetic scaffolds for cartilage tissue engineering. Such studies will facilitate the 
development of optimal  in vivo  matrices, to realize the regeneration of neocartilage tissue that 
is akin to native cartilage, in its tissue properties and function. This study has established that 
IPC-based hydrogels present a good platform to address such questions, and aid in the 






The main objective of this thesis was to study the influence of biochemical cues on MSC 
chondrogenesis and modulation of phenotypic outcomes, employing  IPC-based fibrous 
hydrogels. IPC hydrogels offered the promise of more favorable 3D niches for facilitating MSC 
chondrogenesis and sustained the proliferation of the chondro-differentiated MSCs. IPC 
hydrogels facilitated uniform cell distribution and proximal cell/ECM interactions, representing 
significant advancements on other hydrogel based approaches, which resulted in superior 
chondrogenic outcomes. Further, IPC-based hydrogels with varying biochemical compositions 
were found to have distinct effects, in influencing the phenotypic outcomes of MSC 
chondrogenesis.  
Unmodified IPC-control hydrogels were found to favour a superficial zonal phenotype, 
owing to the chitin-alginate backbone, and less cell-ECM interactions due to lack of adhesive 
cues. The potential of CS to prime a mid zone-like articular cartilage phenotype was 
demonstrated, which was thought to stem from its charge property. Such properties of CS was 
likely to facilitate the association of chondroprogenitor secreted PGs, and enhance retention of 
biologics, which modulate cellular events in forming a stable and uniform cartilage ECM. The 
submicron alignment of Col I in IPC hydrogels was found to facilitate superior chondrogenesis 
by promoting dynamic morphological changes and mediating early and uniform cell-cell 
interactions. Such early cellular events were found to result in generation of a mature 
neocartilage, likely through N-cadherin/β-catenin mediated intracellular signaling events. Col I 
was found to aid a mid-deep zone-like cartilage phenotype, with enhanced expression of 
mechanoresponsive elements indicating the potential of neocartilage generated to facilitate 
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mechanical loading, thus recapitulating native tissue function. HA incorporation favoured a 
deep zone cartilage phenotype, with enhanced potential of differentiating MSCs to enter 
hypertrophic cartilage development, that was suggestive of CD44 receptor mediated signaling 
mechanisms.   
This study also shed light on the optimal matrix requirements, cell morphology, and 
cell-ECM interactions, for MSC-, and chondrocyte-based neocartilage generation. Early 
promotion of cell-ECM interactions, associated loss of rounded chondrocyte morphology, and 
native cell-cell interactions, impaired the development of hyaline cartilage phenotype in 
chondrocytes. In contrast, MSCs necessitated early cell-ECM, and cell-cell interactions, with 
dynamic changes in cell morphology for robust chondrogenesis. The observed differences in 
optimal matrix properties, between a MSC and chondrocyte based approach for cartilage 
regeneration, are likely to have potential implications for co-culture studies aimed at refining 
neocartilage phenotype. 
 
In all,  the hypothesis and main objectives of this study were successfully verified by the 
results obtained. Results from this study demonstrated the significant potential of biochemical 
cues in modulating the functional phenotype of chondrogenic differentiation outcomes. Such 
knowledge would aid in tailoring the optimal matrix microenvironments for MSC based 
approaches towards zonal articular cartilage repair. This study also demonstrated that IPC-
based hydrogels offered an attractive platform to engineer biomimetic hydrogels, for facilitating 






9. LIMITATIONS AND FUTURE DIRECTIONS 
 
This study established the potential of IPC-based approaches to study the influence of 
biochemical cues in improving the phenotype and tissue properties of MSC based chondrogenic 
outcomes. The limitations associated with this study are addressed and discussed in this section. 
 
The concentrations of the biochemical cues studied were kept the same, at 0.25%, to 
facilitate preliminary comparative studies, in demonstrating their potential to generate 
neocartilage tissue of varying chondrogenic phenotypes. But the complete intracellular 
mechanisms  triggered by the extracellular presentation of biochemical cues, were not studied in 
detail. Further refinement of chondrogenic outcomes could be derived by altering the initial 
concentrations of biochemical cues.  Also, other biochemical cues with relevant developmental 
and functional context, such as Col II, could be studied for aiding a robust articular cartilage 
phenotype. It is likely that different cues might exert an optimal influence at different 
concentrations, or even result in subtle differences in phenotypic outcomes. Furthermore, the 
effect of combinatorial biochemical compositions on chondrogenic outcomes is yet to be 
explored. Thus future studies should systematically investigate the dose and combinatorial 
effect of these cues in generating distinct zonal cartilage phenotypes. It could also aid in our 
understanding of the ligand-density dependent nature of underlying mechanisms in bringing 






The differences in hydrogel properties, such as changes in stiffness or viscoelasticity as 
a result of the biochemical cue incorporation in IPC hydrogels was not addressed in this study. 
There were technical challenges in sample preparation and handling for studying the 
compressive properties of IPC hydrogels which arose from the fiber assembled nature of IPC 
hydrogels causing stickiness of the materials, thus hampering the measurement of compressive 
modulus. Future studies could explore rheometer based measurements to aid in the mechanical 
characterization of IPC hydrogels. 
 
Lastly, the unique potential of the IPC-based approach is its ability to stratify the 
constitutive fibers forming the 3D hydrogel. IPC fibers with varying biochemical composition, 
and/or cellularity, could be stratified to form a composite hydrogel construct and facilitate the 
development of zone specific phenotypes in a singular 3D matrix. Challenges remain in 
ensuring the stability and integrity of such composite hydrogels, and in maintaining the 
compartmentalization of different microenvironments/zones, despite cellular remodeling. When 
successfully addressed, implantation of composite hydrogels in relevant animal model studies 
could have the potential for repairing osteochondroal defects, recapitulating the heterogeneity in 
biochemical composition and mechanical properties of native tissue. But significant challenges 
involving the acceptance and integration of implanted hydrogels  in vivo would necessitate 
elaborate studies to realize such objectives. If successful, such studies could  significantly aid in 
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Cellecell and cellematrix interactions are important events in directing stem cell chondrogenesis, which
can be promoted in matrix microenvironments presenting appropriate ligands. In this study, interfacial
polyelectrolyte complexation (IPC) based hydrogels were employed, wherein the unique formation of
submicron size ﬁbers facilitated spatial orientation of ligands within such hydrogels. The inﬂuence of
aligned, collagen type I (Col I) presentation in IPC hydrogel on chondrogenic differentiation of human
mesenchymal stem cells (MSC) was investigated. Early morphological dynamics, onset of N-cadherin/b-
catenin mediated chondrogenic induction and differentiation were compared between MSCs encapsu-
lated in IPC-Col I and IPC-control (without Col I) hydrogels, and a conventional Col I hydrogel. MSCs in
IPC-Col I hydrogel aligned and packed uniformly, resulting in enhanced cellecell interactions and cellular
condensation, facilitating superior chondrogenesis and the generation of mature hyaline neocartilage,
with notable downregulation of ﬁbrocartilaginous marker. Inhibition study using function blocking b1-
integrin antibodies reversed the aforementioned outcomes, indicating the importance of coupling
integrin mediated cellematrix interactions and N-cadherin/b-catenin mediated downstream signaling
events. This study demonstrated the signiﬁcance of oriented ligand presentation for MSC chondro-
genesis, and the importance of facilitating an orderly sequence of differentiation events, initiated by
proximal interactions between MSCs and the extracellular matrix for robust neocartilage formation.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Bone marrow derived mesenchymal stem cells (MSCs) offer an
attractive cell source for cartilage tissue engineering due to their
autologous origins, ease of extraction from bone marrow, high
proliferative capacity in vitro, and their ability to be differentiated
into chondrocytes [1e3] Yet, cartilage equivalents derived
from solely MSCs-based approaches are found to suffer from infe-
rior biochemical content and mechanical strength when compared
with native tissue properties [4,5], in many cases, resulting inram, Life Sciences Institute,
Building, #04-01, 27 Medical
.A. Wan), lsiyz@nus.edu.sg,
(E.H. Lee).
All rights reserved.functionally inferior ﬁbrocartilage formation [6]. To improve
the efﬁciency of stem cell-based tissue engineering for articular
cartilage regeneration, there are increasing efforts to develop
functionalized scaffolds that mimic aspects of the tissue microen-
vironment [7e13]. Various adhesive or biochemical cues have been
tailored into hydrogels to provide appropriate adhesive cues to
improve celleECM interactions and facilitate chondrogenic differ-
entiation and cartilage formation [9e13]. However, a signiﬁcant
shortcoming involving such hydrogels is their inability to facilitate
robust cellecell interactions, which are crucial for induction of
precartilage condensation and initiation of MSC chondrogenesis
[14,15]. Coupled with the low degradability, such hydrogels impede
differentiation associated cellular remodeling of local microenvi-
ronments [9,16,17], hampering the development of a homogenous,
neocartilage tissue in vitro [9e11]. Thus establishing a hydrogel
platform that can present appropriate biochemical microenviron-
ments in a three dimensional (3D) niche, without compromising
D. Raghothaman et al. / Biomaterials 35 (2014) 2607e26162608matrix compliance, cellular distribution and cellecell interactions
is desirable.
To this end, this study reports the use of interfacial poly-
electrolyte complexation (IPC) based ﬁbrous hydrogel, as a poten-
tial 3D cell encapsulation platform for cartilage tissue engineering.
Recent reports have shown chitinealginate based 3D IPC hydrogels
to support the proliferative and differentiation potential of encap-
sulated MSCs [18e22]. Hydrogel fabrication employing IPC tech-
nique has its merits over encapsulation of cells in conventional
hydrogels; IPC ﬁbers are formed readily under aqueous conditions
at room temperature which makes it amenable for incorporating
cells and biochemical cues [23]. Further, the unique formation of
submicron size nuclear ﬁbers, owing to the drawing of poly-
electrolyte complexes, results in unidirectional orientation of the
incorporated cues along such aligned ﬁbers within the hydrogel
(Fig. 1B, C). This offers a high degree of spatial resolution of the
biomimetic cues with respect to the encapsulated cells within each
hydrogel ﬁber (Fig. 1E, F) [18,23e25]. As mesenchymal progenitors
developing into cartilaginous tissues in vivo are known to reside in
collagen type I rich microenvironments [14,26], IPC hydrogels with
collagen type I incorporation (IPC-Col I) were fabricated to study
the effect of Col I on MSCs chondrogenesis, in comparison with IPC
hydrogel without any cues (IPC-control). A comparative analysis
between IPC-Col I and Col I hydrogels was also carried out to
appreciate the inﬂuence of aligned Col I presentation in IPC ﬁbers.
Early cell response and associated molecular events were studied,
along with functional analysis of the resulting neocartilage tissue.
2. Materials and methods
2.1. MSC culture and chondrogenic differentiation
MSCs were generated from bone marrow aspirates of consented human donors
after obtaining approval from the hospital Institutional Review Board. MSCs wereFig. 1. Fabrication of interfacial polyelectrolyte complexation (IPC) ﬁber and ﬁber assemble
the 1% water soluble chitin (WSC) and 1% sodium alginate droplets. (B) Polyelectrolyte comp
conjugated type I collagen (Col I) incorporated IPC ﬁbers showing Col I distribution. (D)
assembled hydrogel with illustration of Col I alignment on nuclear ﬁbers and cell distributio
F-actin staining (red) of the encapsulated MSCs showing cell alignment with the FITC-Col I (g
ﬁgure legend, the reader is referred to the web version of this article.)expanded in DMEM supplemented with 10% FBS and 1% (v/v) penicillinestrepto-
mycin. Chondrogenic differentiation was induced in high glucose DMEM supple-
mented with 107 M dexamethasone, 1% ITSþ premix, 50 mg/mL ascorbic acid, 1 mM
sodium pyruvate, 0.4 mM proline and 5 ng/mL of TGF-b3. MSC pellets consisting of
2.5  105 cells, formed by 200g centrifugation, served as the control to indicate the
chondrogenic efﬁcacy of the MSC samples. Cells were differentiated for a 2e3 week
period, with medium change every 3 days.
2.2. Encapsulation of MSCs in IPC hydrogel
The fabrication of IPC hydrogel by the assembly of IPC ﬁbers using 1% water
soluble chitin (WSC) and 1% sodium alginate solutions was adapted from a previous
report [24]. For ﬁber drawing, 5 ml of each polyelectrolyte solution was dispensed in
close proximity and a pipette tip was used to bring the two droplets into contact. The
ﬁber was drawn upwards at a speed of 0.3 mm/s by attaching the pipette tip to a
linear motor. For ﬁber assembly, multiple ﬁbers drawn simultaneously were fused
using 0.25% sodium alginate solution and collected on a 2-pronged spooling device
[24] and were subsequently removed from the spool and placed in the culture
medium. MSCs were suspended in the WSC solution at a density of 1 104 cells/ml.
Collagenwas incorporated into the IPC hydrogel as methylated collagen (MC) in the
polycation solution (1% WSC, 0.25% MC). MC was prepared by methylation of type I
rat tail collagen as described previously [27].
2.3. Encapsulation of MSCs in collagen hydrogel
A stock solution of rat tail collagen type I in 0.15 M of acetic acid was used to form
3D Col I hydrogels at a ﬁnal concentration of 2.5 mg/mL in 24 well Transwell in-
serts. The Col I mixture containing cells in DMEM was neutralized with 1 N NaOH,
prior to being placed in a humidiﬁed incubator at 37 C in 5% CO2 atmosphere for
gelation. The cell encapsulating density, total cell number per hydrogel, and ﬁnal
concentration of Col I concentration were kept the same as in IPC-Col I hydrogel, to
facilitate comparative studies.
2.4. Integrin inhibition studies
b1 integrin blocking studies were carried out where MSCs were pretreated
with 5 mg/mL of anti-b1 integrin antibody (BD Mab 13, 552828) in serum-free
DMEM media for 15 min. Treated cells were then resuspended in appropriate
seeding density in media supplemented with 2.5 mg/mL of anti-b1 integrin anti-
body prior to encapsulation in IPC-Col I hydrogels. Such cell-laden hydrogels wered hydrogel. (A) Schematic illustration of drawing a hydrogel ﬁber from the interface of
lexation and nucleation of IPC ﬁbers as indicated by arrows. (C) Confocal image of FITC-
Assembly of multiple ﬁbers by fusion and collection on a spooling device. (E) Fiber
n in the IPC ﬁbers (insert). (F) Confocal image of FITC-Col I incorporated IPC ﬁbers, with
reen). Nucleus was stained by DAPI. (For interpretation of the references to color in this
D. Raghothaman et al. / Biomaterials 35 (2014) 2607e2616 2609cultured in chondrogenic induction medium with the inclusion of 2.5 mg/mL of
anti-b1 integrin for a two week differentiation period. An IgG2ak antibody (BD
559073) was used as isotype control at similar concentrations. Cell viability was
assessed by LIVE/DEAD staining kit (Invitrogen, USA), following manufacturer’s
protocol.
2.5. ECM And DNA quantiﬁcation
Samples harvested were digested with 10 mg/mL of pepsin in 0.05 M acetic acid
at 4 C, followed by digestion with elastase (1 mg/mL). A Blyscan sulfated glycos-
aminoglycan (sGAG) assay kit (Biocolor Ltd., Newtownabbey, Ireland), was used
according to manufacturer’s protocol, to quantify sGAG deposition. Absorbance was
measured at 656 nm and sGAG concentration was extrapolated from a standard
curve generated using a sGAG standard. Collagen Type II content was measured
using a captured enzyme-linked immunosorbent assay (ELISA, Chondrex, Redmond,
WA). Absorbance at 490 nm was measured and the concentration of Col II was
extrapolated from a standard curve generated using a type II collagen standard.
Values for sGAG and Col II content obtained were normalized to the total DNA
content of respective samples, measured using Picogreen dsDNA assay (Molecular
Probes, OR, USA). Quadruplicates of each hydrogel group were analyzed from three
independent experiments.
2.6. Histological and immunohistochemical evaluation
Samples were ﬁxed in formalin, dehydrated, parafﬁn embedded, and cut into
sections of 5 mm. For Safranin-O staining, the sections were incubated in hema-
toxylin (SigmaeAldrich), washed and stained with fast green (SigmaeAldrich),
before staining with Safranin-O solution (AcrosOrganics). For immunohistochem-
istry, ultra vision detection kit (Thermoscientiﬁc) was used. Endogenous peroxidase
in the sections was ﬁrst blockedwith hydrogenperoxide before pepsin treatment for
20 min. Samples were treated with monoclonal antibodies of collagen type II (Clone
6B3; Chemicon Inc.) followed by incubation with biotinylated goat anti-mouse (Lab
Vision Corporation). A mouse IgG isotype (Zymed Laboratories Inc.) was used as
control for immunohistochemistry studies.
2.7. Immunoﬂuorescence studies
Samples were ﬁxed in 4% paraformaldehyde and permeabilized with 0.2% Triton
X-100 in PBS. After blocking with 5% BSA/PBS, they were incubated with primary
antibody of followed by appropriate secondary antibodies, then counterstainedwith
DAPI (Millipore). The primary antibodies used included mouse anti-collagen type II
(1:200; Clone 6B3; Chemicon Inc., Temecuela, CA), rabbit anti-sox9 (1:200; Santa
Cruz), mouse anti-N-cadherin (1:200; CloneGC-4; Sigma), rabbit anti-b-catenin
(1:1000; Cell signalling Tech). The secondary antibodies used were AlexaFluor 594
goat anti-mouse IgG (1:200), and AlexaFluor 488 goat anti-rabbit IgG (1:200). For F-
actin staining, after samples were ﬁxed, permeabilized, they were treated with
rhodamine phalloidin (1:500; Millipore) and counterstained with DAPI (Millipore),
and mounted using ﬂuoromount (SigmaeAldrich). For confocal imaging of Col I
hydrogels, samples were cryosectioned and ﬁxed with ice-cold acetone (VWR In-
ternational) at 4 C, before staining with appropriate ﬂuorophores as described
above. Images were captured using a Zeiss LSM 510 Meta confocal and Nikon AIRsi,
and analyzed using LSM image browser, Nikon elements and ImageJ. Quantiﬁcation
of ﬂuorescence signals from confocal microscopy generated images were performed
using ImageJ.
2.8. Real time PCR analysis
Samples were ﬁrst digested in 0.25% collagenase solution at 37 C for 1e2 h.
Cells were collected by centrifugation and total RNA was extracted using the
RNeasy Mini Kit (Qiagen, Valencia, CA) following the manufacturer’s protocol.
RNA concentration was determined using the NanoDrop (NanoDrop Technolo-
gies, Wilmington, DE) and reverse transcription reactions were performed with
100 ng total RNA using iScript cDNA synthesis kit (Biorad Laboratories, Her-
cules, CA). Real-time PCR reactions were conducted using the SYBR green system.
Primer set sequences used in this study are listed in Table 1. Expression of PRG-4
and CILP was analyzed with the customized Taqman probe-based geneTable 1
PCR primer sequences.
Gene Forward primer sequence Reverse primer sequence
GAPDH ATGGGGAAGGTGAAGGTCG TAAAAGCAG CCCTGGTGACC
Aggrecan ACTTCCGCTGGTCAGATGGA TCTCGTGCCAGATCATCACC
Sox9 AGTACCCGCACTTGCACAA CTCGTTCAGAAGTCT CCAGAGCTT
Col I CAGCCGCTTCACCTACAGC TTTTGTATTCAATCACTGTCTTGCC
Col II GGCAATAGCAGGTTCACGTACA CGATAACAGTCTTGCCCCACTT
Col IX CAGGATATCCAGGCCTACCA TCCCTGGTCACCTTCTTCAC
Col X CAAGGCACCATCTCCAGGAA AAAGGGTATTTGTGGCAGCATATT
COMP GGAGATCGTGCAGACAATGA GAGCTGTCCTGGTAGCCAAAexpression system (Applied Biosystems). Real Time RCR reactions using the ABI
7500 Real Time PCR System (Applied Biosystems) were performed at 95 C for
10 min, followed by 40 cycles of ampliﬁcations, consisted of denaturation step at
95 C for 15 s, and extension step at 60 C for 1 min. The level of expression of the
target gene, normalized to GAPDH, was then calculated using the 2DDCt formula
with reference to the undifferentiated MSC.
2.9. Statistical analysis
Statistical analysis (GraphPad Instat3) was done using Student’s t-test for
comparison of two groups and analysis of variance (ANOVA) with Tukey’s post hoc
analysis for comparison of multiple groups, after testing the data for normality. Data
were presented as mean  SD, with the level of signiﬁcance set at p < 0.05. All
quantitative data reported here were averaged from at least three independent
experiments.
3. Results
3.1. MSC chondrogenesis in hydrogel constructs
Striking differences in MSC behavior were observed within the
ﬁrst 24 h of encapsulation in the IPC hydrogels with and without
Col I (Movies S1 and S2). MSCs in IPC-Col I hydrogel aligned uni-
formly along the IPC ﬁbers with an elongated, ﬁbroblastic
morphology, whereas they formed small clusters within the IPC-
control ﬁbers. Analysis of mRNA expression of chondrogenic
markers, Col II, aggrecan and Sox9 at days 14 and 21 by RT-PCR
revealed that IPC hydrogels facilitated signiﬁcant upregulation of
these markers in comparison with IPC-control hydrogel, Col I
hydrogel and the control pellet culture (Fig. 2A). Macroscopic
analysis showed differences in hydrogel contraction for the three
groups of hydrogel (Fig. S1A). MSCs-laden IPC-Col I hydrogel
exhibited signiﬁcant contraction, up to 60% of its original area,
within the ﬁrst 7 days of chondrogenic induction (Fig. S1B). In
contrast, MSCs-laden IPC-control and Col I hydrogel exhibited
signiﬁcantly less amount of contraction (<20% and 40% respec-
tively) during this period.
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.biomaterials.2013.12.008.
Analysis of zonal cartilage marker expression demonstrated
that IPC-control and IPC-Col I hydrogels were inﬂuencing
phenotypic fate of the differentiated cells. Expression of super-
ﬁcial zone markers, Col I and Proteoglycan-4 (PRG-4), and middle
zone marker, cartilage intermediate layer protein (CILP), were
found to be upregulated in IPC-control hydrogel (Fig. 2A). On the
other hand, markers for matrix maturity, cartilage oligomeric
matrix protein (COMP) and collagen type IX (Col IX) were found
to be signiﬁcantly upregulated in IPC-Col I hydrogel, over that of
IPC-control and Col I hydrogels. When expression levels of the
aforementioned markers were normalized to their respective
degree of differentiation, as indicated by Col II mRNA expression
level, the phenotypic differences were maintained and more
pronounced between IPC-Col I hydrogel to that of IPC-control
and Col I hydrogel (Fig. 2B). In comparing phenotypic outcomes
between IPC-Col I and Col I hydrogels, to that of pellet culture
(Fig. 2B), the former downregulated the expression of Col I and
PRG-4, whereas no signiﬁcant differences were observed in the
expression of middle zone marker, CILP. Expression of hyper-
trophic marker collagen type X (Col X) was upregulated in IPC-
Col I hydrogel, in comparison with both IPC-control and Col I
hydrogels, suggesting early induction of hypertrophy. However,
when normalized with Col II expression, it was obvious that
expression levels of Col X were drastically suppressed when
MSCs were cultured in all hydrogels, in comparison with MSC
pellet culture (Fig. 2B). In contrast to the phenotypic differences
brought about by IPC-control and IPC-Col I hydrogels, the control
pellet culture resulted in neocartilage of inferior quality, with
lower expression levels of Col II, aggrecan, CILP, COMP and Col IX,
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Fig. 2. Expression analysis of cartilaginous genes in various hydrogel groups. (A) Real time PCR analysis of mRNA expression levels of cartilaginous genes in different hydrogel
groups and MSC pellet at days 14 and 21 of chondrogenic differentiation. Expression was normalized to their respective GAPDH expression and expressed as fold changes relative to
undifferentiated MSCs. n  4 per group, mean  SD. (B) Expression of zonal cartilage markers in different hydrogels and MSCs pellet as a function of their ratios with respective to
Col II expression. * denotes statistically signiﬁcant difference between IPC-Col I and IPC-control, Col I hydrogel, pellet at same time point. # denotes statistically signiﬁcant difference
between IPC-Col I and IPC-control, Col I hydrogel at same time point denotes. @ denotes statistically signiﬁcant difference between IPC-control and IPC-Col I at same time point.
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cartilage phenotype (Fig. 2A).3.2. Inﬂuence of Col I on cell proliferation and ECM formation in
hydrogel constructs
Cell proliferation in different hydrogels was studied by evalu-
ating the total DNA content. IPC-Col I hydrogel was found to
enhance the proliferation of chondroprogenitor cells signiﬁcantly,
in comparison with IPC-control, Col I hydrogel and pellet culture
(Fig. 3A). Quantiﬁcation of sGAG and Col II in neocartilage tissue
showed that MSCs encapsulated in IPC-Col I hydrogel deposited
signiﬁcantly higher levels of these ECM components during chon-
drogenesis, relative to IPC-control and Col I hydrogel (Fig. 3B, C). In
comparison with all hydrogel groups, the ECM content of MSC
pellet culture was the least (Fig. 3B, C), despite having similar cell
proliferation rates as that of IPC-control hydrogel (Fig. 3A), sug-
gestive of the need for 3D hydrogel culture of MSCs for efﬁcient
chondrogenic differentiation. Histological evaluation of the neo-
cartilage generated in the IPC hydrogels after 3 weeks of chon-
drogenic differentiation revealed that IPC-Col I hydrogel facilitated
superior MSC chondrogenesis in comparison with IPC-control
hydrogel. Uniform staining of cartilaginous proteoglycan compo-
nents and Col II was observed in IPC-Col I hydrogel compared to
localized staining of smaller tissue clusters in IPC-control hydrogel
(Fig. 3D). The homogenous distribution of ECM components was
indicative of the ability of IPC-Col I hydrogel to facilitate uniform
MSC differentiation throughout the entirety of the hydrogel,
resulting in a stable ECM matrix.3.3. Cellematrix and cellecell interactions in hydrogel constructs
To investigate the mechanism underlying the enhanced MSC
chondrogenesis observed in IPC-Col I hydrogel, changes in early cell
morphology were studied by F-actin staining of the MSCs at days 1,
4 and 7 under chondrogenic induction (Fig. 4A). MSCs in IPC-
control hydrogel formed small, local clusters throughout the
length of the ﬁbers by day 1, which continued to grow in size and
number throughout the course of study, with no other signiﬁcant
changes (Fig. 4A). In contrast, encapsulated MSCs in the IPC-Col I
hydrogel appeared as elongated cells exhibiting ﬁbroblastic
morphology, linearly stacked in rows. MSCs were found to be
adjacent and aligned to the incorporated Col I at day 1 (as
demonstrated by proximity of F-actin and FITC-Col I signals in
Fig. 4A). A shift from elongated to a rounded cell morphology was
seenwith the initiation of cell condensation and clustering by day 4
in IPC-Col I hydrogels. By day 7, more clustering and contraction
was seenwith remodeling of the microenvironment in IPC ﬁbers by
the encapsulated MSCs. in IPC-Col I hydrogels.
Immunoﬂuorescence analyses of N-cadherin and b-catenin
staining were carried out at days 4 and 7 to address the onset of
precartilage condensations (Fig. 4B). Stronger, cellular junction
expression of N-cadherin was detected at day 4 in the IPC-Col I
hydrogel, whereas expression of N-cadherin was only detected in
the peripheral cells of the cell clusters formed in IPC-control
hydrogel, suggestive of uniform onset of precartilage condensa-
tion in the former system. b-catenin expression was largely
membrane-bound in both the hydrogels at day 4, whereas trans-
location of b-catenin from membranous region to the cytoplasmic
space and the nucleus was observed at day 7 in the IPC-Col I
D. Raghothaman et al. / Biomaterials 35 (2014) 2607e2616 2611hydrogel (indicated by an arrow in merged image channel in
Fig. 4B). b-catenin expression in the IPC-control hydrogels
remained predominantly in themembranous regions at both days 4
and 7 (indicated by arrowheads, Fig. 4B), suggestive of a lack of
transcriptional b-catenin activation in these MSCs. The reduction of
the strong N-cadherin expression in regions of IPC-Col I ﬁbers at
day 7, could be correlated to intracellular translocation of b-catenin
(indicated by arrows in N-cadherin channel in Fig. 4B), suggestive of
progression in MSCs chondrogenesis from precondensation to
chondrogenic commitment, and activation of chondrogenic gene
expression [28,29]. Immunoﬂuorescence staining of Col II and Sox9
at days 4 and 7 provided further evidence (Fig. 4C), where IPC-Col I
hydrogel was found to induce higher deposition of Col II by the
differentiating MSCs and intensiﬁed nuclear localization of Sox9
(indicated by arrows in Fig. 4C).
A morphological study of cells undergoing chondrogenesis in
Col I hydrogel at day 4 revealed that MSCs in the periphery of the
hydrogels (Region a, Fig. 5A) displayed an elongated morphology,
with substantial cellecell interactions similar to that observed in
IPC-Col I hydrogel. In contrast, the inner regions of the Col I
hydrogel (Region b, Fig. 5A) were populated by mostly single cells,
displaying rounded morphology with minimal cellecell contacts.
Such differences in cell morphology in the peripheral and inner
regions of the Col I hydrogel were consistent from day 1 through
day 7 (Fig. S2). Expression of N-cadherin was much more pro-
nounced in the peripheral regions (Region a, Fig. 5B) in comparison
with the inner regions (Region b, Fig. 5B), indicative of non-uniform
cellecell interactions in these different regions of the Col I hydrogel.
b-catenin staining also demonstrated differences in the two regions
of the Col I hydrogel, where cells in the inner regions of the
hydrogel had a more membranous expression of b-catenin. Trans-
location of b-catenin expression from membranous to cytoplasmic
and near nuclear regions was observed in cells from the peripheral
regions of hydrogel (as shown in Region a, Fig. 5B) suggestive of
active b-catenin mediated MSCs chondrogenic differentiation inFig. 3. Cell Proliferation, ECM quantiﬁcation and histological analysis of chondrogenic outco
pellet at days 14, 21, n  4 per group, mean  SD. (B) Total sGAG and (C) Col type II conten
Histological analysis of chondrogenic outcomes in IPC hydrogels at day 21 by Safranin-O and
between IPC-Col I and IPC-control, Col I hydrogel, pellet at same time point. # denotes statis
@ denotes statistically signiﬁcant difference between IPC-Col I and pellet control, at same tthis region. This was validated by the enhanced expression of
chondrogenic markers, Col II and Sox9 in the peripheral regions
(Region a, Fig. 5C), relative to the inner regions of the Col I hydrogel
(Region b, Fig. 5C). Quantiﬁcation of Col II immunoﬂuorescence
signals in samples from these two regions (SI methods) demon-
strated signiﬁcantly higher Col II expression in the peripheral re-
gions (Fig. 5D). These studies indicated that MSCs in Col I hydrogels
did not share a uniform temporal proﬁle of chondrogenic
commitment.
3.4. Inhibition of cellematrix interaction in IPC-Col I hydrogels
As earlier studies indicated signiﬁcant differences in cell
morphology and cellecell contacts in the hydrogel groups, we
investigated the role of cellematrix interactions in MSC chondro-
genesis in the IPC-Col I hydrogel. AsMSCs are known to engage Col I
through b1 integrins [30], MSCs were treated with anti-b1 integrin
antibody before encapsulation in IPC-Col I hydrogels. MSCs pre-
treated with an isotype control antibody served as the controls.
Live/dead staining showed that cell viability was not signiﬁcantly
affected by pre-treatment with the antibodies, although cell pro-
liferation appeared to be hampered by integrin inhibition
(Fig. S3A). F-actin staining analysis showed that anti-b1 integrin
treated cells in IPC-Col I hydrogel were unable to acquire the
ﬁbroblastic morphology, neither at day 1, nor at day 7 (Fig. 6A). Cells
in the isotype control group aligned with ﬁbroblastic morphology
at day 1, and went on to condense and remodel the ﬁbers by day 7,
akin to the behavior of untreated MSCs in IPC-Col I hydrogel
(Fig. 4A). Concomitantly, a reduced degree of hydrogel contraction
was observed in anti-b1 integrin treatment group (<30%), while
contraction of the control group was in line (>45%) with that
observed in untreated MSCs IPC-Col I hydrogel (Fig. S3B). In MSCs
pre-treatedwith anti-b1 integrin, N-cadherin expressionwas found
to be abrogated at days 4 and 7 (Fig. 6B), while N-cadherin
expressionwas not affected in the control isotype group (Fig. 6B). b-mes in various hydrogel groups. (A) Total DNA content in different hydrogels and MSC
t normalized with total DNA content of the samples. n  4 per group, mean  SD. (D)
Col type II immunohistochemical staining. * denotes statistically signiﬁcant difference
tically signiﬁcant difference between Col I hydrogel and IPC-control at same time point.
ime point.
Fig. 4. Early cellular and molecular events during chondrogenic commitment of MSCs. (A) Differences in cell morphology of the encapsulated MSCs in IPC-control hydrogels and
FITC-conjugated IPC-Col I (green) hydrogels at days 1, 4 and 7, as seen by F-actin staining (red). (B) Temporal changes in expression of markers for chondrogenic condensation, N-
cadherin (green) and b-catenin (red), in IPC-control hydrogels and IPC-Col I hydrogels at day 4 and 7. (C) Expression of chondrogenic markers Col II (green) and Sox9 (red) in IPC-
control hydrogels and IPC-Col I hydrogels at day 4 and 7. Nucleus was stained by DAPI, shown in blue. (Scale bar: 50 mm.) (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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integrin-treatedMSCs in IPC-Col I hydrogel at days 4 and 7 (Fig. 6B),
while its translocation was observed at day 7 in the control isotype
group (as shown by arrow in Fig. 6B). RT-PCR analysis of the
chondrogenic outcomes in these two groups demonstrated that the
early and robust chondrogenesis in the anti-b1 integrin group was
signiﬁcantly reduced, to levels observed in IPC-control hydrogel
(Fig. 6C). In contrast, the control isotype group exhibited compa-
rable expression levels of the chondrogenic markers to that of
untreated MSCs in IPC-Col I hydrogel. Notably, the phenotypicoutcome of neocartilage generated was also reversed in the anti-b1
integrin treated group. Expression levels of Col I and PRG4 were
upregulated, while Col X, Col IX and COMP decreased signiﬁcantly,
to levels comparable with that of IPC-control hydrogel.
4. Discussion
Hydrogels are attractive biomaterials for use as scaffolds to
facilitate cartilage regeneration because of their innate hydrated
structure, biocompatibility, and ability to incorporate ECM cues.
Fig. 5. MSC morphology and early chondrogenic commitment in Col I hydrogels. (A) F-actin staining (red) of MSC in peripheral (Region a) and inner regions (Region b) of the
hydrogel at day 4 differentiation. Nucleus was stained by DAPI in blue. (B) Changes in expression and localization of N-cadherin (green) and b-catenin (red) were shown in the
peripheral (Region a) and inner regions (Region b) of the hydrogel at day 4. (C) Differences in expression of chondrogenic markers Col II (green) and sox9 (red) observed between
the peripheral (a) and inner regions (b) of the hydrogel. (D) Fluorescence quantiﬁcation of Col II expression in peripheral and inner regions of Col I hydrogel normalized to cell
number in the respective regions. * Student’s t test, p < 0.05. (Scale bar: 50 mm.) (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
D. Raghothaman et al. / Biomaterials 35 (2014) 2607e2616 2613However, most hydrogels maintain the encapsulated cells in
spherical morphology which inherently limit direct cellecell in-
teractions that are essential for early mesenchymal condensation
process and initiation of MSC chondrogenesis [14,15]. Although
enhanced MSC chondrogenesis has been observed with the provi-
sion of biochemical cues to improve cellematrix interactions, the
reported deposition of ECM by Poly (ethylene glycol) or hyaluronic
acid hydrogel-encapsulated cells was found to be restricted to the
pericellular domain, even after 6 weeks of prolonged culture [9e
11,16,17].
In this report, MSC chondrogenesis was investigated in IPC-
based 3D hydrogel ﬁbers, in the presence or absence of Col I. The
unique formation of submicron size, nuclear ﬁbers in IPC-based 3D
ﬁbers (Fig. 1) [31], and the presentation of Col I on such aligned
ﬁbers, directed uniform alignment of MSCs with an elongated,
ﬁbroblastic morphology. This resulted in extensive cellematrix and
cellecell interactions in IPC-Col I hydrogel, as early as within 24 h
post cell encapsulation (Fig. 4A). Temporal changes in cell
morphology of the encapsulated MSCs in IPC-Col I hydrogel
mimicked the sequential changes in cell morphology that are
observed during in vivo chondrogenic process [14]. IPC-Col I
hydrogel was found to facilitate an early onset of chondrogenic
differentiation (Fig. 4) and robust cartilaginous tissue formation
(Figs. 2 and 3) over that of IPC-control, Col I hydrogel and the pellet
culture control. The robustness of the neocartilage generated in the
IPC-Col I hydrogel was demonstrated by the highly upregulated
mRNA expression of COMP and Col IX (Fig. 2). This is of great sig-
niﬁcance as COMP and Col IX are implicated in matrix assembly,
maturation, and mechano-responsiveness of articular cartilage.
Both COMP and Col IX mediate enhanced collagen ﬁbril assembly
[32,33], and regulate the anchorage and organization of othermatrix macromolecules such as proteoglycans [33], which are
associated with the maturation [34]and enhanced mechanical
properties [35]of the cartilage tissues.
Signiﬁcant hydrogel contraction was observed by day 4 in IPC-
Col I hydrogel (Fig. S1), which was likely to have arisen from
MSCs undergoing precartilage condensation, where strong celle
Col I interactions caused the ﬁbers to be pulled in the direction of
contraction. MSCs in IPC-control hydrogel exhibited less hydrogel
contraction in comparison with IPC-Col I hydrogel, suggesting
relatively inferior celleECM interactions (Fig. 4A). Such obser-
vations were consistent with studies correlating the degree of
hydrogel contraction with chondrogenic differentiation [36], as
IPC-Col I hydrogel facilitated superior chondrogenic outcomes in
this study. Immunoﬂuorescence analysis of markers of pre-
cartilage condensation validated the observed hydrogel
contraction to be reﬂective of the onset and progression of pre-
cartilage condensation. Stronger and consistent expression of N-
cadherin at cell junctions was detectable in the IPC-Col I
hydrogel, followed by translocation of b-catenin from membra-
nous region to the cytoplasm and nucleus of encapsulated MSCs,
which was not detected in the IPC-control hydrogel (Fig. 4B). A
recent study involving a modiﬁed hyaluronic acid hydrogel
functionalized with N-cadherin mimetic peptides established its
signiﬁcance in regulating onset of chondrogenesis and cartilage
matrix deposition by the encapsulated MSCs [37]. Further, in
TGFb-induced chondrogenesis of human MSCs, activation of N-
cadherin expression and the accumulation of b-catenin in the
nucleus, and subsequent promotion of b-catenin activated tran-
scriptional activity, are signiﬁcantly implicated in the commit-
ment of MSCs to chondrogenic lineage [28,29,38e40]. Such
concomitant temporal activation proﬁles and localization
Fig. 6. Effect of blocking cellematrix interactions by b1-integrin inhibition on MSC chondrogenesis in IPC-Col I hydrogels. (A) Differences in MSC morphology in IPC-Col I hydrogels
treated with anti-b1 integrin and control antibody at days 1, 4 and7, as seen by F-actin staining (red). (B) Temporal changes in expression of N-cadherin (green) and b-catenin (red)
in IPC-Col I hydrogels treated with anti-b1 integrin and control antibody at day 4 and 7. Nucleus was stained by DAPI as blue. (Scale bar: 50 mm.) (C) Comparative analysis of
chondrogenic outcomes by real time PCR analysis. Samples n  4 per group, mean  SD. * denotes statistically signiﬁcant difference between untreated IPC-Col I hydrogels and IPC-
control hydrogels, b-1 integrin antibody treated IPC-Col I hydrogels at same time point. # denotes statistically signiﬁcant difference between b-1 integrin antibody treated and
control antibody treated IPC-Col I hydrogels at same time point. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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condensation underscore the efﬁcacy of chondrogenic differen-
tiation in the IPC-Col1 hydrogel, reﬂected by the heightened
nuclear localization of Sox9 (Fig. 4C), and the subsequent
enhancement in chondrogenic gene expression (Fig. 2).
The differences in spatio-temporal expression of N-Cadherin/
b-catenin during chondrogenesis in the two IPC hydrogel groups
might also account for the differential expression pattern of
cartilage phenotypic markers. We detected speciﬁc upregulation
of superﬁcial zone markers (Col I, PRG-4), and middle zone
marker (CILP) in the IPC-control hydrogel (Fig. 2). In contrastCOMP, Col IX and Col X were highly upregulated in IPC-Col I
hydrogel, whereas their expression in IPC-control hydrogel was
hardly detected. In TGFb-induced MSC chondrogenesis, involve-
ment of Smad-dependent and Smad-independent mitogen-acti-
vated protein (MAP) kinases pathways are reported [41]. Further,
substrate-dependent regulation of N-cadherin expression and
intracellular b-catenin signaling, and their cross-talk with other
pathways such as ERK1/2 or Smad2/3 was recently reported in
MSCs spheroids cultured on chitosan or chitosan grafted with
hyaluronan [42]. It is thus likely that the spatio-temporal
expression of N-Cadherin/b-catenin, brought about by the
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hydrogel, might have resulted in differential activation of intra-
cellular pathways, inﬂuencing differential expression of carti-
laginous genes.
We speculate that the early onset of elongated MSC
morphology and higher cell packing densities in IPC-Col I
hydrogel are pivotal in initiating an early and robust chondro-
genic differentiation. Activation of integrin dimers, caused by
binding of ligands such as Col I to their extracellular domains, is
known to result in the association of their cytoplasmic domains
with the actin cytoskeleton [43]. Such integrin driven changes in
cell morphology facilitate enhanced cellecell interactions,
through N-cadherin expression during condensation events.
Activation of N-cadherin to initiate cellecell junctions is also
known to be stabilized by actin cytoskeleton, to coordinate
junction development with cell movement and polarization, and
to maintain junction integrity [44]. Such actin links involve a-
and b-catenins [45,46] through a conserved region in cyto-
plasmic domains of N-cadherins, whose speciﬁc function is to
form strong actin linkages [44]. Thus it could be postulated that
the interplay of such cellular-molecular events strengthened the
role of celleECM interactions in MSC chondrogenesis. This rela-
tionship between celleECM interaction (through integrin
engagement)-driven morphological changes, and subsequent
effects on condensation and chondrogenic commitment (N-cad-
herin/b-catenin translocation), was validated by inhibiting early
celleECM interactions in IPC-Col I hydrogel by using anti-b1
integrin antibodies. Not only was the cell morphology affected,
concomitant precartilage condensation was also delayed with no
observable expression of N-cadherin even up to day 7 after
chondrogenic induction (Fig. 6A, B). Also consistent was the
reduced degree of MSCs mediated hydrogel contraction
(Fig. S3B), suggesting weaker MSC chondrogenesis, which was
validated by RT-PCR analysis showing a reduction in chondro-
genesis to levels similar to that seen in IPC-control (Fig. 6C).
Although signiﬁcant cytotoxicity was not observed with anti-b1
integrin treatment (Fig. S3A), reduced cell proliferation and celle
cell interaction dynamics were noted which could have arisen
due to inhibition of other biological functions of b1 integrins [47].
Notably, blocking integrin mediated cellematrix interaction
completely reversed the neocartilage phenotype (Fig. 6C), further
implicating celleECM driven intracellular signaling events as
phenotypic fate determinants.
The coupling of ECM mediated morphological dynamics with
cellecell interactions in the initiation of MSC chondrogenesis is
further evidenced with the cellular events in the conventional Col I
hydrogel. MSCs in Col I hydrogel did not exhibit a uniform cell
morphology, cellecell interaction, and temporal proﬁle of chon-
drogenic commitment (Fig. 5). In comparing the chondrogenic
outcomes between Col I and IPC-Col I hydrogels, in addition to
weaker chondrogenesis, expression of matrix maturation makers,
COMP and Col IX were hardly detectable in the Col I hydrogel
(Fig. 2). This outcome also correlates with less contraction observed
in Col I hydrogel during chondrogenesis (Fig. S1). Phenotypically, an
enhanced superﬁcial zone like (PRG-4), ﬁbrocartilaginous (Col I)
tissue was generated in Col I hydrogel, albeit with lesser cartilage
hypertrophy (Col X) when compared to IPC-Col I hydrogel (Fig. 2).
Given the equivalent cell seeding density and initial Col I concen-
tration in the IPC-Col I and Col I hydrogels, we speculate that the
different outcomes were likely to arise from the different presen-
tation of Col I in the two systems. IPC ﬁbers presented Col I on
aligned, submicron nuclear ﬁber [21,31] while Col I hydrogel is
reported to have a random collagen ﬁbril distribution [48], result-
ing in differential cellecell interactions in the two systems, and
consequently the extent of MSC chondrogenesis. Our resultsimplicate the need to not only create a niche biochemical micro-
environment for MSC chondrogenesis, but also the importance of
spatial orientation of the chosen biochemical cue. By facilitating
robust cellematrix interactions and achieving better cellecell in-
teractions, Col I in IPC hydrogel promoted the dynamic changes in
cellular morphology and precartilage condensation for optimal
chondrogenesis, thereby achieving a more robust chondrogenic
outcome.
5. Conclusion
In this study, we demonstrated that IPC-based ﬁbrous hydrogels
offered favorable 3D niches for facilitatingMSC chondrogenesis and
offered amechanically compliantmicroenvironment that sustained
the proliferation of the chondro-differentiated MSCs. Signiﬁcantly,
the submicron alignment of Col I in IPC hydrogels was found to
facilitate superior chondrogenesis by mediating early and uniform
cellecell interactions, resulting in generation of a mature neo-
cartilage, likely through N-cadherin/b-catenin mediated intracel-
lular signaling events. Our results demonstrate the signiﬁcance of
oriented ligand presentation for MSC chondrogenesis, and under-
score the importance of facilitating proximal interactions between
MSCs and the extracellular matrix, to drive subsequent cellular and
molecular events for robust neocartilage formation. Collectively,
these results demonstrate that IPC-based hydrogels offer an
attractive platform to engineer biomimetic hydrogels, for facili-
tating robust MSC chondrogenesis and improving functional tissue
outcomes.
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